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ABSTRACT 
Traditional forensic DNA profiling by PCR of short tandem repeats is considered a 
robust and reliable method of human identification. However, difficulties can occur 
when the starting DNA template is limited in quantity or quality. Various methods to 
improve the sensitivity of the PCR have been suggested for use with samples containing 
low levels of starting template. While these methods do allow for increasingly smaller 
amounts of DNA to be examined, stochastic sampling effects seen in the final profiles 
often make interpretation of results difficult, indicating a need for improved low 
template DNA analysis and interpretation strategies.  This project, therefore, aimed to 
investigate and develop alternative methods for analysis of samples with limited starting 
template. 
 
Initial work on this project aimed to assess the current methods of low template DNA 
analysis. The LCN method used by forensic laboratories involves dividing a low 
template DNA extract into several replicates, usually three, and generating a consensus 
profile which includes only alleles seen in two or more of the replicates. It seems 
counter-intuitive to split an already low amount of DNA into even smaller amounts and 
so, in this study, the quality of consensus profiles derived through replicate analysis of a 
low template amount of DNA split into three was compared to profiles obtained using 
that whole low template DNA extract for a single amplification. Overall, results showed 
that the consensus profile was less informative than the profile obtained using the entire 
low template sample, with increased allele and locus drop out observed with replicate 
analysis. However, by constructing a consensus profile any spurious alleles were 
eliminated from the final profile. Such additional alleles, in the form of increased stutter 
or random allele drop in, were sometimes observed in profiles from a single 
amplification. 
 
This project also examined methods to increase, in a non-exponential manner, the DNA 
template available for STR PCR analysis.  A novel Pre-PCR technique was 
investigated, where the STR region of interest was first amplified in a linear fashion so 
that a single new copy of the target was produced with each Pre-PCR cycle. The 
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resulting product was then subjected to standard PCR analysis. Results showed that 
more alleles were recovered in each profile with Pre-PCR amplification compared to 
samples amplified without the Pre-PCR procedure. Furthermore the peak height ratios 
did not differ greatly in samples with and without Pre-PCR treatment. This indicated 
that the linear amplification of the Pre-PCR was increasing the number of template 
copies available for the PCR without introducing substantial amplification bias. This 
contrasts with additional exponential amplification where there is significant increase in 
amplification bias observed. 
 
Various whole genome amplification chemistries were also examined as possible 
methods for increasing the DNA template prior to STR analysis. Modifications to the 
recommended protocols were also investigated. Results showed that a novel AT WGA 
kit amplified the DNA in the most representative fashion, with more alleles recovered 
and higher peak height ratios compared to other commercial WGA kits. Slight 
improvements were seen in the results when the AT WGA reaction was divided prior to 
amplification then pooled for STR analysis. 
 
Laser microdissection was used to collect single and small numbers of cells for STR 
PCR analysis. DNA from the cell samples was amplified using both standard and 
increased cycle PCR protocols to determine if improved results could be obtained with 
additional PCR cycles. Cells were also subjected to WGA prior to STR analysis to 
determine if further improvements could be observed. Various extraction methodologies 
were examined to determine which best disrupted the cells for WGA. Results showed 
that best results were achieved using an increased cycle PCR amplification rather than 
WGA, with a complete STR profile obtained from as few as five buccal cells using a 
34-cycle PCR. 
 
In the final study, mitochondrial DNA was analysed as an alternative to autosomal STR 
markers for forensic identification using low template DNA. Results showed that 
complete HV1 and HV2 sequences could be obtained using as little as 0.01pg to 0.1pg 
of genomic DNA. Various WGA techniques were examined, with sequencing 
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successfully performed on product obtained from all WGA kits when diluted genomic 
DNA was amplified. Laser microdissected cells were also used as starting template for 
HV1 sequencing with limited success. A complete HV1 profile was obtained from a 
single buccal cell when the sample was used directly for mtDNA sequencing. However, 
amplifying the cells with WGA prior to sequencing was largely unsuccessful. 
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CHAPTER 1 
 
INTRODUCTION AND LITERATURE REVIEW 
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1.1 Introduction 
Since its first use in a forensic setting in 1986 [1], DNA profiling has become a 
powerful investigative tool and a compelling form of evidence when presented in court.  
DNA profiling can be used to identify victims of crime, and can also link a suspect to a 
crime scene or a suspect to a victim due to its ability to provide essentially unique 
personal identification. One of the main limitations of existing forensic DNA profiling 
techniques lies in the minimum quantity and quality of DNA fragments that can be 
examined. Forensic samples may contain only small amounts of DNA or be degraded 
into small fragments. This can result in the failure of DNA profiling techniques to 
produce a profile all together, or a reduction in quality of the profile obtained. Issues 
associated with DNA profiling from low amounts of starting template, known as 
stochastic effects, make interpretation of profiles difficult [2-6]. Many forensic samples 
contain DNA from more than one person and these mixed samples are extremely 
challenging to resolve when working with low levels of DNA due to the inherent 
stochastic effects. 
 
The current methods of DNA profiling which utilise the Polymerase Chain Reaction 
(PCR) and capillary electrophoresis (CE) are extremely sensitive, allowing for highly 
discriminative DNA profiles to be obtained from as little as thirty human cells, or 
approximately two hundred picograms of DNA [7-13]. However due to the sensitivity 
of the technique there has come an increased desire to profile even smaller amounts of 
DNA, in what is termed Low Copy Number (LCN), or Low Template DNA (LTDNA) 
analysis [14].   This project aims to investigate the reliability of current methods of 
LTDNA typing and generate novel methods which can overcome the inherent issues 
associated with working with low amounts of DNA template. Much of the current 
research in LTDNA analysis is aimed at improving STR profile interpretation strategies. 
This project aims to reduce stochastic effects such that improved interpretation 
strategies are not necessary, and LTDNA profiles can be analysed in the same manner 
as conventional DNA profiles. 
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This chapter will briefly describe the biology of DNA and review the current practices 
of forensic DNA profiling.  This chapter will then give an in-depth discussion on Low 
Template DNA profiling, including the various methods used to perform the analysis, 
validation and interpretation issues, challenges to LTDNA analysis and current and 
future techniques that can be utilised to avoid the inherent issues of LTDNA typing. 
 
1.2 Biology of DNA 
Almost every cell in the human body contains genetic material inherited from both 
parents.  This genetic material, called deoxyribonucleic acid (DNA), is condensed and 
packaged into structures called chromosomes, which are found in the nucleus of the 
cell.  The fundamental units of heredity, the genes, can be found at specific 
chromosomal locations, or loci.   The human cell contains twenty-three pairs of 
chromosomes, with one member of each pair inherited from the mother, and the other 
from the father.  The twenty-third pair consists of the sex chromosomes, with females 
having a pair of X chromosomes and males having one X and one Y chromosome. 
Therefore, with the exception of X- and Y-linked genes in male cells, each cell contains 
two copies of every gene, which influence the same trait, but are not necessarily 
identical. These different versions of the same gene are called alleles. 
 
Within the chromosome, DNA forms a double helix, where two complementary strands 
join together to form a ladder-like structure. Each strand of the helix is composed of 
subunits called nucleotides, each of which consists of a deoxyribose sugar molecule, a 
phosphorous containing group and a nitrogen containing molecule called a base. There 
are four different bases that can be used to form a nucleotide: adenine (A), thymine (T), 
cytosine (C), or guanine (G). The two strands in the double helix are joined by these 
bases in a very specific manner; A can only bind to T, and C can only bind to G, in a 
relationship known as complementary base pairing.  The human genome contains 
approximately three billion base pairs, and it is the specific sequence of these base pairs 
that determines the role of the DNA molecule, coding for approximately thirty thousand 
genes. However, this coding DNA only comprises approximately two per cent of the 
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total human genome [15, 16]. The remaining ninety-eight per cent consists of non-
coding DNA, and it is this non-coding DNA that is the focus of forensic DNA analysis. 
 
Genetic variation between individuals can occur as changes to the sequence at particular 
base positions or as differences in the sequence length. Individuals are thought to have 
millions of single base changes, known as single nucleotide polymorphisms (SNPs) [15, 
16]. Such changes can include substitutions, insertions or deletions. SNPs have potential 
as forensic markers since they can give information of an individual‘s identity, lineage, 
ancestry and phenotype [17].  
 
Differences in sequence length generally occur in repeated segments of DNA. 
Approximately 50% of the human genome is made up of repetitive elements [16]. One 
class of these repetitive elements, known as simple sequence repeats (SSRs), make up 
approximately 3% of the total DNA and have shown a high degree of length 
polymorphism in the human population [16]. SSRs can be divided into two broad 
categories: minisatellites, which have a core repeat unit of 14 to 500 bases; and 
microsatellites, which have a core repeat unit of 1 to 13 bases [16].  Microsatellites, also 
called Short Tandem Repeats (STRs), are the marker of choice for current forensic 
DNA profiling practices due to their high variability between individuals and their 
ability to be amplified using the polymerase chain reaction (PCR).  
 
 
1.3 Current practices in forensic DNA profiling 
1.3.1 Polymerase Chain Reaction  
The Polymerase Chain Reaction (PCR) is a technique that allows for exponential 
copying of specific DNA sequences using only a small amount of starting material [18]. 
This is typically achieved through a precise three-step heating and cooling pattern 
(Figure 1.1).  The first step involves heating the DNA to 90-95°C so that the double 
helix denatures, leaving two single strands. The reaction temperature is then lowered to 
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between 50-70°C which allows for a short sequence of DNA, called a primer, to 
hybridise to the complementary sequence, which flanks the target region to be 
amplified. The temperature is then increased to between 70-75°C, where a thermostable 
enzyme, Taq DNA polymerase, extends the primers by adding complementary 
nucleotides to make a double stranded copy of the target sequence. Each of these three 
steps – denaturation, primer annealing and extension of the new strand – makes up one 
PCR cycle. Because the PCR replicates DNA exponentially, there can potentially be up 
to a billion copies of the target sequence from the initial DNA template after thirty PCR 
cycles.  
 
 
 
Figure 1.1 The Polymerase Chain Reaction (PCR). A precise three step heating and cooling 
pattern to allow for (1) denaturation of the double stranded DNA so that (2) primers can bind to 
the DNA flanking the target sequence. Primers are the extended by DNA polymerase (3). These 
steps make up one PCR cycle. There can potentially be up to one billion copies of the target 
sequence after 30 PCR cycles. 
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PCR is regarded as a reliable, reproducible and robust reaction, well suited for forensic 
analysis due to its ability to exponentially amplify samples with limited template quality 
and quantity. PCR is also suitable for multiplexing, where multiple loci can be 
examined in one reaction. The STR loci used for forensic human identification have 
core repeat sequences that are generally four bases in length, and these units are 
repeated a variable number of times [19]. The number of repeated segments at any 
particular locus can differ greatly between individuals, such that examination of 
multiple STR loci can identify individuals in a population with a high power of 
discrimination [19]. Just like the genes, every individual has two copies of each STR 
locus due to the maternal and paternal inheritance of chromosomes. Alleles at each 
locus can either have the same number of repeats, known as a homozygous locus, or a 
different number of repeats, known as a heterozygous locus (Figure 1.2). 
 
 
Figure 1.2 Short tandem repeat (STR) loci. The homozygous locus has two alleles with the 
same number of core repeat sequences. The heterozygous locus has two alleles with different 
numbers of core repeat sequences. Primer binding regions are constant regardless of the number 
of core repeat sequences. 
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The ability to examine multiple loci in one reaction allows for a high power of 
discrimination to be achieved with minimum sample consumption.  PCR kits, 
containing polymerase, nucleotides and primers that target multiple loci, are produced 
commercially. The reaction conditions, namely temperatures, time at each temperature, 
the number of amplification cycles and the target loci vary depending on the kit used. 
The primers in commercial kits are tagged with one of three or four different coloured 
fluorescent labels. After the PCR, the fluorescently labelled product is subject to CE 
with laser induced fluorescence detection to obtain the DNA profile. 
 
1.3.2 Post-PCR analysis 
1.3.2.1 Capillary electrophoresis 
Capillary electrophoresis is used to size separate different alleles after amplification by 
PCR [20]. DNA amplicons that are fluorescently labelled during PCR are injected into a 
capillary containing a viscous polymer. By application of an electric current, smaller, 
negatively charged DNA molecules will migrate more rapidly than larger fragments, 
such that fragments are separated by size. As the DNA fragments migrate, they are 
detected using a laser which excites the fluorescent label attached to the primers, 
causing an emission of light at a particular wavelength. The wavelength and intensity of 
the emitted fluorescence is detected by a Charge Coupled Device (CCD) panel. This 
CCD is connected to a computer system which utilises specific software to interpret the 
data to produce a DNA profile [20] (Figure 1.3). 
 
The instrument software determines the size of the fragments by recording the time 
taken for each fragment to migrate through the capillary and comparing it to internal 
size standards to determine the number of repeated segments that are in each allele [20]. 
By analysing the size of the alleles and colour of the dye detected, the software 
interprets the data and provides the locus and allele information in the form of an 
electropherogram. The intensity of the fluorescence indicates the amount of each 
amplicon present in the sample, and this is represented by the height of the peak on the 
electropherogram, measured in arbitrary Relative Fluorescence Units (RFU).  
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Figure 1.3 Sample electropherogram using the PowerPlex® ESI 16 system. This STR 
profile was obained using 500pg starting template. Boxes under the peaks display the number of 
core repeat units (top number) and the peak height in RFU (bottom number) for each allele.  
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1.3.2.2 DNA profile interpretation 
When comparing unknown evidentiary DNA profiles to known DNA profiles, results 
can fall into one of three categories: an inclusion, where the known contributor cannot 
be excluded as the source of the evidentiary item; exclusion, where the person is not the 
source of the evidence profile; or inconclusive [21]. In order to prevent potential bias in 
the profile interpretation, it is imperative that evidence samples are interpreted before 
any individual‘s reference sample [22]. Evidence can be from a single source or from 
multiple sources. Mixture samples may contain DNA from individuals at relatively 
equal amounts, or may show major and minor contributors to the profile.  
 
A number of biological artefacts can be observed in the electropherogram after PCR and 
CE, including stutter peaks, heterozygote peak imbalance, and near threshold peaks. 
These artefacts can complicate the interpretation of a profile, and therefore 
interpretation guidelines, such as minimum peak height thresholds, stutter ratios and 
minimum peak height ratios can be implemented to manage their presence in a profile. 
Such artefacts could also indicate the presence of a second contributor to the profile and 
therefore detection and interpretation thresholds and peak height ratio requirements can 
also assist with determining what constitutes a major and/or minor contributor in a 
mixed sample based [22]. 
 
1.3.2.2.1 Thresholds 
In conventional DNA analysis, minimum peak heights are established to eliminate 
instrument noise from the profile, and peaks that fall below these thresholds are not 
interpreted or interpreted with caution [23]. For STR analysis, two thresholds are often 
set. The first, known as the analytical threshold [21] or limit of detection (LOD) [24], is 
generally set at around 50 RFU and reflects the sensitivity of the CE instrument. Peaks 
that fall below this threshold may be masked by background noise created by the 
instrument [24].   
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Consequently, this threshold helps indicate a potential allele for the profile. The second 
threshold is called the stochastic threshold [21] or low template DNA threshold [24]. 
This threshold is generally set at around 150 RFU to 200 RFU and establishes the 
minimum peak height for alleles such that it can be confidently concluded all alleles at a 
locus are present and no genetic components have failed to amplify during PCR due to a 
low amount of starting template, DNA degradation or PCR inhibition [22]. 
 
Peaks above the stochastic threshold are considered true alleles, such that if only one 
peak appears in the profile and it is above the stochastic threshold, then the locus can be 
designated as homozygous and included in the statistical analysis of the profile [24]. If 
the locus appears heterozygous with two peaks present in the profile, and both are above 
the stochastic threshold, then it assumed that all alleles in the sample are accounted for 
and this locus can also be used in the statistical analysis of the profile [24]. If a single 
peak appears at a locus, and this peak falls below the stochastic threshold then the locus 
is considered to be a potential heterozygote as one allele may have failed to amplify 
during the PCR process [24].  
 
Determination of the threshold values should be based on the individual laboratory‘s 
internal validation studies [21]. If the stochastic threshold is set too high then too many 
true homozygote loci would be designated as potential heterozygotes, which would 
result in an increased number of false inclusions [24]. If it is set too low, then a locus 
could be erroneously designated as a homozygote, and this could result in a false 
exclusion, such that a suspect would fail to match the crime scene [24]. Furthermore, 
difficulties can arise if the peaks fall on or approach the determined threshold [4, 24]. 
This is particularly notable if two peaks are seen in the profile, but one is above the 
threshold, while the other is below the threshold [23].  
 
 
 
 
11 
 
1.3.3.2.2 Stutter 
Stutter product occurs as a result of slipped-strand mispairing during the PCR process 
[25]. In this process, a region of the primer-template complex becomes unpaired during 
the extension stage of PCR, allowing for slippage of either the primer or template 
strand, with one repeat unit forming a non-base-paired loop (Figure 1.4). As a 
consequence, PCR product is shorter than the actual allele by one repeat unit (n-1) [25, 
26]. Under conventional DNA profiling conditions, it can be difficult to determine 
whether a low RFU peak is a real allele from a second contributor or stutter product of 
an adjacent allele because stutter peaks are the same length as actual potential PCR 
products and are therefore seen in the same position in the electropherogram that an 
actual allele would be seen [25, 26]. 
 
Figure 1.4 A model of Slipped-Strand Mispairing. (1) DNA polymerase extends the new 
DNA strand. If the DNA polymerase falls off the template strand the extending strand can break 
apart (2). When the two strands re-anneal the template strand loops out such that the extending 
strand will be misaligned with the template strand by one repeat unit (3). The newly synthesized 
strand is therefore one repeat unit shorter than the original template (4) [26]. 
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While the peak height or area of the stutter peak is generally seen to be less than 10 to 
15 per cent of the associated allele [26, 27] it is important for laboratories to perform 
internal validation studies to establish guidelines for the interpretation of potential 
stutter peaks as conditions can vary between laboratories depending on several factors, 
including the instruments and STR kits used (Figure 1.5). If the height of a peak in the 
stutter position is greater than the determined stutter threshold then the peak should be 
considered to be an actual allele from a minor contributor [27]. 
 
 
Figure 1.5 Stutter peak in the n-1 position of the 13 allele at locus D16S539. Note that the 
peak height of the stutter peak (115 RFU) is less than the general stutter threshold of 10% of the 
true allele (1432 RFU) and would generally not be considered an actually allele. 
 
 
1.3.2.2.3 Heterozygote Peak Balance 
Under standard PCR conditions, using the optimum amount of DNA, heterozygote 
peaks at a locus should be seen at relatively equal heights (Figure 1.6). If peak heights 
at a locus are significantly imbalanced this could be indicative of a mixture sample. 
Peak height ratio requirements can therefore be used to assist in determining whether a 
sample is from a single source or multiple sources [22]. Peak height ratios are 
determined by dividing the peak height in RFU of the smaller allele at a locus with the 
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RFU value of the larger peak, then multiplying this value by 100 to express the peak 
height ratio as a percentage [21]. Peak height ratio requirements should be based on 
empirical data, and these requirements can be separate values for each locus or one 
value for all loci [22]. Typically, peak height ratio threshold values range from 60-70% 
[22]. Samples are considered to have originated from a single source if the peak height 
ratios for all heterozygous loci are above the determined threshold values, and may be 
considered to be from more than one individual if one or more loci are below the 
determined peak height ratio threshold [21]. 
 
 
 
 
Figure 1.6 Peak height balance of alleles at heterozygous locus D18S51.  Panel (1) shows 
alleles with similar peak heights – 854 RFU and 859 RFU – with a peak height ratio of 99.42%, 
indicative of a single source sample. Panel (2) shows significant peak height imbalance, with 
one peak at 85 RFU and the other at 209 RFU, giving a peak height ratio of 40.67% which 
could be indicative of a mixture sample. 
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1.4 Low template DNA analysis 
Conventional DNA typing methods using commercial STR kits are optimised for use of 
approximately 200pg to 2ng of DNA to provide robust, reliable results [7-13]. However 
by making small adjustments to the PCR process, even smaller amounts of DNA have 
been profiled [14]. In 1997, using standard PCR conditions, van Oorschot & Jones 
reported single STR profiles from touched objects, with at least 1ng of DNA being 
collected from each swabbed object [28]. Later that year Findlay et al [14] reported six-
STR locus profiling from a single human cell by increasing the number PCR cycles 
from the standard 28 to 34. In 1999 this process, known as Low Copy Number (LCN) 
DNA profiling, was implemented in the United Kingdom by the Forensic Science 
Service (FSS) [2].  
 
1.4.1 Definition of low template DNA 
Low Template DNA (LTDNA) has been variously characterised as either any technique 
used to increase the sensitivity of DNA profiling or using an amount of DNA below a 
specific level [29]. LTDNA can also be referred to as ‗touch‘ or ‗trace‘ DNA [23, 30]. 
The term LTDNA is often used interchangeably with LCN DNA, however LCN was 
coined by the FSS for the specific method of increasing the PCR cycle number to 
analyse low template DNA. There has been much debate in the literature about how to 
define LTDNA; however there is a general consensus for the definition proposed by 
Budowle et al [31] that states LTDNA is the ―analysis of results below the stochastic 
threshold for normal interpretation‖. This is usually associated with samples that 
contain a starting template of less than 100pg of DNA, or the equivalent of 
approximately 17 diploid cells [2, 3, 6, 32] 
 
1.4.2 Current methods of LTDNA analysis 
The use of LCN analysis or other methods to increase sensitivity are not widespread in 
the international forensic community. LCN was first used by the FSS in the United 
Kingdom [2]. However, with the close of the FSS in 2012, there are now only two 
commercial providers of LTDNA analysis in the UK: Orchid Cellmark Ltd and LGC 
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Forensics. A 2008 review of LTDNA analysis commissioned by the UK Forensic 
Science Regulator reported that Orchid Cellmark and LGC Forensics use a standard 28-
cycle PCR then undertake product concentration prior to optimised CE [33]. The FSS, 
who adopted the term LCN to describe their method, increased the number of PCR 
cycles from 28 to 34 using the Second Generation Multiplex Plus (SGM Plus) kit from 
Applied Biosystems [2]. This LCN method of increasing PCR cycle number has been 
used to produce DNA profiles from: single cells [14]; less than 100pg of genomic DNA 
[2]; touched objects, including doors, windows, clothing, and car steering wheels [34], 
glass, wood and metal [35] and spade and slate handles [36]; fingerprints on glass [37, 
38] and paper [39, 40]; shoe insoles [41] aged and degraded bone [42] and ancient hair 
[43]. 
 
The LCN method has been adopted by the Environmental Science and Research (ESR) 
laboratory in New Zealand [6] and the Netherlands Forensic Institute [4]. A similar 
method has been employed by the Office of the Chief Medical Examiner (OCME) in 
New York State, however this laboratory only uses 31 PCR cycles, while also reducing 
the PCR volume, increasing the annealing time and varying the CE time and voltage 
[3].  Other suggested methods for LTDNA analysis include spin column purification of 
the PCR product [44], increasing the annealing time to 20 minutes per cycle [45], 
combining an increased annealing and extension time, increased cycle number and 
reduced primer concentration [46] or increasing the capillary injection settings [47]. 
 
1.4.3 Interpretation issues associated with LTDNA analysis 
Increasing the number of PCR cycles and other LTDNA techniques as used by forensic 
laboratories can give improved results from both low copy number and degraded DNA 
samples. However, the profiles produced may be difficult to interpret and the benefits of 
increased sensitivity must be balanced against the reduction in quality seen in most 
LTDNA profiles. Common interpretation issues noted with profiles from a small 
starting template include stochastic sampling effects, issues with replicate analysis, 
difficulties in setting detection thresholds, problems with mixture analysis and 
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secondary transfer and the inability to determine the tissue source for many LTDNA 
samples.  
 
1.4.3.1 Stochastic effects 
Stochastic effects associated with LTDNA analysis have been well documented [2, 3, 5, 
6, 23, 33] and are considered part of the normal results [48]. Effects such as 
heterozygote peak imbalance, allele and locus dropout, increased stutter height and 
allele drop in have been noted in LTDNA profiles since the LCN technique was first 
proposed by Findlay et al [14]. Such effects can lead to a reduced profile quality, 
making the profile problematic to interpret (Figure 1.7). Stochastic effects are 
particularly problematic since many LTDNA samples contain DNA from more than one 
individual. 
 
1.4.3.1.1 Peak height imbalance and drop out 
When sufficient starting template is present both alleles are generally amplified in equal 
amounts by the PCR. However, due to the kinetics of the PCR process, when sampling 
from a low amount of starting template, primers may not bind to both alleles at a locus 
in equal amounts, so that one allele may be preferentially amplified over the other [23]. 
This can be seen in the electropherogram as a significant height difference between the 
peaks of a heterozygote locus. This can cause problems in the interpretation of a profile 
because significant heterozygote peak height imbalance is generally a feature of a 
mixture in a conventional profile, while this feature is typical of LCN profiles [31]. 
 
In extreme cases of heterozygote peak imbalance, one allele may fail to amplify 
altogether, resulting in allele dropout [23]. This can be problematic for the interpretation 
of a profile as the remaining peak may be falsely designated as a homozygote, which 
could potentially lead to an adventitious match, or a false exclusion of the true source of 
the sample [23]. In some cases both alleles may fail to amplify, known as locus dropout 
[23].  A study by Alessandrini et al [35] found that locus drop out was mainly seen in 
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loci with larger amplicon sizes (300-400bp), while allele dropout is seen at 
approximately the same levels in all loci. 
 
1.4.3.1.2 Stutter 
Another stochastic sampling effect that can make STR profiles difficult to interpret is 
the increased height of stutter peaks [23]. Under standard amplification conditions, the 
peak height or area of the stutter peak is generally less than 10 to 15 per cent of the 
associated allele [26, 27]. However when examining low levels of DNA, the height of 
stutter peaks has been shown to increase, such that the stutter peak can be as high, or 
higher than the actual allele [3]. This could result in the stutter peak being mistaken for 
an actual allele, which could in turn result in an adventitious match or a false exclusion 
of the source of the sample [23].  
 
1.4.3.1.3 Allele drop in and contamination 
Due to the sensitivity of the PCR process, low levels of contaminating DNA may be 
amplified resulting in additional alleles seen in the profiles. This can either be allele 
drop in, which has been defined as occasional independent allelic events, or gross 
contamination, which originates from a single unknown individual that is unrelated to 
the crime event [30]. This contamination may be from laboratory personnel, low level 
DNA in reagents and consumables, sample to sample cross contamination, background 
contamination at a crime scene or contamination during evidence collection and 
handling [23]. Contamination is especially problematic when profiling from LTDNA, as 
methods used to increase sensitivity, such as increasing the cycle number to 34 or 
increasing the CE injection settings, also increase the amplification of spurious alleles 
that would previously not amplify to that level [35, 38, 47, 49]. In some instances the 
spurious alleles may be preferentially amplified over the correct alleles giving rise to a 
false genotype or a mixture profile that masks the true profile [35]. This can be 
particularly problematic if allele drop out occurs in conjunction with allele drop in, 
especially if the peak height of the accessory allele has reached that of the true allele, 
and can result in an incorrect assignment being made [35].  
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1.4.3.2 Replicate analysis 
Regardless of the process used to improve LTDNA profiling, stochastic effects such as 
allele drop out, allele drop in and heterozygote peak imbalance are expected to occur 
[50]. To accommodate this, current LTDNA analysis has implemented interpretation 
strategies to minimize the risk associated with the lack of reproducibility and stochastic 
effects seen in LTDNA profiles [48]. The number of attempts to genotype a low 
template sample is limited by the sample size [32]. Consequently when endeavouring to 
profile potential LTDNA samples, the entire evidence sample is generally consumed in 
the DNA extraction process. Therefore in order to create the impression of repeatability 
Gill et al [2] recommended a duplicate analysis approach, where a DNA extract is split 
into two or more aliquots and only alleles seen at least twice in the replicate profiles are 
admitted to the final DNA profile. This method, referred to as the ‗Biological Model‘ 
[2], was adopted to accommodate the inherent stochastic effects of LCN DNA typing. 
The underlying premise of this method is that observing alleles more than once 
increases the confidence that an allele is a ‗true‘ allele, assuming that contamination is 
not inherent in the sample [23]. This biological model is particularly useful for the 
elimination of non-repeating spurious alleles that appear in a profile as a result of allele 
drop in [2-6].  
 
Petricevic et al [6] describes the method used by the ESR, whereby samples are 
amplified in duplicate and only alleles seen in both replicates included in the consensus 
profile. This is similar to the original FSS method, where the sample was initially split 
into three aliquots, but PCR and CE is only performed on two of the aliquots. The third 
aliquot was stored in the event that further testing becomes necessary [51]. In the FSS 
method, alleles at a locus had to be seen in both replicates in order to be included in the 
final profile [2]. The OCME in New York State and the Netherlands Forensic Institute 
have similar interpretation strategies to the FSS. However, in these laboratories all three 
aliquots are amplified [3, 4]. The NFI interpretation method involves using alleles that 
are detected in two or three of the replicates to form the consensus profile [4]. At the 
OCME, for heterozygous loci all alleles seen in at least two of the three replicates are 
included in the consensus profile. For a homozygous locus, the allele must appear in all 
three replicates [3]. Other methods of replicate analysis, such as dividing the sample 
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into four aliquots and including alleles seen in two of the replicates [14, 52], generating 
a composite profile that includes all alleles seen in the replicate profiles [53] or pooling 
the sample aliquots post-PCR for a single CE injection, [3, 52] have been suggested as 
possible alternatives to the original biological model. 
 
A validation study of the OCME interpretation standards reported one hundred per cent 
correct allelic assignments over one hundred and seven non-probative case work 
samples and three hundred and nineteen forensic case work samples [3]. However this 
does not mean that a full profile was obtained for these samples, just that none of the 
alleles that were designated were different to reference profiles.  Gill and Buckleton 
[54] concede that the use of replicates and the consensus strategy will not necessarily 
produce complete genotypes. 
 
As stated by Budowle et al [31], reproducibility is invoked by requiring alleles to be 
present in multiple amplifications of the same sample. However, this generally involves 
diluting the samples, and diluting rather than concentrating a sample is ―contrary to 
current effective practices‖ [31].  Therefore, while these replication and interpretation 
strategies are intended to minimize the risk involved in LTDNA analysis, Budowle, 
Eisenberg and van Daal [23] argue that splitting an already small sample into multiple 
aliquots would increase the stochastic effects seen in LTDNA profiles because fewer 
template molecules are subject to the PCR process in each reaction. As a consequence, 
differences are often noted in replicates of the same sample [4, 48, 54]. While Gill et al 
[2] state that the collation of results from replicates to produce a consensus profiles is a 
―demonstration of reproducibility‖, Buckleton [48] states that reproducibility is lost at 
low levels and it is expected that one replicate at LTDNA levels will vary from another; 
profiles from replicates will be broadly similar but alleles present in one replicate may 
be smaller or not present in another replicate. Gill and Buckleton [54] further state that 
reproducibility cannot be expected for replicate profiles, although results may still be 
reliable. Consequently, Gill and Buckleton [54] state it is not the existence of 
variability, but rather the magnitude and potential consequences of any variability that 
needs to be assessed and reported to the court, and it is then the court‘s responsibility to 
decide what weight to place on the evidence.  
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Budowle, Eisenberg and van Daal [23] suggest that efforts should be made to 
concentrate LTDNA samples rather than diluting and splitting for replicate analysis, as 
―common sense dictates that splitting a sample into multiple aliquots exacerbates the 
limitations of LCN typing‖. Alessandrini et al [35] state that performing replications of 
the PCR amplification from a LTDNA sample in order to obtain a consensus profile is 
difficult to apply in casework as the entire extract needs to be used to attempt positive 
results.  However Buckleton [48] states that stochastic effects are expected even from a 
non-replicated sample. Gill et al [2] further state that it is still preferable to carry out 
duplicate analysis rather than concentrate a sample, as this did not usually increase the 
overall concentration of DNA above the stochastic threshold. However work from this 
project has shown that the most informative profile is gained by a single amplification 
with the entire extract [55]. 
 
Despite the issues surrounding consensus profiling, this redundancy approach is the 
primary method for LTDNA profile interpretation, with all laboratories conducting 
LTDNA analysis performing some form of replicate analysis, either duplicate or 
triplicate [23]. However, statistical tools are being developed that may accommodate 
issues such as drop in and drop out. [56-61]. If the statistical programs can incorporate 
these stochastic issues into the model, the evidence could be maximized by applying 
these tools to the DNA profile that contains the most information with the proper 
uncertainty/confidence associated. Such statistical tools have been implemented into 
some laboratories, but are generally still in the early days of development and validation 
and are not widespread in the forensic community.  
 
1.4.3.3 Detection thresholds 
Budowle, Eisenberg and van Daal [23] question the reliability of thresholds for LTDNA 
samples. Under standard PCR conditions LTDNA peak heights would normally fall 
below the stochastic threshold. However, efforts to increase the sensitivity of the 
reaction, such as increasing the PCR cycle number, can increase the peak height 
substantially so alleles can meet or exceed the established threshold for STR typing. 
Therefore peaks that do meet or exceed the threshold after manipulation do not 
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necessarily indicate a reliable result, since these thresholds were established using 
different conditions to LTDNA analysis techniques [23]. Since there is currently no 
purported way to establish a LTDNA typing threshold this will continue to be a 
weakness of the application [23]. 
 
Gill and Buckleton [30] state that thresholds cannot be set for low template samples, as 
the underlying model is continuous, such that there is no set point where it is absolutely 
certain that all events will be captured.  Buckleton [48] further comments on the notion 
of arbitrary thresholds being imposed on continuous scales, stating, ―the concept that all 
is good above the threshold and below it all is bad, is false, and laced with traps into 
which the adversarial process could lead discussion‖. 
 
1.4.3.4 Mixture interpretation 
Difficulties can arise in the interpretation of LTDNA profiles that appear to contain 
DNA from more than one source [2-4, 22, 23, 35, 49, 62-65]. Indeed, stochastic 
variation is most problematic for mixture samples. Issues such as ADO and peak height 
imbalance, combined with the possibility of allele sharing, can make determining the 
number or contributors or source of the contributions difficult. Many LTDNA samples 
are touch samples, therefore low levels of DNA from background contamination can be 
mixed with an evidence sample. There are currently no well developed guidelines for 
the analysis of such mixture profiles [22, 23]. However, many of the software programs 
currently being developed have incorporated statistical methodologies for mixture 
interpretation [57-59].  
 
In conventional DNA profiles, features that are indicative of a mixture, such as three or 
more alleles at a locus or significant peak height imbalance, are typical features of an 
LTDNA profile [31]. In LTDNA profiles, more than two alleles at a locus could be 
allele drop in or a stutter peak that has been increased in height by the measures used to 
increase the sensitivity of the reaction [23]. Furthermore, heterozygote peak imbalance 
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is a common feature of profiles obtained from a low starting template amount due to 
preferential amplification of particular alleles [23].  
 
LTDNA profiling is frequently more complicated when the alleles from the major 
contributor to a profile are above the stochastic threshold for interpretation and the 
alleles from the minor contributor are below the stochastic threshold [30, 49].  
Furthermore, due to the increased risk of contamination and the ease at which secondary 
and tertiary transfer of genetic material can occur at LTDNA levels, it can be 
challenging to determine which, if any, of the profiles are relevant to the investigation 
[28, 30, 35, 39]  
 
1.4.3.5 Secondary transfer 
In one of the first studies to examine the possibility of obtaining DNA profiles from 
fingerprints, Van Oorschot and Jones [28] found that DNA could be transferred from 
objects to the hands of the next person to hold the object.  Furthermore, objects that had 
been handled by many people all produced profiles with multiple alleles of varying 
intensity. Although DNA from the last holder of the object was usually present, their 
profile was not always the strongest one detected [28]. Balogh et al [40] found similar 
results in their study of DNA profiling from touched paper, such that conclusions could 
not be drawn on the number of donors involved in a mixture stain on the basis of allele 
quantity, and the strongest profile obtained was not always from the person who last 
touched the object. This shows that trace DNA recovered from a crime scene may not 
be associated with the forensic event in question. If a mixture profile is obtained it may 
not be possible to determine whether the mixed stain occurred from mixing of 
biological samples during an alleged crime, or even if DNA was deposited at the same 
time [30, 35]. Therefore, as stated by Alessandrini et al [35] ―the possible contemporary 
presence of artefacts derived from amplification of LCN DNA recovered from 
fingerprints left on objects from multiple handlers means use of multiple allele profiles 
is problematic, even when proposed rules for interpretation of mixed profiles are 
observed‖. 
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1.4.3.6 Tissue of origin determination 
Information regarding the tissue of origin for LTDNA samples can be of great 
importance in reconstructing the crime event in question. At present, tissue of origin 
determination for LTDNA samples is not possible. Most of the currently used 
presumptive and confirmatory tests for tissue identification are based on protein 
analysis, and involve enzymatic or immunological assays [17]. However, many 
presumptive tests have low specificity and sensitivity while many confirmatory tests are 
laborious and can consume much of the evidence sample [17]. Furthermore, 
confirmatory tests for some commonly encountered forensic tissue samples, such as 
saliva or vaginal secretions, are not available, [17].  Alternatives to the current protein 
assays, such as mRNA [66, 67] and microRNA analysis [68] or DNA methylation 
studies [68] are being investigated. Advantages of these methods over traditional 
presumptive and confirmatory test include increase specificity, faster analysis times and 
reduced sample consumption. Also, since these methods use PCR based techniques they 
could be integrated easily into the current forensic DNA workflow. 
 
1.4.4 Challenges to LTDNA analysis 
Since its introduction in 1999, there was limited challenge to the use of the LCN 
technique for legal purposes until the Omagh Bombing trial in 2007. In this case, the 
trial judge, Justice Weir, expressed concerns in relation to the handling and preservation 
of the DNA evidence and of the scientific validity of the 34 PCR-cycle LCN DNA 
profiling technique  [33]. Questions were also raised about whether the LCN process 
had been properly validated both internally and externally, with Justice Weir stating, 
―The absence of an agreed protocol for the validation of scientific techniques prior to 
their being admitted in court is entirely unsatisfactory‖ [70]. This resulted in a brief 
suspension of LCN profiling and prompted the UK‘s Forensic Science Regulator to 
commission a review of LTDNA analysis [71].  
 
The review acknowledged that the failure rates for LTDNA analysis were high and that 
LTDNA profiling had not yet achieved legal and scientific consensus, reflecting the 
challenging nature of analysis [33]. The review also set out twenty-one 
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recommendations for improvement of LTDNA analysis. These recommendations 
included improving education and training for police and crime scene offices on 
collection and storage of LTDNA samples and training and competency standards for 
LTDNA analysts in the laboratory. The review also recommended that all samples 
submitted to the criminal justice system be quantified and that national standards should 
be developed for LTDNA profiles in regards to extraction and quantification of DNA 
and interpretation of stochastic effects, mixtures and partial or contaminated profiles 
[33]. Despite the numerous recommendations, the review ultimately concluded that "the 
science supporting the delivery of Low Template DNA (LTDNA) analysis is sound" 
and the companies providing the service have "validated their process in accord with 
accepted scientific principals" [33].  
 
Critics of the review argue that while LTDNA analysis may have investigative value the 
process is not ready for use as evidence in court due to the associated stochastic effects 
[23, 71-73].  Both Gilder et al [72] and Jamieson and Bader [73] state the conclusions of 
the Caddy report are inconsistent with the recommendations, and that ―superficial 
characterisations such as ‗robust‘ and ‗fit for purpose‘ are a denial of the serious 
scientific questions that remain about the reliability and validity of LCN testing‖ [72].  
Budowle, Eisenberg and van Daal [23] argue that because the LCN assay is not 
reproducible it cannot be considered robust by conventional standards. They also state 
that LCN is currently only appropriate for identifying missing persons and human 
remains and developing investigative leads, and caution should be taken if using this 
technique for other endeavours such as criminal proceedings [23].  Jamieson and Bader 
[73] suggest the lack of widespread scientific support for the LCN technique shows that 
it is not internationally recognised as valid or reliable.  According to Gilder et al [72] 
this lack of consensus and the availability of alternatives to LTDNA analysis, such as 
miniSTRs [74-76] and mitochondrial DNA analysis, means that it is unlikely that LCN 
based STR testing will be embraced by crime labs in the United States. A 2004 survey 
of forensic service providers in Australia and New Zealand [77] revealed that most 
Australian laboratories did not allow variation to the standard PCR protocol, regardless 
of whether the sample being analysed would be considered LTDNA or conventional. 
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Budowle et al [31] state that before LCN typing is undertaken, limitations of analysis 
should be disclosed to all involved, including other laboratory personnel, supervisors, 
police, lawyers, the court and the public. Gill and Buckleton [54] support this call for 
caution and attention to potential bias, but state that ―if due care is taken and the court is 
candidly appraised of the limitations of the technique then it is the court‘s purpose to 
weigh the strength of the evidence‖ and it is not the role of the scientist to act as a 
gatekeeper to decide whether evidence should or should not be reported.   
 
Gill and Buckleton [54] also state that the relevance of the evidence was the true cause 
of confusion in the Omagh trial, not the process of achieving and interpreting the 
profile. The presence of trace DNA in the form of non-discrete samples such as body 
fluid stains or cellular debris may not indicate the originating tissue source or how it 
became evidential; however it is only for the scientist to consider if this DNA is from 
the suspect or a random man, not whether it was deposited during the commission of a 
crime or through other deliberate or inadvertent transfer [54]. Gilder el al [72] argue that 
the inability to discern the tissue source of DNA or how long DNA has been associated 
with an article can significantly reduce the weight that can be attached to the findings of 
a LTDNA profile match. In contrast Gill & Buckleton [54] state that not knowing the 
mode of transfer does not invalidate the profile result as long as it is correctly 
interpreted. However no agreement exists on how the results of LTDNA profiles should 
be interpreted [72, 73]. As stated by Linacre [50], ―While a consensus of agreement and 
acceptance may be achieved, it is unlikely that a new methodology will gain absolute 
acceptance by all. It is also important to allow new techniques to be introduced into the 
criminal justice system and to encourage research‖.  McCartney [71] warns that flawed 
or misinterpreted science can lead to miscarriages of justice and the court need to take 
precautions against admitting unreliable scientific evidence stating, ―there remains an 
important difference between what can be reported in scientific literature and what 
should be used as evidence‖.  
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1.4.5 Methods to improve LTDNA analysis 
Budowle & van Daal [17] suggest that rather than splitting the sample, research should 
concentrate on methods that reduce stochastic effects and increase the efficiency of the 
PCR process, such that LTDNA samples produce comparable profile results to 
conventional DNA samples.  Methods can include making changes to the current STR 
practices such as: use of laser microdissection (LMD) to isolate single cells; and 
increasing the quantity of the sample before PCR using whole genome amplification 
(WGA). Examination of low template samples could also be undertaken using 
alternatives to STR typing such as mitochondrial DNA (mtDNA) analysis. 
 
1.4.5.1 Changes to current short tandem repeat practices 
1.4.5.1.1 Laser microdissection 
Laser Microdissection (LMD), also called Laser Capture Microdissection, is a technique 
for isolating highly pure cell populations through the direct visualisation of cells [78-
83].  Various LMD platforms exist that differ in cell separation and capture processes.  
Infrared capture systems involve the transfer of laser energy to a thermolabile polymer, 
such that the polymer melts to the selected cells to form a polymer-cell composite. 
Removal of the polymer from the tissue surface shears the embedded cells of interest 
away from the tissue section [78]. UV cutting systems involve the volatilization of cells 
surrounding a selected area followed by either catapulting or gravity to collect the cells 
of interest [78]. 
 
The ability to separate individual cells from a sample is of particular interest for forensic 
analysis. Mixtures of body fluids from different individuals or samples with small 
amounts of cells are common occurrences in forensic casework [79, 82]. LMD has been 
used to separate sperm cells from epithelial cells for application in sexual assault 
casework [79, 84, 85] as well as separating chorionic villi from the maternal component 
of products of conception for forensic paternity testing [80, 83]. LMD has also been 
used to separate blood and buccal cells from mixtures [81], non-sperm male cells from 
mixtures [86, 87] and the lower follicle from telogen hair [82]. 
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STR analysis of LMD cells found that a full forensic DNA profile could be obtained 
from 15 to 25 epithelial cells or 30 to 50 sperm cells under standard 28-cycle PCR 
conditions [88-90]. Increasing the PCR cycle number to 33 or 30 cycles allowed for 
complete DNA profiles to be obtained from 10 or 15 epithelial cells respectively [91, 
92]. Applying WGA to LMD isolated cells prior to forensic STR analysis has also been 
attempted [93]. With prior WGA, a complete DNA profile could be obtained from as 
little as 5 buccal cells [93]. However this result was not consistent, with the majority of 
5 and 10 cell samples and half of the 20 cells samples showing some measure of allele 
drop out in the STR profile [93]. WGA of LMD isolated single or small numbers of 
cells has also been demonstrated in other fields such as medical and cancer genetics and 
these results show promise for forensic applications [94-96]. 
 
1.4.5.1.2 Whole genome amplification 
WGA has been proposed as a promising method for increasing the template copy 
number of limited quantity DNA samples prior to traditional DNA profiling [17].  
Theoretically, WGA should be capable of copying all of the DNA in a representative 
fashion to produce large quantities of product for standard forensic analysis [17]. 
Several methods of WGA have been investigated for their ability to amplify genetic 
material in an unbiased fashion using various amounts of starting template.  
 
Early WGA methods used PCR to amplify the template DNA. Methods include the 
Primer Extension PCR (PEP) [97], Degenerate Oligonucleotide Primed PCR (DOP-
PCR) [98], Tagged PCR (T-PCR) [99] and inter-Alu-PCR [100]. These techniques 
utilize random, partially degenerate, tagged random and Alu-based primers respectively 
and Taq DNA polymerase to amplify the genomic DNA [97-100]. Each of these 
methods has been used to amplify the genomic DNA from single and small numbers of 
sperm [98], blastomeres [101-103], and buccal cells [101], as well as various 
concentrations of diluted genomic DNA [99, 104, 105].  In all cases some amount of 
amplification failure in the downstream analysis was observed [101-105]. However, 
PEP and DOP were shown to produce the most complete coverage for microsatellite 
analysis compared to other PCR-based techniques [101]. Advancements to the PEP and 
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DOP-PCR methods have been introduced, with the Improved PEP (I-PEP) [105, 106], 
Modified I-PEP, (mI-PEP) [106] and LL-DOP-PCR (long products from low templates) 
[105, 107] all showing increased reaction efficiency compared to the traditional PEP 
and DOP-PCR methods.  
 
Overall the PCR-based WGA methods have shown some success with downstream PCR 
and microsatellite analysis [97, 101, 102, 104-108]. However, these WGA procedures 
generally result in DNA fragments of less than 1 kb long [97, 98, 104] which could 
affect the success of forensic DNA profiling methods. The PCR-based techniques are 
also thought to produce large amounts of non-specific amplification product [104]. 
Additionally, PCR-based WGA has been shown to increase the incidence of -4 and +4 
stutter [101, 108] which could further complicate DNA profile interpretation.  
 
An alternative WGA method, termed Multiple Displacement Amplification (MDA), has 
been shown to produce higher yields [109-113] and improved genome coverage [108, 
111, 113-115] compared to PCR based methods. MDA uses random hexamer primers 
and DNA polymerase from the bacteriophage φ29 to amplify linear DNA in an 
isothermal reaction, without the need for thermal cycling [116, 117]. The φ29 DNA 
polymerase has extremely tight binding to the DNA resulting in high processivity of the 
enzyme (approximately 2400 base pairs per minute) and 3‘ to 5‘ exonuclease activity 
for improved replication accuracy [118].   Furthermore, the use of exonuclease resistant 
primers allows for high DNA yields [117]. The random primers and φ29 DNA 
polymerase bind at multiple sites throughout the denatured DNA where new strands are 
synthesised. When one polymerase reaches a double strand DNA, such as that caused 
by adjacent φ29 DNA polymerase, it displaces the newly formed strand to continue 
extension. The random primers and φ29 DNA polymerase can then bind to the 
displaced strands where extensions of these primers form a hyperbranched DNA 
structure [117] (Figure 1.8).  
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MDA followed by STR analysis of single or small amounts of human cells has been 
reported, however all state that stochastic effects associated with LTDNA are still 
observed [119-123]. All report various levels of allele drop out, with the average 
number of correct loci observed per profile ranging between 53% and 80% [119, 122, 
123]. Heterozygote peak imbalance was also noted in the resulting STR profiles 
obtained from the MDA product of single cells [119-123]. However, such phenomenon 
were reported to decrease when observing 2-5 cells and profiles obtained from WGA of 
10 or 20 cells were comparable to profiles from conventional levels of genomic DNA 
[119]. 
 
 
 
Figure 1.8 Whole genome amplification by Multiple Displacement Amplification. (1) 
Random hexamer primers bind to denatured DNA. (2) Phi29 polymerase extends the primers to 
form double stranded DNA. (3) Phi29 displaces the DNA to continue the extension of the 
strand, as hexamer primers bind the newly formed DNA. (4) The extension of the primers on 
the new strands form hyperbranched DNA. Image modified from [114]. 
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STR profiling following MDA of DNA diluted to LTDNA amounts has also been 
investigated [115, 124, 125]. For each case, allele drop out was observed in the STR 
profile when less than 1ng [115], 500pg [125] or 250pg [126] was used as the starting 
template. Despite this, results showed that the profiling success of LTDNA increased 
with MDA, with one study reporting an average of 7 more alleles being observed in 
WGA samples than non WGA samples from 10pg of starting template [115].  However, 
none of the LTDNA samples, with or without WGA, produced STR profiles that had all 
alleles present [115]. Peak height imbalance, stutter and allele dropout were also 
observed in many samples [115, 125, 126]. A direct comparison of 28-cycle STR 
profiling from MDA of LTDNA obtained from fingerprints with 34-cycle STR profiling 
of the unamplified low level sample has been performed, with results showing that the 
median number of correct alleles detected from a 34 cycle PCR was 80% higher than 
WGA samples [126]. 
 
Methods for reducing the preferential amplification in the MDA reaction have been 
investigated. Such methods include the addition of molecular crowding agents to the 
MDA reaction [127, 128] combining MDA reactions of denatured and non-denatured 
DNA [129] and designing novel primers [130]. Of these methods, only the molecular 
crowding technique was assessed using LTDNA as the template for WGA. While the 
molecular crowding did improve the MDA efficiency compared to MDA without 
crowding, none of the MDA methods with or without crowding were able to 
consistently produce complete STR profiles when the starting template was less than 
500pg [127].Of the other two mentioned methods, both were investigated using large 
amounts of DNA (more than 50ng) as the WGA template. However both reported 
reduced amplification bias compared to control samples [129, 130].  
 
These studies indicate that currently, WGA using MDA can be successful when 
working with as little as 10 whole cells, however when observing either low levels of 
diluted genomic DNA or mock casework samples such as fingerprints, the stochastic 
effects are still amplified and the quality of the STR DNA profile can be reduced.  
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1.4.5.2 Alternatives to short tandem repeat analysis 
1.4.5.2.1 Mitochondrial DNA analysis 
The mitochondrial genome is a circular molecule consisting of 16569 base pairs. The 
mitochondrial DNA (mtDNA) contains a coding region, which includes sequences for 
two ribosomal RNAs, 22 transfer RNAs and 13 proteins, and a 1100bp non-coding or 
control region, also known as the Displacement loop (D-loop) [131]. This control region 
is of particular interest for forensic analysis as it contains two hypervariable regions, 
HV1 and HV2. These regions have been shown to rapidly evolve allowing for variation 
between individuals that can be detected through DNA sequencing for identification 
purposes [132]. The mitochondrial genome was originally sequenced by Anderson et al 
[133] and this Anderson Sequence or Cambridge Reference Sequence is, with some 
slight modification [134], used as a reference for which all mtDNA sequences are 
compared. 
 
Mitochondrial DNA sequencing is routinely used in forensic analysis to help identify 
biological samples when the nuclear DNA template amount is too low or too degraded 
for conventional STR analysis. Each cell can potentially contain hundreds to thousands 
of copies of the mtDNA [135], which is significantly greater than the nuclear DNA of 
which there are only two copies per cell. Consequently, mtDNA assays are more 
sensitive, allowing for examination of samples that are typically unsuitable for 
traditional DNA profiling. The circular structure of mtDNA may also protect it from 
degradation, further increasing the likelihood of obtaining a result when autosomal STR 
typing is problematic [136]. Various sample types have been used for mtDNA 
sequencing, including bone [132, 137-141], skin [137], hair [140, 142-146], teeth [140, 
141, 147], blood [139, 144, 146], fingernails [140, 146], saliva [140, 143, 148] and 
faeces [149], as well as numerous forensic samples such as earrings, toothbrushes, q-
tips, drinking glass rims, chewing gum, razors and cigarette butts [146].  
 
The increased sensitivity of mtDNA analysis has raised concerns regarding the ease of 
which contamination could occur [150, 151]. Strict anti-contamination practices must 
therefore be observed. Such practices can include, but are not limited to: dedicated 
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laboratories; use disposable gloves, caps and gowns; separation of pre- and post-PCR 
work areas; regular UV irradiation of equipment and; extraction and amplification of 
evidence prior to reference examination [151].  
 
Another key issue that must be considered when analysing mtDNA is the inheritance 
pattern of the mitochondrial genome. Mitochondria are inherited from the mother as a 
single haplotype, with paternal mitochondria destroyed early in the embryogenesis 
process [152, 153]. As such any maternal relatives would, barring mutation, have the 
same mtDNA sequence. This has both positive and negative consequences for forensic 
analysis. The ability to confirm identify through any maternal relative when direct 
comparison cannot be made can be of great benefit, especially in cases of missing 
persons and mass disaster identification [132, 154-156]. However, in the identification 
of unknown samples collected from crime scenes, the fact that there are potentially 
many common HV1/HV2 types can significantly lower the mtDNA power of 
discrimination compared to traditional STR profiles [156].  Furthermore, since mtDNA 
is essentially inherited as a single locus, statistical analysis to determine the frequency 
of an mtDNA type in a population is often limited to the ―counting method‖, where the 
number of times a particular type has been observed in various databases is presented 
[131, 150, 154]. Confidence intervals and likelihood ratios have also been applied to 
help evaluate the strength of mtDNA evidence [155]. 
 
Consideration must also be given to the fact that sequencing does not allow for the 
resolution of mixture samples, which is particularly disadvantageous for LTDNA 
samples as many contain DNA from more than one individual [157]. This can also be 
further complicated by the presence of heteroplasmy, a situation where more than one 
mtDNA type is present in a single individual [150, 151]. Both length and sequence 
heteroplasmy have been observed, and can occur in three ways: 1. Individuals may have 
more than one mtDNA type in a single tissue. 2. Individuals may show one mtDNA 
type in one tissue and a different type in another tissue. 3. Individuals may be 
heteroplasmic in one tissue sample and homoplasmic in another tissue sample [151]. 
Any of the described situations could complicate evidence interpretation. However, the 
presence of heteroplasmy does not automatically invalidate the use of mtDNA in 
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forensic analysis [151, 154] as long as the limitations are recognised and accounted for 
in evidence interpretation. 
 
To increase the power of discrimination of mtDNA, numerous coding region SNP 
genotyping panels have been developed that can be used in conjunction with HV1/HV2 
sequencing [158-163]. Such panels can assist in resolving common haplotypes or can be 
used as a screening tool to eliminate suspects prior to sequencing. Whole genome 
sequencing has also been suggested as a method of increasing the discriminating power 
of mtDNA [156, 164-167]. Initially this was performed through traditional sequencing 
methods [156, 164]. However, recently introduced massively parallel sequencing 
technologies have the potential to provide faster and less expensive methods that can 
achieve greater coverage in single reactions [165-167]. These methods have been shown 
to produce data that have a high level of consistency with Sanger-type sequencing 
methods [167]. However, many of the discrepancies observed were related to the 
analysis software‘s alignment algorithms, indicating room for improvement in this area 
[167].   
 
1.5 Project aims 
The overall aim of this project was to investigate the reliability of the current methods 
of LTDNA analysis and develop novel methods which could overcome the inherent 
issues associated with working with low amounts of DNA.  
The specific aims of this thesis were: 
1. To investigate whether concentrating a sample for LTDNA analysis would result 
in an increased quality STR profile compared with the current practice of 
splitting extracts into separate aliquots and constructing a consensus profile from 
the split sample profiles. 
2. To develop a novel Pre-PCR amplification technique to increase the DNA 
starting template amount available for STR analysis through a non-exponential 
first round PCR. 
3. To investigate WGA as a method for improving STR analysis of LTDNA by: 
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A) Examining the ability of commercial and novel WGA chemistries to 
amplify LTDNA for STR analysis.  
B) Determining if modifications to the manufacturer‘s protocols could 
improve the MDA efficiency to result in a more complete forensic 
STR profile with reduced allelic imbalance. 
4. To investigate the utility of LMD for routine forensic analysis, specifically: 
A) To determine if cells collected by LMD could be analysed using 
traditional and increased sensitivity PCR methods. 
B) To compare STR profiles from LMD cells, which therefore contain a 
known number of genome copies, to profiles generated from the 
equivalent amount of diluted genomic DNA to determine if cell 
samples were amplifying in the same manner as DNA dilutions. 
C) To determine if a novel WGA kit could be applied to LMD cells to 
produce more complete forensic STR profiles with reduced allelic 
imbalance. 
5. To investigate the applicability of mtDNA sequencing to LTDNA samples, 
specifically:  
A) To determine the limit of detection of the mtDNA sequencing 
procedure. 
B) To examine the ability of commercial and novel WGA chemistries 
that target both nuclear and mtDNA to amplify LTDNA for 
mitochondrial control region sequencing. 
C) To examine the ability of a WGA kit that specifically targets mtDNA 
to amplify LTDNA for mitochondrial control region sequencing. 
D) To determine if the mtDNA specific WGA kit could be applied to 
LMD cells for improved mitochondrial control region sequencing. 
Information gained from these studies could provide police and forensic scientists with 
more reliable methods for human identification from LTDNA samples. This would be 
particularly relevant for identification of forensic evidence samples such as touch or 
trace DNA, missing persons or mass disaster victims. This knowledge could also be 
applied to other fields such as oncogenetics, preimplantation genetic diagnosis, or 
ancient DNA studies where genetic analysis is often required on small cell numbers or 
even single cells. 
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CHAPTER 2 
 
COMPARISON OF STR PROFILING FROM LOW 
TEMPLATE DNA EXTRACTS WITH AND 
WITHOUT THE CONSENSUS PROFILING 
METHOD 
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2.1 Introduction 
Polymerase chain reaction (PCR)-based short tandem repeat (STR) analysis is 
considered the method of choice for forensic DNA profiling. The prominence of the 
technology is due to the sensitivity of detection from exponential amplification of target 
molecules by the PCR and the highly polymorphic nature of STRs [19]. This general 
method allows for small amounts of DNA, between 200pg and 2.5ng, to be analysed 
with commercial DNA profiling kits [7-11]. 
 
In the late 1990s, the Low Copy Number (LCN) technique was introduced to increase 
the sensitivity of the PCR so that substantially less DNA could be profiled [14]. With 
this particular process the number of PCR cycles was increased from 28 to 34 resulting 
in increased results from single cell DNA analysis [14]. The term LCN is often used 
interchangeably with LTDNA. However, in this paper, LCN will refer specifically to 
the technique of increasing the number of PCR cycles, whereas LTDNA will refer 
generically to the analysis of samples with 100pg or less starting template. Amounts 
less than 100pg are considered likely to produce results below the stochastic threshold 
for standard interpretation [31]. 
 
The LCN technique can increase the number of alleles observed in a LTDNA profile. 
However, interpretation difficulties can arise from the exaggerated stochastic effects 
associated with low levels of starting template. Such effects are well documented and 
include heterozygote peak imbalance, allele and locus drop out, increased stutter height 
and allele drop in [2-6]. 
 
To accommodate the inherent stochastic effects of LCN DNA typing, a method of 
replicate analysis has been adopted (referred to as the ‗Biological Model‘). In this 
model, a sample is divided into separate aliquots, generally two or three, and a 
consensus profile is derived from the replicates that only includes alleles that appear in 
two or more of the replicates [2]. This biological method is particularly useful for the 
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elimination of non-repeating spurious alleles that appear in a profile as a result of allele 
drop in [2-6]. Other methods of replicate analysis, such as dividing the sample into four 
aliquots and including alleles seen in two of the replicates [4], generating a composite 
profile that includes all alleles seen in the replicate profiles [53] or pooling the sample 
aliquots post-PCR for a single CE injection, [3] have been suggested as possible 
alternatives to the original Biological Model. 
 
Critics of the Biological Model suggest that splitting an already low level sample into 
multiple aliquots would increase the stochastic effects seen in LTDNA profiles because 
fewer template molecules are subject to the PCR process in each reaction. As a result, 
differences are more likely to be seen in replicates of the ―same‖ sample [23]. 
Additionally, by creating a consensus profile, valuable information from the replicates 
can be lost, with one study reporting the loss of approximately one third of the alleles 
obtained [5]. Therefore, critics of the Biological Model advocate efforts should be made 
to concentrate LTDNA samples rather than diluting and splitting for replicate analysis 
[23]. 
 
Advocates of the Biological Model maintain that a loss of reproducibility is the normal 
result of LTDNA profiling and, therefore, it is not the existence of variability, but rather 
the magnitude and potential consequences of any variability that needs to be assessed 
and reported [48, 54]. It has been stated that replicate analyses are preferable to 
concentrating a sample as this would not usually increase the overall concentration of 
DNA above the 100 pg stochastic threshold, with stochastic effects still expected to 
occur in non-replicated samples [54]. However, little empirical evidence has been 
provided which shows that splitting a LTDNA extract and creating a consensus profile 
produces a more accurate STR profile than a concentrated LTDNA sample or vice 
versa. 
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This study aimed to investigate whether concentrating a sample for LTDNA analysis 
would result in an increased quality STR profile compared with the current practice of 
splitting extracts into separate aliquots and constructing a consensus profile from the 
split sample profiles. Samples with known profiles were used for all experiments. 
Profiles from low template samples were compared to high template reference profiles 
to assess profile quality. Profile quality was measured in terms of the presence of allele 
drop out, locus drop out and allele drop in, as well as an analysis of the peak heights and 
peak height ratios in profiles obtained using the different analysis methods. 
 
2.2 Methods 
2.2.1 Sample preparation 
This project was approved by the Bond University Human Research Ethics Committee 
(BUHREC), approval number RO743. Whole blood samples were provided by five 
anonymous donors with informed consent. DNA was extracted from using the 
BioRobot EZ1® Workstation with the EZ1® DNA Blood Kits (QIAGEN, Hilden, 
Germany) according to the manufacturer‘s instructions.  
 
The DNA extracts were quantified using a real time quantitative PCR assay. This assay 
amplified a 91bp fragment of 15q31, which contains the OCA2 locus. The primer 
sequences were 5‘-GCT GCA GGA GTC AGA AGG TT-3‘ (forward primer) and 5‘-
CAT TTG GCG AGC AGA ATC C-3‘ (reverse primer). Primers were used at a final 
concentration of 200nM. This assay was performed on the Rotor-Gene™ 6000 
(QIAGEN) real-time rotary analyser with 4μL of 1:100 dilution DNA extract in a 25μL 
reaction volume using SensiMix™ HRM Master Mix and EvaGreen dye to monitor 
amplification (Bioline, London, UK). PCR cycling conditions were as follows: 95ºC for 
15 minutes to activate Taq DNA polymerase, then 40 cycles of 95ºC for 15 seconds, 
60ºC for 10 seconds, 72ºC for 10 seconds. Genomic DNA of known concentrations 
(Promega Corp, Madison, WI, USA) was used to make a standard curve for 
quantification. Extracts were diluted to low template levels of 100pg/μl and 25pg/μl. 
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2.2.2 Short tandem repeat analysis 
STR analysis was performed using the PowerPlex® ESI 16 Kits (Promega Corp). The 
manufacturer‘s protocol recommends 30 PCR cycles. Therefore, the samples subjected 
to the ―Standard Cycle PCR‖ were amplified for 30 cycles. Samples that were analysed 
using the ―Increased Cycle PCR‖ were amplified for 34 cycles. Amplification was 
performed in 25μl reaction volumes using a GeneAmp® PCR System 9700 (Life 
Technologies, Carlsbad, CA, USA). 
 
Two series of reactions were carried out. For the first series, 100pg or 25pg of DNA 
templates were placed into one STR amplification reaction. Samples were amplified 
with 30 or 34 PCR cycles. For each template amount and cycling condition, the five 
donor samples were amplified in triplicate, to generate a total of 15 profiles per template 
amount and cycling protocol. For the second series of reactions, 15 (5 extracts amplified 
in triplicate) 100pg and 25pg samples were divided into 3 aliquots, so that 3 reactions 
containing approximately 33.3pg or approximately 8.3pg of template DNA respectively 
were performed for each 100pg or 25pg sample. Each 33.3pg and 8.3pg aliquot was 
amplified with 34 PCR cycles, giving a total of 45 of each 33.3pg and 8.3pg profiles, 
resulting in 15 consensus profiles for both template amounts. Reference profiles for 
each of the five donors were obtained using the standard cycling protocol using 500pg 
DNA template as recommended by the PowerPlex® ESI 16 manufacturer (Promega 
Corp.). Electropherograms for all samples were obtained using the 3130 Genetic 
Analyser (Life Technologies). For each sample, a loading cocktail of 10μl Hi-DiTM 
Formamide (Life Technologies) and 1μl of CC5 Internal Lane Standard 500 (Promega 
Corp) was mixed with 1μl of amplified product and denatured for three minutes at 
95°C. After cooling, samples were injected on the 3130 using a 3kv, 5-second injection 
as is the recommended PowerPlex® ESI 16 protocol. Data were analysed using 
Genemapper ID® software version 3.2.1 (Life Technologies) and PowerPlex® ESI 16 
panel and bin files. A detection threshold of 50 RFU was used for analysis of all sample 
profiles as per Tucker et al. [12]. 
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2.2.3 Profile interpretation 
Electropherograms for all LTDNA samples were compared with 500pg control profiles 
(the recommended template amount for PowerPlex® ESI 16 Kits), to determine if 
exaggerated stochastic sampling variation was evident and to what extent. For each 
profile peak heights, allele drop out, locus drop out and allele drop in were noted. Peak 
height ratios were calculated by dividing the height of the smaller peak in a 
heterozygote pair by the height of the larger peak. A peak height ratio of zero was 
recorded if one allele in the pair failed to amplify. Peak height ratio averages were 
calculated in two ways. The first calculation used only the heterozygote loci that 
showed both alleles. The second calculation used all loci in the first calculation, as well 
as known heterozygote loci that had a peak height ratio of 0% due to allele drop out. 
While a single peak, and in effect a 0% peak height ratio, would not normally be 
evaluated when analysing an unknown profile, these profiles were obtained from known 
sources. If the peak height ratios are to be used as a measure of how well both alleles at 
a locus amplify during the PCR then the 0% peak height ratios are an important 
indicator of the efficiency of the entire reaction. If both alleles at a heterozygous locus 
failed to amplify, the locus was not used in calculating the peak height ratio average and 
median. 
 
Locus specific stutter filters provided by the PowerPlex® ESI 16 manufacturer are as 
follows: 4% (THO1), 8% (D16S539), 9% (D18S1179), 10% (D2S441), 11% (FGA), 
12% (D3S1358 and D10S1248), 14% (D19S433), 15% (D1S1656, vWA and D21S11), 
17% (D18S51), 18% (D2S1338), 19% (D12S391) and 25% (D22S1045). Since the 
profiles were from known single source origins a general stutter threshold of 15% was 
also applied to samples that were subjected to a standard cycle PCR. Stutter has been 
shown to increase when measures, such as increasing the number of PCR cycles, are 
taken to improve the detection of low template samples [2]. To compensate for the 
increased stutter seen in LCN profiles, a stutter threshold of 20% was applied to 
samples that underwent the increased cycle PCR, based on the method of Caragine et 
al., who observed 97% of stutter was filtered out using a 20% filter for low template 
samples amplified with an increased cycle PCR and increased injection conditions [3]. 
If the peak height of an allele in the −4 stutter position exceeded the relevant threshold 
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it was designated as an allele and categorized as allele drop in. No stutter threshold was 
set for +4 stutter, and consequently any alleles that were present in the +4 stutter 
positions were designated as alleles and deemed to be allele drop in. 
 
For each of the replicate samples in the second series of reactions, consensus profiles 
were constructed based on the method outlined by Caragine et al. [3], such that an allele 
had to be seen in at least two replicates to be included as a true allele in the composite 
profile. 
 
2.3 Results 
The first series of reactions, which amplified 100pg or 25pg in a single STR 
amplification, resulted in 15 profiles at standard cycles and 15 profiles at increased 
cycles for each starting template amount. Example electropherograms of the single 
reaction LTDNA samples and a 1ng reference sample can be seen in Figures 2.1 to 2.3 
and 2.7 to 8.8. Each set of 15 profiles comprised 240 total loci. Of the total loci, 183 
(approximately 76%) were heterozygous.  
 
The second series of reactions, in which 15 100pg or 25pg samples were divided into 3 
aliquots for an increased cycle amplification, produced 45 profiles, and as such 15 
consensus profiles, for each template amount. Example electropherograms from 3 
individual profiles used to construct a consensus profile for both template amounts can 
be seen in Figures 2.4 to 2.6 (100pg) and Figure 2.9 to 2.11 (25pg). All example 
electropherograms used DNA from the same donor, with artefacts such as allele drop 
out, locus drop out, increased stutter and allele drop in indicated on the profiles. An 
illustration on how consensus profiles were derived can be seen in Figure 2.12. Each set 
of 45 profiles consisted of 720 total loci, with 549 (approximately 76%) of these being 
heterozygous. Each set of 15 consensus profiles comprised 240 total loci, 183 of which 
were heterozygous.  
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2.3.1 Allele Recovery 
Using 100pg of starting template, allele recovery was consistent regardless of the 
amplification method used, with no significant differences seen between the samples 
amplified in a single reaction with 30 PCR cycles, samples amplified in a single 
reaction with 34 PCR cycles and samples divided for amplification and consensus 
profile construction (Figure 2.13). As shown in Figure 1, an average of 98.5% of the 
correct alleles were recovered in each profile using standard PCR cycling conditions, all 
profiles showed 100% allele recovery using a single 34 cycle PCR and an average of 
96.2% of the correct alleles were seen in each consensus profile. When the starting 
template amount was reduced to 25pg significant differences in allele recovery were 
noted when comparing the 30 PCR cycle samples, which showed an average of 58.8% 
of the correct alleles per profile, to both the 34 PCR cycles samples amplified in a single 
reaction (80.5% of the correct alleles recovered per profile) and the consensus profiles 
(43.5% of the correct alleles recovered per profile) (Figure 1). 
 
 
Figure 2.13 Correct alleles recovered in samples amplified using standard and increased 
cycle reactions. Results represent the average percentage of alleles recovered per 16-locus 
multiplex PCR sample. Fifteen reactions were performed for each amplification method. Error 
bars represent standard error of the mean.  A 2-way ANOVA with Bonferroni post-tests was 
performed to compare allele recovery obtained using the standard 30 cycle PCR with samples 
amplified using the increased cycle reaction and the consensus profiling method. As indicated 
*** represents a p value of less than 0.001. 
57 
 
2.3.2 Allele drop out 
The amplification of 100pg of starting template using the standard cycling protocol 
resulted in profiles with little observable allele drop out. Only six (3%) of the 
heterozygote loci showed allele drop out, with each drop out event occurring in different 
profiles (Table 2.1). When the number of cycles was increased to 34, allele drop out was 
eliminated. However, when the 100pg samples were split for amplification, the resulting 
consensus profiles showed an increase in allele drop out. Of the 15 consensus profiles, 
16 examples of allele drop out were seen, representing 9% of the total heterozygote loci. 
The number of drop out alleles per consensus profile ranged from 0 to 4, with an 
average of 1.73 drop out events per profile. 
 
Table 2.1 Allele drop out (ADO) 
 
 Number of 
ADO 
% Heterozygote Loci 
with ADO 
100pg Starting Template 
     30 PCR Cycle Amplification 
          Non-split Samples (n
a = 183) 6 3% 
    34 PCR Cycle Amplification 
          Non-split Samples (n = 183) 0 0% 
          Split Samples (n = 549) 114 21% 
          Consensus Profiles (n = 183) 16 9% 
25pg Starting Template 
    30 PCR Cycle Amplification 
          Non-split Samples (n = 183) 80 44% 
    34 PCR Cycle Amplification 
          Non-split Samples (n = 183) 61 33% 
          Split Samples (n = 549) 250 46% 
          Consensus Profiles (n = 183) 92 50 % 
a 
n is the total number of heterozygote loci 
 
Allele drop out significantly increased as the amount of starting template was reduced. 
Using the standard cycle protocol, amplification of 25pg of starting template resulted in 
80 occurrences of allele drop out over 15 profiles, representing 44% of the total 
heterozygous loci (Table 2.1). The number of drop out alleles per profile ranged 
between 3 and 8, with an average of 5.4 allele drop out events per profile. When the 
samples were subjected to an increased cycle PCR, the percentage of allele drop out was 
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reduced to 33%, with 61 examples of allele drop out over 15 profiles. The number of 
drop out alleles in each profile obtained using the increased cycling method ranged 
between 2 and 7, with an average of 4.07 per profile. However, when 25pg of starting 
template was split for amplification the resulting consensus profiles showed an increase 
in allele drop out, with 92 cases over the 15 consensus profiles, which corresponds to 
50% of the total heterozygous loci. The number of drop out alleles per profile ranged 
between 2 and 10, with an average of 7.67 drop out events in each profile. 
 
2.3.3 Locus drop out 
For the purpose of this study, and in all subsequent chapters, locus drop out was defined 
as the single allele from a homozygous locus, or both alleles from a heterozygous locus 
missing from the profile. In the latter case, both missing alleles were not each counted 
individually as allele drop out. Locus drop out was not seen in any of the profiles 
obtained from 100pg starting template, regardless of whether the sample was amplified 
using the standard or increased cycle PCR (Table 2.2). When the 100pg samples were 
divided into three 33pg aliquots and used to construct a consensus profile, the individual 
profiles did show some locus drop out, with 12 instances seen across the 720 loci. The 
consensus profiles derived from the aliquots were complete and correct since locus drop 
out did not occur at the same locus more than once in any set of three replicate profiles. 
 
Locus drop out was much more evident in the 25pg samples (Table 2.2). Under standard 
cycling conditions, 51 examples of locus drop out were recorded over the 240 total loci 
(21%). Between 0 and 7 loci dropped out per sample, with an average locus drop out of 
3.4 per sample. This drop out was reduced when the number of PCR cycles was 
increased, with only 13 (5%) of the total loci dropping out. Under the increased cycle 
amplification condition, the number of locus drop out events per sample ranged between 
none and two, with an average of less than one drop out locus per profile. However, 
when the samples were split and a consensus profile was derived, locus drop out 
increased, with 79 instances seen in the 15 consensus profiles, representing 33% of the 
total loci. The number of drop out loci per sample ranged from 3 to 10, with an average 
of 5.27 loci dropping out in each consensus profile. 
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Table 2.2 Locus drop out (LDO) 
 Number of 
LDO 
% Loci with 
LDO 
100pg Starting Template 
    30 PCR Cycle Amplification 
          Non-split Samples (n
a = 240) 0 0% 
   34 PCR Cycle Amplification 
          Non-split Samples (n = 240) 0 0% 
          Split Samples (n = 720) 12 2% 
          Consensus Profiles (n = 240) 0 0% 
25pg Starting Template 
   30 PCR Cycle Amplification   
          Non-split Samples (n = 240) 51 21% 
   34 PCR Cycle Amplification 
          Non-split Samples (n = 240) 13 5% 
          Split Samples (n = 720) 245 34% 
          Consensus Profiles (n = 240) 79 33% 
a 
n is the total number of loci 
 
2.3.4 Allele drop in 
Allele drop in was minimal under standard cycling conditions, with only two additional 
alleles seen across all 100pg sample profiles, one of which was seen in the −4 stutter 
position and the other seen in the +4 stutter position (Table 2.3). Drop in increased 
when the samples were amplified with the increased cycle PCR, with 32 additional 
alleles seen in the resulting 15 profiles. The number of drop in alleles per sample ranged 
between 0 and 4, with an average of 2.13 additional alleles seen in each sample. Allele 
drop in also occurred in the profiles of the split samples, with a total of 32 additional 
alleles seen in the 45 split sample profiles. However, the consensus method requirement 
for an allele to be seen twice effectively counteracted this drop in, so that no additional 
alleles were seen in the 15 consensus profiles. 
 
A similar pattern was observed in the 25pg sample profiles. No additional alleles were 
seen in the standard cycle PCR profiles, but 6 drop in alleles were noted in the 15 
increased cycle PCR profiles. When the samples were divided into 3 aliquots for 
amplification, 15 additional alleles were seen in the 45 split sample profiles. However, 
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again, the consensus method eliminated this drop in, so that no additional alleles were 
seen in the consensus profiles. 
 
Table 2.3 Allele drop in (ADI) 
 Allele Drop In Placement Number 
of ADI 
% Loci 
with ADI Minus 4 Plus 4 Random 
100pg Starting Template 
   30 PCR Cycle Amplification 
       Non-split Samples (n
a = 240) 1 1 0 2 0.3% 
   34 PCR Cycle Amplification 
       Non-split Samples (n = 240) 2 10 20 32 13% 
       Split Samples (n = 720) 11 11 10 32 4% 
       Consensus Profiles (n = 240) 0 0 0 0 0% 
25pg Starting Template 
   30 PCR Cycle Amplification 
       Non-split Samples (n = 240) 0 0 0 0 0% 
   34 PCR Cycle Amplification 
       Non-split Samples (n = 240) 2 1 3 6 3% 
       Split Samples (n = 720) 10 1 4 15 2% 
       Consensus Profiles (n = 240) 0 0 0 0 0% 
Total (n = 2,400) 26  
(30%) 
24 
(27%) 
37  
(43%) 
87 4% 
a 
n is the total number of loci 
 
Of the 87 additional alleles observed across all profiles, 26 were seen in the ‗-4‘ stutter 
position. Alleles in this position were only counted as drop in if their peak height 
exceeded the nominated stutter ratio filters (locus specific stutter filters followed by a 
manual examination using a 15% filter for samples amplified with the standard number 
of cycles and 20% for samples amplified with an increased cycle PCR). Indeed, 140 
additional peaks were actually seen in −4 stutter positions; however, 114 were removed 
from the final profiles by the stutter filters. Twenty-four additional alleles were 
observed in ‗+4‘ stutter positions. While 23 of the 24 additional alleles in +4 positions 
had peak heights less than 20% of the true allele, a filter was not set for +4 stutter; 
therefore, additional alleles in this position were counted as drop in. The remaining 37 
additional alleles were placed throughout the profiles. 
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2.3.5 Peak heights and peak height ratios 
For the 100pg samples amplified with 30 PCR cycles, the height of homozygous peaks 
ranged from 185 to 847 RFU, with an average peak height of 520 RFU. The height of 
heterozygous alleles ranged between 55 and 725 RFU, with an average of 261 RFU 
(Table 2.4). The peak height ratio range for heterozygote loci was 16% to 99% with a 
peak height ratio average of 69%. When taking into account the heterozygote loci that 
had a peak height ratio of 0% due to allele drop out, the average was reduced to 67% 
(Table 2.5). 
 
The peak heights increased when the number of PCR cycles was increased to 34. For 
homozygous alleles, the peak heights ranged between 622 and 7,609 RFU with an 
average height of 4,129 RFU. The peak height range for alleles at heterozygous loci was 
139 to 5,805 RFU with an average height of 1,925 RFU (Table 2.4). However, 
increasing the number of PCR cycles resulted in a slightly reduced peak height ratio 
average of 65%, with a peak height ratio range of 6% to 100% (Table 2.5). Allele drop 
out was not seen in any of the 100pg increased cycle profiles; therefore, only one 
calculation was performed. 
 
The 100pg samples that were split for amplification and were subject to 34 PCR cycles 
displayed peak heights higher than those subjected to the 30-cycle amplification, 
presumably because the increased number of cycles compensates for the decreased 
template amount. The heights of homozygous peaks ranged from 166 to 6,131 RFU, 
with an average height of 1,610 RFU. The heterozygous loci showed a peak height 
range of 56 to 4,123 RFU, with an average peak height of 763 RFU (Table 2.4). The 
peak height ratio range for heterozygous loci showing both alleles was 8% to 99%, with 
an average of 57%. Inclusion of the 114 heterozygote loci that had a 0% peak height 
ratio, the average was reduced to 45% (Table 2.5). 
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Amplification of 25pg starting template resulted in a peak height reduction compared 
with the 100pg samples. Under standard PCR cycling conditions, the heights of 
homozygous peaks ranged between 51 and 337 RFU, with an average of 149 RFU. For 
heterozygous loci, the peak height range was 50 to 360 RFU, with an average height of 
190 RFU (Table 2.4). The peak height ratios range for the heterozygous loci was 35% to 
99% with an average 68%. When all heterozygous loci that showed at least one allele 
were included in the calculation, the average peak height ratio was reduced to 29% 
(Table 2.5). 
 
As with the 100pg samples, by increasing the number of PCR cycles the average peak 
height for the 25pg samples also increased. For homozygous alleles, the average peak 
height was 1,259 RFU, with a range of 212 to 3,475 RFU. The height of heterozygous 
alleles ranged between 58 and 3,500 RFU, with an average height of 708 RFU (Table 
2.4). Considering only the heterozygous loci that showed both alleles, the peak height 
ratio range was 10% to 99%, resulting in a peak height ratio average of 56%, a 
reduction compared to the average of the standard cycle samples. However, when the 
heterozygous loci that had a peak height ratio of 0% were included in the average 
calculation, the peak height ratio average was higher compared to the standard cycle 
profiles at 36%, due to the reduction in allele drop out (Table 2.5). 
 
For the 25pg samples split for amplification, the heights of the alleles were increased 
compared with the standard cycle amplification samples due to the increased number of 
PCR cycles utilized. For homozygous alleles, the peak heights ranged from 59 to 2,144 
RFU; however, the average height was only 541 RFU. The range for heterozygous 
allele heights was similar at 53 to 2,077 RFU, with an average height of 386 RFU 
(Table 2.4). The peak height ratio range of heterozygous loci showing both alleles was 
16% to 100%, with an average of 64%. However, when the 250 heterozygous loci that 
had a peak height ratio of 0% were included in the calculation, the average was reduced 
to 19% (Table 2.5). 
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2.4 Discussion 
This study supports previous studies that showed increasing the number of PCR cycles 
will increase the sensitivity of detection for STR profiling of LTDNA samples. 
However, while 100pg has been noted as the upper limit for what may be considered a 
low template sample [14, 31], this research shows that when using the current 
generation multiplex kits, there may be less benefit to increasing the number of PCR 
cycles when this amount of DNA template is available for amplification. When 100pg 
of template was amplified using the PowerPlex® ESI 16 kit with an increased cycle 
PCR additional alleles were seen in the profiles. This is not surprising due to the 
increased sensitivity of the PowerPlex® ESI 16 kit, which has been shown to produce 
full profiles down to 62.5pg using its standard cycling protocol [12]. Furthermore, the 
standard protocol for this kit already utilizes 30 PCR cycles, as opposed to other 
commercially produced multiplex kits that use 28 or 29 cycles as the standard cycle 
number. 
For the 100pg samples amplified using the standard cycling protocol, there were only 6 
instances of allele drop out in the resulting 15 profiles, no locus drop out and only 2 
spurious alleles seen overall. Of the two additional alleles, one was in the −4 position 
and one was in the +4 position to true alleles. When measured against their respective 
true alleles, the allele in the −4 position had a peak height ratio of 26%, while the allele 
in the +4 position had a peak height ratio of 36%. The position of the alleles could 
indicate that they are increased stutter rather than true drop in alleles. However, given 
the height of the additional peaks, particularly the +4 allele, it may be that they are true 
drop in. Furthermore, the additional alleles occurred at heterozygous loci, and in both 
cases the two correct alleles were also present. The presence of the ‗drop in‘ alleles 
would normally indicate a potential mixture sample, with the additional alleles not part 
of the major profile. However, the other 14 loci showed no additional minor alleles, 
which would indicate the likely drop in or artefact nature of these allele peaks. In 
comparison, the 100pg samples amplified with 34 cycles did not display any drop out. 
However, 32 additional peaks were seen across the 15 profiles, the majority of which 
were not in the stutter positions. Of the additional alleles, 10 were seen at homozygous 
loci, which could mean that the loci could be falsely interpreted as heterozygote loci. 
However, given that the peak height ratios of nine of the additional alleles were less 
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than 3% of the true allele, this is unlikely. One drop in allele had a peak height ratio of 
10% compared to the true allele, but this additional allele was seen in the +4 stutter 
position, and would also be interpreted with caution. Overall, these results suggest that 
performing one standard cycle PCR is preferable to performing one increased cycle 
reaction when 100pg of template are available for amplification because of the large 
reduction in allele drop in. 
 
When the template amount is reduced, this research demonstrates that there is 
significant benefit to increasing the number of PCR cycles for STR typing in terms of 
the increased amount of information seen in the resulting profiles. With a starting 
template amount of 25pg, increasing the number of PCR cycles resulted in a 22% 
increase in the number of correct loci seen overall compared to the standard cycle 
profiles. Both allele and locus drop out were markedly reduced and the peak heights and 
peak height ratios both improved. However, as with the 100pg samples, increasing the 
number of PCR cycles for the amplification of 25pg did result in more drop in alleles 
seen in the profiles. Compared to the standard cycle profiles, which did not show any 
additional alleles, the increased cycle profiles displayed six loci with additional alleles. 
Of these additional alleles, four were seen at heterozygous loci, with three of these loci 
also containing both true alleles. The fourth locus did display allele drop out in 
conjunction with the allele drop in, so it is possible this locus would be interpreted 
incorrectly. The peak height ratio of the drop in allele compared to the remaining allele 
was only 9%, indicating that this would be interpreted with caution. However, if the 
drop in allele was considered not part of the major profile, the locus could then be 
falsely interpreted as homozygous. Of the two additional alleles that occurred at 
homozygous loci, one occurred in the −4 stutter position but was not removed by the 
stutter filter as it had a peak height ratio of 29%. The other was in the +4 stutter 
position, with a peak height ratio of 7%. If an increased cycle procedure were 
implemented for LTDNA amounts as low as 25pg, the profile interpretation would need 
to accommodate the chance of an allele resulting from allele drop in. 
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For both starting template amounts, the data show that splitting the sample into three 
aliquots and constructing a consensus profile did not result in the most informative 
profile compared with a profile where the DNA extract was amplified in one reaction. 
While the consensus profile approach did eliminate allele drop in, all other measures of 
profile quality were improved when the sample was not split. The original purpose of 
the Biological Model approach was to eliminate spurious alleles from the final 
consensus profile and give confidence that the final profile contains only the alleles of 
the actual contributor. The former was demonstrated by our results, with no additional 
alleles in the consensus profiles. This is important, as additional alleles in the profile 
can result in an incorrect interpretation, where either a homozygous locus is interpreted 
as a heterozygous locus or, if the drop in occurs in conjunction with a drop out, the 
wrong genotype may be assigned for that locus. This could have serious ramifications 
for casework, as errors in the profile could then lead to false inclusion or exclusion of 
suspects, or false matches if the profile is subjected to a database search. 
 
The consensus profile results showed that a large amount of information was lost when 
the starting template was divided for amplification. This was especially evident in the 
25pg samples. Compared to the profiles obtained with the full 25pg using a 34-cycle 
reaction, the consensus profiles showed a notable increase in allele and locus drop out. 
When the entire sample was amplified with 34 PCR cycles, 67% of the loci were 
complete and correct, 25% were heterozygous loci that showed only one allele, 5% 
showed complete locus drop out and 3% showed allele drop in. When the 25pg was 
split for amplification, the resulting consensus profile showed only 29% of the loci as 
complete and correct, 38% were heterozygous loci that showed only one allele and 33% 
displayed complete locus drop out. This loss of information that occurs when the 
sample is divided for amplification is not surprising, since the starting template amount 
in each of the split samples is barely more than the DNA that is available from a single 
cell, and that is only if the starting 25pg is divided equally into thirds. In reality, any of 
the three aliquots could contain less than a single copy of the genome. Furthermore, if 
the majority of the 25pg template happens to end up in one aliquot, then the consensus 
profiling method may effectively eliminate much information that would be gained 
from that aliquot‘s profile because it does not appear in one of the other aliquot profiles. 
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While repeatability is an important measure of reliability, the fact that so much 
information is lost in the attempt to repeat the results would suggest that the consensus 
profiling method may not be giving the most informative profile for samples with such 
a low level of starting template. It could then be argued that the gain of having 
confidence that no allele drop in has occurred is not sufficient compensation for the loss 
of profile information. This is particularly so given the increased occurrence of stutter in 
the split profiles, since a stutter and drop in are in fact both incorrect alleles. The results 
from the 25pg split samples show 10 additional alleles in the −4 stutter position, 1 in the 
+4 stutter position and 4 in other positions. As a consequence, many of the incorrect 
alleles being eliminated from the consensus profile are likely increased stutter, which is 
not actually seen in such high amounts in the non-split profiles (six additional alleles 
overall, two of which are in the −4 stutter position, one in the +4 stutter position, and 
three in random positions). Based on the allele drop in results, the use of a higher stutter 
filter for the −4 position and implementation of a +4 stutter filter would significantly 
reduce the incidence of apparent allele drop in. Therefore, a profile interpretation 
method that accommodates the increased stutter may be warranted. 
 
It should be noted that, since allele and locus drop out and allele drop in still occurred 
when a low template DNA sample was amplified in a single reaction, a robust statistical 
analysis model that takes the stochastic effects into consideration must be applied to the 
data. A statistical analysis taking these stochastic effects into consideration should, of 
course, also be applied to the consensus profiles. It is noteworthy that this study was 
confined to single source samples. Interpretation of mixture profiles generated from 
LTDNA samples deriving from more than one individual would be more complex. 
Sample degradation or the presence of PCR inhibitors – issues commonly seen with low 
template samples – would further complicate profile interpretation. However, this study 
has shown that a consensus profile from a split single source sample contains 
considerably less information than a single profile from a non-split sample. It would, 
therefore, be preferable to build a statistical model that can be applied to the single 
LTDNA profile since this should provide the most information. 
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2.5 Conclusion 
Overall, this study has demonstrated that performing standard cycling STR typing on 
non-split DNA extracts will result in profiles with a higher percentage of total loci 
compared with the consensus profiling technique. Increasing the number of PCR cycles 
improves the sensitivity of the reaction compared with a standard cycle PCR. However, 
samples containing template amounts on the upper limits of what would be considered 
low template DNA may not actually benefit from the increased amplification because of 
the additional alleles, either drop in or stutter, that can appear in the profile. The repeat 
nature of the consensus profiling method does eliminate the problem of allele drop in 
seen with an increased number of PCR cycles, which has important implications for 
casework. However, consensus profiling also results in the least informative profiles 
due to increased allele or locus drop out. It also results in more ‗incorrect‘ alleles in the 
individual profiles used to obtain the consensus profile as a result of increased stutter. 
Simply performing a single standard cycle PCR on the entire sample produced the most 
complete profiles when 100pg of starting template are available for amplification. When 
only 25pg of template are available, it would be beneficial to amplify the entire extract 
with an increased cycle PCR in terms of acquiring a profile with the most information 
possible. While this must be balanced against the possibility of drop in, it is important to 
realize that increased stutter alleles that are likely to appear in the split sample profiles 
are also incorrect alleles and are more likely to be reproducible than ‗random‘ allele 
drop ins. 
 
Performing a single STR reaction from the whole low template sample does eliminate 
any chance of repeating the profile. In this sense, consensus profiling may be preferred 
because the results are seen as repeatable. However, the impression of repeatability 
gained by the consensus profiling method must be balanced against the notable loss of 
information that occurs when a LTDNA sample is divided for amplification. While 
consensus profiling does have its benefits, the method may not be producing the most 
informative STR profiles for samples where the template amount is limited. 
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CHAPTER 3 
 
LINEAR AMPLIFICATION OF TARGET PRIOR TO 
PCR FOR IMPROVED LOW TEMPLATE DNA 
RESULTS 
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ADDENDUM 
Work from this chapter has been accepted for publication in BioTechniques. 
 
Portions of this work were presented at the 25
th
 World Congress of the International 
Society for Forensic Genetics 2013. 
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3.1 Introduction 
DNA profiling has become a powerful investigative tool and a compelling form of 
evidence when presented in court. Current profiling techniques which utilise the PCR 
and CE to type STR loci are extremely sensitive, allowing for as little as 200pg of DNA 
to be routinely analysed with various commercial kits [7-11]. However due to the 
sensitivity of the technique there has come an increased attempt to profile even smaller 
amounts of DNA.  
 
One of the most popular methods for increasing the sensitivity of detection is the LCN 
technique, which employs an increased number of PCR cycles [14]. Other methods for 
increasing sensitivity can include post-PCR purification [5, 44] or modifying the CE 
injection conditions [3, 5]. These methods have been shown to increase the number of 
alleles seen in a profile compared with profiles obtained using conventional methods. 
However, exaggerated stochastic effects such as peak height imbalance, allele and locus 
drop out, increased stutter and allele drop in are commonly observed and can cause 
interpretation difficulties [2-6, 44].  
 
Methods, such as WGA and nested PCR, have been suggested as potential ways to 
improve the yield of low level samples prior to STR analysis. Various WGA techniques 
have demonstrated improved allele detection but in most cases large stochastic effects 
were still observed [114, 115, 119-121, 126]. Nested PCR also has shown improved 
STR profile results [126, 168]. However, nested PCR still relies on an exponential 
amplification and thus preferential amplification of one allele in the initial PCR may 
amplify the stochastic effects observed after the second reaction, particularly increased 
stutter, allele drop out and heterozygote peak imbalance. 
 
In this study a method was investigated to increase the DNA starting template amount 
available for STR analysis through a non-exponential first round PCR amplification. In 
this method, low template DNA samples were divided into two aliquots and a first 
round PCR is performed with one primer only, with the forward and reverse STR 
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primers placed in separate aliquots. The two aliquots were then pooled for a typical 
PCR with the forward and reverse primer pair. As a proof of concept, initial reactions 
targeted a single locus to determine if the Pre-PCR procedures could increase the 
amount of amplifiable target for the PCR without the additional complication of 
multiplexing. Experiments were then performed targeting multiple loci in a single 
reaction using primers targeting all loci in a commercial DNA profiling kit. 
 
3.2 Methods 
3.2.1 Sample preparation 
This project was approved by the Bond University Human Research Ethics Committee 
(BUHREC), approval number RO743. Whole blood was provided by four anonymous 
donors with informed consent. DNA was extracted using the BioRobot EZ1® 
Workstation with the EZ1® DNA Blood Kits (QIAGEN, Hilden, Germany) according 
to the manufacturer‘s instructions. DNA extracts were quantitated using the method 
outlined in section 2.2.1. Extracts were diluted to low template levels of 100pg/µl, 
50pg/µl, 25pg/µl, 12.5pg/µl and 6.25pg/µl.  
 
3.2.2 Single locus experiments 
3.2.2.1 First round non-exponential PCR (Pre-PCR) 
Initial PCRs were performed using HotStar Taq Mastermix Kits (QIAGEN) according 
to the manufacturer‘s instructions with the exception that reaction volumes were 
reduced to 10μl.  Eleven reactions were performed for each starting template amount 
using the DNA from a single donor. For each template amount to be analysed, half of 
the total template was amplified with the forward primer for the vWA locus while half 
was amplified using the reverse primer. Sequences for the forward and reverse primers 
were obtained from published data [10] (Forward Primer = 5‘-
GCCCTAGTGGATGATAAGAATAATCAGTATGTG-3‘. Reverse Primer = 5‘- 
GGACAGATGATAAATACATA GGATGGATGG-3‘). First round PCRs were 
performed for either 10 or 20 cycles. Amplification was performed using a GeneAmp® 
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PCR System 9700 (Life Technologies, Carlsbad, CA, USA). PCR cycling conditions 
were as follows: 95ºC for 15 minutes, then 10 or 20 cycles of 94ºC for 30 seconds, 55ºC 
for 30 seconds, 72ºC for 30 seconds, followed by a 72ºC hold for 15 minutes. Samples 
were then cooled and held at 4ºC. Forward and reverse primer reactions were pooled 
prior to the second vWA amplification. 
 
3.2.2.2 Second round exponential PCR and capillary electrophoresis 
Single-plex STR analysis was performed on the pooled samples using the HotStar Taq 
Mastermix Kits according to manufacturer‘s instructions. For each pooled sample 10µl 
was amplified with a 30-cycle PCR with the remaining 10µl amplified using a 35-cycle 
PCR. Amplification was performed using a GeneAmp® PCR System 9700. PCR 
cycling conditions were as follows: 95ºC for 15 minutes, then either 30 or 35 cycles of 
94ºC for 30 seconds, 55ºC for 30 seconds, 72ºC for 30 seconds, followed by a 72ºC hold 
for 15 minutes as per manufacturer‘s instruction. Samples were then cooled and held at 
4ºC. STR analysis also was performed on 100pg, 50pg, 25pg, 12.5pg and 6.25pg control 
samples that did not undergo the Pre-PCR processing using the same 30- or 35-cycle 
PCR conditions as described above.  
 
CE was performed using a DNA High Resolution gel cartridge on a QIAxcel System 
(QIAGEN). The OM500 method (5kV for 500 seconds) was used for fragment 
separation. The QIAxcel system produces a digital gel image for each sample as well as 
providing fragment length and signal intensity information.  
 
The DNA donor was known to be heterozygous for the vWA locus. Previous STR 
analysis using the PowerPlex® ESI 16 kit (Promega Corp, Madison, WI, USA) showed 
the sample  was 13,16. Based on the placement of the primers used this should result in 
QIAxcel fragments of approximately 135bp and 147bp in length, respectively. Results 
were analysed to assess allele drop out (ADO) and locus drop out (LDO) levels using a 
50 RFU detection threshold. The mean peak height and mean peak height ratio (PHR) 
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were calculated for each set of profiles obtained using the various Pre-PCR and second 
round PCR methods. The peak height ratios were calculated by dividing the height of 
the smaller peak by the height of the larger peak in the heterozygote pair. If allele drop 
out occurred at the locus, a peak height ratio of 0% was recorded. The peak height 
averages were calculated in two ways. First, the average of all the PHRs from sample 
profiles that showed both alleles was calculated. The second calculation included the 
PHRs from the profiles that showed both alleles, as well as the 0% PHRs recorded in 
profiles that showed allele drop out. Since the PHRs are used to measure how well both 
alleles at a locus amplified, including the 0% PHRs would help to indicate the 
efficiency of the entire reaction. If complete LDO occurred then locus this was not used 
in calculating the PHR average. 
 
3.2.3 Multiplex experiments 
3.2.3.1 First round non-exponential PCR (Pre-PCR) 
Pre-PCRs were performed using PowerPlex® ESI 16 kit. Profiles from three individuals 
were obtained for each starting template amount.  Reactions were performed according 
to the manufacturer‘s instructions with the following exceptions: reaction volumes were 
halved to 12.5μl and a 1μM primer mix containing unlabeled forward or reverse primers 
for the loci targeted in the ESI 16 kit was used instead of the provided primer mix. For 
each template amount to be analysed, half of the total template was amplified with the 
forward primer mix while half was amplified using the reverse primer mix. Forward and 
reverse primers were provided by Promega Corp. First round PCRs were performed for 
either 10 or 20 cycles. Amplification was performed using a GeneAmp® PCR System 
9700 (Life Technologies, Carlsbad, CA, USA). PCR cycling conditions were as 
follows: 96ºC for 2 minutes, then 10 or 20 cycles of 94ºC for 30 seconds, 59ºC for 2 
minutes, 72ºC for 90 seconds, followed by a 60ºC hold for 45 minutes. Samples were 
then cooled and held at 4ºC. Forward and reverse primer reactions were pooled prior to 
the second amplification. 
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3.2.3.2 Second round exponential PCR and capillary electrophoresis 
Multiplex STR analysis was performed on the pooled samples using the PowerPlex® 
ESI 16 kit according to manufacturer‘s instructions. For each pooled sample 12.5µl was 
amplified with a 30-cycle PCR. Amplification was performed using a GeneAmp® PCR 
System 9700. PCR cycling conditions were as follows: : 96ºC for 2 minutes, then 30 
cycles of 94ºC for 30 seconds, 59ºC for 2 minutes, 72ºC for 90 seconds, followed by a 
60ºC hold for 45 minutes as per manufacturer‘s instruction. Samples were then cooled 
and held at 4ºC. STR analysis also was performed on 100pg, 50pg, 25pg, 12.5pg and 
6.25pg control samples that did not undergo the Pre-PCR processing using the same 30-
cycle PCR conditions as described above.  
 
Electropherograms for all samples were obtained using the 3130 Genetic Analyser (Life 
Technologies). For each sample, a loading cocktail of 10μl Hi-DiTM Formamide (Life 
Technologies) and 1μl of CC5 Internal Lane Standard 500 (Promega Corp) was mixed 
with 1μl of amplified product and denatured for three minutes at 95°C. After cooling, 
samples were injected on the 3130 using a 3 kV, 5-second injection as is the 
recommended PowerPlex® ESI 16 protocol. Data were analysed using Genemapper 
ID® software version 3.2.1 (Life Technologies) and PowerPlex® ESI 16 panel and bin 
files. A detection threshold of 50 RFU was used for analysis of all sample profiles.  
 
Results were analysed to assess allele drop out (ADO) and locus drop out (LDO) levels. 
The mean peak height and mean peak height ratio (PHR) were calculated for each set of 
profiles obtained using the various Pre-PCR and second round PCR methods. The peak 
height ratios were calculated by dividing the height of the smaller peak by the height of 
the larger peak in the heterozygote pair. If allele drop out occurred at the locus, a peak 
height ratio of 0% was recorded. The peak height averages were calculated in two ways. 
First, the average of all the PHRs from sample profiles that showed both alleles was 
calculated. The second calculation included the PHRs from the profiles that showed 
both alleles, as well as the 0% PHRs recorded in profiles that showed allele drop out. 
Since the PHRs are used to measure how well both alleles at a locus amplified, 
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including the 0% PHRs would help to indicate the efficiency of the entire reaction. If 
complete LDO occurred then this locus was not used in calculating the PHR average. 
 
3.3 Results and Discussion 
The aim of this study was to develop a method that could reduce the stochastic sampling 
issues generally associated low template DNA analysis. It was proposed that dividing 
samples into two aliquots for a single-strand Pre-PCR amplification with either the 
forward or reverse primer followed by pooling the single strand products would provide 
an increased number of target molecules for STR analysis, with less stochastic effects 
than by solely performing exponential amplification. This is premised on the fact that 
the single primer reactions will generate more template in a linear or non-exponential 
manner. Since only one copy of the template is produced with each cycle the product 
generated would likely not be prey to exaggerated stochastic sampling effects, as there 
is a higher probability of a single primer annealing to the template, compared to 
traditional PCR where there is a requirement for both primers to sit down on the 
template for balanced amplification. 
 
For each template amount, samples were subjected to single locus experiments as well 
as multiplex reactions. Samples were subjected to 10-cycle or 20-cycle Pre-PCR 
amplifications with the forward or reverse primers (one primer for single locus 
experiments, primer mix of all forward or reverse primers for the multiplex reactions) 
followed by a 30- or 35-cycle amplification with the primer pair. The results of the 
analyses were compared with control samples for each template amount that only 
underwent the 30- or 35-cycle PCRs.  
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3.3.1 Single locus experiments 
3.3.1.1 30-cycle PCR 
Pooled Pre-PCR products and control samples were initially subjected to a 30-cycle 
PCR since this is the middle of the range recommended by the HotStar Taq Mastermix 
Kit manufacturers (25-35 cycles recommended). Furthermore, many of the commercial 
STR kits use a similar cycle number. Results for each sample amount are summarized in 
Tables 3.1 and 3.2. 
 
All samples subjected to the 30-cycle PCR without Pre-PCR processing failed to 
amplify. When the 10 cycle Pre-PCR was introduced improvements were seen in the 
number of loci with both alleles present for the 100pg, 50pg and 25pg samples. Results 
were further improved when the 20 cycle Pre-PCR was used (Figure 3.1).  
 
 
 
Figure 3.1 Correct genotypes recovered (30 cycle PCR). Results represent the percentage of 
samples recovered with the correct genotype after a 10- or 20-cycle Pre-PCR procedure 
followed by a 30-cycle PCR targeting a single locus. Eleven reactions were performed for each 
amplification method. Samples amplified without the Pre-PCR failed to detect any alleles. 
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With a 20-cycle Pre-PCR all 100pg sample profiles showed both alleles compared to 
82% for the 10-cycle Pre-PCR samples. The average PHR for the 100pg samples 
amplified with a 20-cycle Pre-PCR was 75%, which is slightly lower than the 10-cycle 
Pre-PCR samples of 81%, likely due to the increased allele recovery of the 20-cycle 
Pre-PCR. The increase in allele recovery and the similar PHR averages in the Pre-PCR 
samples indicate that the linear amplification provided by the Pre-PCR was sufficient to 
increase the starting template amount without substantially introducing peak height 
imbalance. 
 
 
The 50pg samples that underwent the 20-cycle Pre-PCR showed 55% of samples with 
both alleles, compared to 27% with the 10-cycle Pre-PCR, with a PHR average of 74%. 
However the remaining 45% of samples showed allele drop out, indicating that there is 
still some preferential amplification of particular alleles despite the linear amplification 
of the Pre-PCR. It is interesting to note that the PHR average for the 50pg samples 
amplified with the 10-cycle Pre-PCR is 90%, which is higher than the PHR average of 
81% for the 100pg samples also amplified with a 10-cycle Pre-PCR. However, this 
difference is also likely due to the increased allele recovery in the 100pg samples.  The 
majority of results for the 25pg and 12.5pg Pre-PCR samples showed partial profiles or 
complete LDO. This indicates that the Pre-PCR did not sufficiently increase the copy 
number of the target sequence for use as template for the 30-cycle PCR, so that both 
alleles could be observed using the QIAxcel detection system. It is possible that a 
greater number of Pre-PCR cycles would produce more complete allele, locus and 
profile results with these lower amounts of template. 
 
Peak heights were generally higher in the 20-cycle samples compared to the 10-cycle 
samples. The exception was the 25pg samples, which showed a greater average peak 
height in the 10-cycle samples compared to the 20-cycle samples. While this is an 
unexpected result, the total allele recovery was higher in 25pg samples amplified with 
the 20-cycle Pre-PCR compared to 10-cycle samples, indicating that the 20-cycle Pre-
PCR was more efficient despite the slight reduction in peak heights. 
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Table 3.1 30-Cycle single locus PCR amplification – allele recovery and peak heights  
 
  Profiles with 
both alleles 
Profiles with 
Allele Drop 
Out 
Profiles with 
Locus Drop 
Out 
Mean peak 
height (RFU) 
(Std. Dev.) 
100pg: No Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
 10-Cycle Pre-PCR 82% (7/11) 18% (4/11) 0% (0/11) 79 (22) 
 20-Cycle Pre-PCR 100% (11/11) 0% (0/11) 0% (0/11) 216 (81) 
50pg: No Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
 10-Cycle Pre-PCR 27% (3/11) 9% (1/11) 64% (7/11) 72 (22) 
 20-Cycle Pre-PCR 55% (6/11) 45% (5/11) 0% (0/11) 111 (34) 
25pg: No Pre-PCR 0% (0/11)) 0% (0/11) 100% (11/11) 
a
 
 10-Cycle Pre-PCR 9% (1/11) 0% (0/11) 91% (10/11) 131 (34) 
 20-Cycle Pre-PCR 18% (2/11) 55% (6/11) 27% (3/11) 74 (28) 
12.5pg: No Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
 10-Cycle Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
 20-Cycle Pre-PCR 0% (0/11) 18% (2/11) 82% (9/11) 66 (4) 
6.25pg: No Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
 10-Cycle Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
 20-Cycle Pre-PCR 0% (0/11) 0% (0/11) 100% (11/11) 
a
 
a
 Mean peak height not available as zero alleles appeared across all samples 
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Table 3.2 30-Cycle single locus PCR amplification – peak height ratios 
  ADO (0%) Not Included In 
The PHR Calculation 
ADO (0%) Included In The 
PHR Calculation 
  n
a
 Mean 
PHR 
Std. 
Deviation 
n
b
 Mean 
PHR 
Std. 
Deviation 
100pg: No Pre-PCR 0 - - 0 - - 
 10-Cycle Pre-PCR 7 81% 13% 11 51% 42% 
 20-Cycle Pre-PCR 11 75% 13% 11 75% 15% 
50pg: No Pre-PCR 0 - - 0 - - 
 10-Cycle Pre-PCR 3 90% 9% 4 54% 50% 
 20-Cycle Pre-PCR 6 74% 11% 11 41% 40% 
25pg: No Pre-PCR 0 - - 0 - - 
 10-Cycle Pre-PCR 1 * * 1 * * 
 20-Cycle Pre-PCR 2 83% 9% 8 21% 39% 
12.5pg: No Pre-PCR 0 - - 0 - - 
 10-Cycle Pre-PCR 0 - - 0 - - 
 20-Cycle Pre-PCR 0 - - 2 0% 0% 
6.25pg: No Pre-PCR 0 - - 0 - - 
 10-Cycle Pre-PCR 0 - - 0 - - 
 20-Cycle Pre-PCR 0 - - 0 - - 
n
a
 is the number of samples with both alleles present out of 11 total samples 
n
b
 is the number of samples with at least one allele present out of 11 total samples 
- PHR average and Std. deviation could not be calculated as zero alleles were present 
*PHR average and Std. deviation could not be calculated as only one allele pair present 
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3.3.1.2 35-cycle PCR 
The number of 30-cycle samples that showed complete LDO indicated that this 
combination of PCR chemistry and the QIAxcel system is not as sensitive as other 
fluorescence based STR kits and CE detection methods which have shown results with 
the examined template amounts amplified with 30 PCR cycles [12, 13]. As a 
consequence, samples were further analysed using a 35-cycle PCR. The results are 
summarized in Tables 3.3 and 3.4.  
 
More alleles were recovered with the 35-cycle experiments. For all template amounts, 
implementing either of the Pre-PCR procedures followed by the 35-cycle amplification 
produced a higher percentage of samples with both alleles compared to the control 
samples. Furthermore, the 20-cycle Pre-PCR samples showed a higher percentage of 
profiles with both alleles compared to 10-cycle Pre-PCR samples (Figure 3.2) Example 
QIAxcel digital gel images for each template amount can be seen in Figures 3.3 to 3.7.  
 
 
Figure 3.2 Correct genotypes recovered (35 cycle PCR). Results represent the percentage of 
samples recovered with the correct genotype after a single locus 35-cycle PCR with and without 
Pre-PCR treatment. Eleven reactions were performed for each amplification method. 
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With the 20-cycle Pre-PCR, all 100pg and 50pg samples showed both alleles. In 
comparison, 91% of 100pg and 50pg samples showed both alleles with 10-cycle Pre-
PCR and 91% and 73% respectively displayed both alleles without Pre-PCR 
amplification.  
 
The most notable differences were seen in the lower starting template samples. With 
25pg starting template only 36% of control samples showed both alleles. When the Pre-
PCR procedures were used the number of samples with both alleles increased to 64% 
with the 10-cycle Pre-PCR and 73% with the 20-cycle Pre-PCR. With 12.5pg starting 
template, none of the control samples showed both alleles. However, introducing the 
Pre-PCR techniques increased the recovery to 18% for 10 cycle samples and 73% for 
20-cycle samples and an increased number of Pre-PCR cycles may improve this further. 
The 6.25pg samples that were subjected to the 20-cycle Pre-PCR showed only 27% of 
profiles with both alleles while 64% showed partial profiles. The 10-cycle Pre-PCR 
samples also showed 27% of profiles with both alleles but only 46% with partial 
profiles. Without the Pre-PCR, the 6.25pg samples did not produce any profiles with 
both alleles and only produced 18% with partial profiles. 
Figure 3.3 Example QIAxcel digital gel image from 100pg starting template amplified with 
35 PCR cycles with and without Pre-PCR processing. Bands seen at 135bp and 147bp 
represent the 13 and 16 alleles of the WVA locus. 
 
84 
 
 Figure 3.4 Example QIAxcel digital gel image from 50pg starting template amplified with 
35 PCR cycles with and without Pre-PCR processing. Bands seen at 135bp and 147bp 
represent the 13 and 16 alleles of the WVA locus. Additional faint bands of less than 100bp can 
be seen in the first and third samples amplified with the 10 cycle Pre-PCR likely due to primer 
dimer. 
 
 
 Figure 3.5 Example QIAxcel digital gel image from 25pg starting template amplified with 
35 PCR cycles with and without Pre-PCR processing. Bands seen at 135bp and 147bp 
represent the 13 and 16 alleles of the WVA locus. Additional faint bands of less than 100bp can 
be seen in the samples amplified with both Pre-PCR procedures likely due to primer dimer. 
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Figure 3.6 Example QIAxcel digital gel image from 12.5pg starting template amplified 
with 35 PCR cycles with and without Pre-PCR processing. Bands seen at 135bp and 147bp 
represent the 13 and 16 alleles of the WVA locus. Additional faint bands of less than 100bp can 
be seen in the samples amplified with both Pre-PCR procedures likely due to primer dimer. 
 
 
 Figure 3.7 Example QIAxcel digital gel image from 6.25pg starting template amplified 
with 35 PCR cycles with and without Pre-PCR processing. Bands seen at 135bp and 147bp 
represent the 13 and 16 alleles of the WVA locus. Additional faint bands of less than 100bp can 
be seen in the samples amplified with both Pre-PCR procedures likely due to primer dimer. 
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Table 3.3 35-Cycle single locus PCR amplification – allele recovery and peak heights 
 Profiles with 
both alleles 
Profiles with 
Allele Drop 
Out 
Profiles with 
Locus Drop 
Out 
Mean peak 
height (RFU)    
(Std. Dev.) 
100pg: No Pre-PCR 91% (10/11) 9% (1/11) 0% (0/11) 331 (165) 
 10-Cycle Pre-PCR 91% (10/11) 9% (1/11) 0% (0/11) 1071 (407) 
 20-Cycle Pre-PCR 100% (11/11) 0% (0/11) 0% (0/11) 1479 (466) 
50pg: No Pre-PCR 73% (8/11) 27% (3/11) 0% (0/11) 199 (81) 
 10-Cycle Pre-PCR 91% (10/11) 9% (1/11) 0% (0/11) 642 (413) 
 20-Cycle Pre-PCR 100% (11/11) 0% (0/11) 0% (0/11) 1059 (485) 
25pg: No Pre-PCR 36% (4/11) 27% (3/11) 36% (4/11) 165 (44) 
 10-Cycle Pre-PCR 64% (7/11) 27% (3/11) 9% (1/11) 470 (225) 
 20-Cycle Pre-PCR 73% (8/11) 27% (3/11) 0% (0/11) 825 (404) 
12.5pg: No Pre-PCR 0% (0/11) 18% (2/11) 82% (9/11) 110 (25) 
 10-Cycle Pre-PCR 18% (2/11) 36% (4/11) 46% (5/11) 274 (130) 
 20-Cycle Pre-PCR 73% (8/11) 27% (3/11) 0% (0/11) 527 (337) 
6.25pg: No Pre-PCR 0% (0/11) 18% (2/11) 82% (9/11) 85 (50) 
 10-Cycle Pre-PCR 27% (3/11) 46% (5/11) 27% (3/11) 246 (120) 
 20-Cycle Pre-PCR 27% (3/11) 64% (7/11) 9% (1/11) 363 (215) 
 
  
87 
 
Table 3.4 35-Cycle single locus PCR amplification – peak height ratios  
 ADO (0%) Not Included In 
The PHR Calculation 
ADO (0%) Included In The 
PHR Calculation 
  n
a
 Mean 
PHR 
Std. 
Deviation 
n
b
 Mean 
PHR 
Std. 
Deviation 
100pg: No Pre-PCR 10 79% 19% 11 72% 30% 
 10-Cycle Pre-PCR 10 83% 14% 11 75% 28% 
 20-Cycle Pre-PCR 11 79% 6% 11 79% 6% 
50pg: No Pre-PCR 8 70% 19% 11 51% 37% 
 10-Cycle Pre-PCR 10 70% 28% 11 63% 34% 
 20-Cycle Pre-PCR 11 68% 20% 11 68% 20% 
25pg: No Pre-PCR 4 91% 7% 7 52% 49% 
 10-Cycle Pre-PCR 7 62% 18% 10 44% 34% 
 20-Cycle Pre-PCR 8 65% 28% 11 47% 38% 
12.5pg: No Pre-PCR 0 - - 2 0% 0% 
 10-Cycle Pre-PCR 2 38% 16% 6 13% 21% 
 20-Cycle Pre-PCR 8 55% 22% 11 40% 32% 
6.25pg: No Pre-PCR 0 - - 2 0% 0% 
 10-Cycle Pre-PCR 3 58% 22% 8 22% 32% 
 20-Cycle Pre-PCR 3 32% 4% 10 10% 16% 
n
a
 is the number of samples with both alleles present out of 11 total samples 
n
b
 is the number of samples with at least one allele present out of 11 total samples 
- PHR average and Std. deviation could not be calculated as zero alleles were present 
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Across all template amounts, the average peak height was greater with the Pre-PCR 
procedures compared to control samples. Furthermore, for each template amount, the 
20-cycle Pre-PCR produced higher peaks than seen in the 10-cycle Pre-PCR samples. 
 
For the 100pg and 50pg starting templates, PHR averages for the control, 10-cycle and 
20-cycle samples were all very similar despite the increase in allele recovery and peak 
height (79%, 83% and 79% respectively for the 100pg samples and 71%, 70% and 68% 
respectively for the 50pg samples when looking at profiles that showed both alleles, and 
72%, 79% and 79% respectively for the 100pg samples and 51%, 63% and 68% 
respectively for 50pg samples when the 0% PHRs were included in the calculation). 
These results indicate that the Pre-PCR is providing more template copies for STR 
analysis without considerably introducing peak height imbalance.  
 
For the 25pg samples there was a reduction in the PHR average for samples with both 
alleles present when the Pre-PCR methods were introduced, from 91% for control 
samples down to 62% for 10-cycle samples and 65% for 20-cycle samples. This 
reduction in PHR average is likely because the Pre-PCR step allows for additional 
alleles to be detected that would not normally be seen in the control samples. Indeed 
there was a was an increase of 28% in the number of samples that showed both alleles 
in the 10-cycle Pre-PCR samples compared to the control samples, and an increase of 
37% for the 20-cycle Pre-PCR samples compared to the control samples. These 
additional small peaks seen in the Pre-PCR samples would have reduced the peak height 
ratios, whereas the same alleles would likely have dropped out completely in the control 
samples and therefore not contributed to the peak height ratio calculations.  
 
Some additional bands were seen in the QIAxcel profiles. Of the 350 total samples 48 
additional alleles were noted. All but 2 of these additional alleles were seen in the Pre-
PCR treated samples.  The two additional alleles were seen in the same profile. Of the 
46 additional alleles seen in Pre-PCR samples, all except one were seen in the 35-cycle 
89 
 
samples. However, the fragment length range for the alleles of the vWA locus is 123bp 
to 171bp and 47 of the 48 additional bands were within the range of 61bp to 108bp. The 
remaining additional band was 358bp in length. Since most of these fragments are 
shorter than the smallest possible allele for the locus and almost all are only present in 
the Pre-PCR samples they are likely a product of primer dimer from the excess primers 
in the reaction rather than true contamination. As such they would not be likely to be 
detected as alleles or even artefacts in a well-developed and balanced fluorescent STR 
kit. 
 
3.3.2 Multiplex experiments 
Results for the multiplex reactions also showed improvements in the total number of 
alleles recovered with the implementation of the Pre-PCR procedures (Figure 3.8). 
Details of all results can be seen in Tables 3.5 and 3.6. For all template amounts, more 
loci showed both alleles within each multiplex profile with the Pre-PCR than control 
samples amplified with the ESI 16 kit alone. The 100pg and 12.5pg samples showed a 
greater number of loci with both alleles correct in the 20-cycle Pre-PCR compared to 
the 10-cycle Pre-PCR. The 50pg, 25pg and 6.25pg samples showed a slightly higher 
number of loci with both alleles correct with the 10-cycle Pre-PCR compared to the 20-
cycle Pre-PCR. However, for the 25pg samples the number of alleles recovered in total 
was greater with the 20-cycle Pre-PCR.  
 
Peak heights were also greater in the Pre-PCR samples compared to the controls. 
Despite the increase in allele recovery and peak height, the peak height ratios did not 
differ greatly for the control, 10-cycle and 20-cycle Pre-PCR samples with 100pg, 50pg 
and 25pg starting templates (71%, 59% and 64% respectively for the 100pg samples, 
72%, 65% and 76% respectively for the 50pg samples and 66%, 60% and 61% 
respectively for 25pg samples when looking at loci that showed both alleles, and 67%, 
59% and 64% respectively for the 100pg samples, 55%, 55% and 58% respectively for 
50pg samples and 16%, 38% and 32% respectively for 25pg samples when the 0% 
PHRs were included in the calculation). This indicates that neither Pre-PCR procedure 
introduced further stochastic variation.   
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Figure 3.3 Correct alleles recovered in multiplex samples amplified with and without Pre-
PCR processing. Results represent the average percentage of alleles recovered per 16-locus 
multiplex PCR sample. Three reactions were performed for each amplification method. Error 
bars represent standard error of the mean. A 2-way ANOVA with Bonferroni post-tests was 
performed to compare results from 10-cycle pre-PCR and 20-cycle pre-PCR samples to samples 
amplified without either pre-PCR procedure. As indicated,** represents a p-value of less than 
0.01 and *** represents a p-value of less than 0.001. 
 
 
 
The 12.5pg and 6.25pg control samples had higher peak height ratio averages compared 
to the 10- and 20- cycle Pre-PCR samples (93%, 41% and 66% respectively for the 
12.5pg samples and 96%, 59% and 65% respectively for the 6.25pg samples when 
looking at loci that showed both alleles). However, like the single locus experiments, 
this is likely due to the increased allele recovery seen in the Pre-PCR samples. 
Furthermore, although the control samples have a higher mean PHR, the PHR averages 
(looking at loci with both alleles present) for the 12.5pg 20-Cycle Pre-PCR samples and 
the 6.25pg 10- and 20-cycle Pre-PCR samples are still at a reasonable level for single 
source samples. 
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With 100pg starting template the 10- and 20-cycle Pre-PCR produced STR profiles with 
all loci correct. However below this template amount, while there was an increase in 
allele recovery overall with the Pre-PCR, none of the control, 10- or 20-cycle Pre-PCR 
samples showed the complete multiplex STR profile. Since the second round PCR only 
used half of the pooled Pre-PCR sample results could be improved if the entire Pre-PCR 
sample was used.  Further improvements may also be seen with an increase in the 
number of Pre-PCR cycles. The linear amplification of the Pre-PCR step has not 
introduced further stochastic variation compared to samples amplified without Pre-PCR 
processing when 20 Pre-PCR cycles were used. However, there is the possibility of 
introducing amplification bias if the number of Pre-PCR cycles is increased. 
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Table 3.5 Multiplex PCR amplification – allele recovery and peak heights 
 Correct Loci Loci with 
Allele Drop 
Out 
Loci with 
Locus Drop 
Out 
Mean peak 
height 
(RFU)    
(Std. Dev.) 
100pg: No Pre-PCR 96% (46/48) 4% (2/48) 0% (0/48) 204 (80) 
 10-Cycle Pre-PCR 100% (48/48) 0% (0/48) 0% (0/48) 514 (500) 
 20-Cycle Pre-PCR 100% (48/48) 0% (0/48) 0% (0/48) 742 (542) 
50pg: No Pre-PCR 77% (37/48) 19% (9/48) 4% (2/48) 118 (49) 
 10-Cycle Pre-PCR 85% (41/48) 13% (6/48) 2% (1/48) 330 (302) 
 20-Cycle Pre-PCR 79% (38/48) 19% (9/48) 2% (1/48) 372 (277) 
25pg: No Pre-PCR 23% (11/48) 38% (18/48) 39% (19/48) 94 (36) 
 10-Cycle Pre-PCR 60% (29/48) 25% (12/48) 15% (7/48) 187 (132) 
 20-Cycle Pre-PCR 58% (28/48) 36% (17/48) 6% (3/48) 197 (147) 
12.5pg: No Pre-PCR 10% (5/48) 15% (7/48) 75% (36/48) 78 (31) 
 10-Cycle Pre-PCR 21% (10/48) 41% (20/48) 38% (18/48) 143 (100) 
 20-Cycle Pre-PCR 48% (23/48) 36% (17/48) 17% (8/48) 156 (127) 
6.25pg: No Pre-PCR 4% (2/48) 13% (6/48) 83% (40/48) 70 (13) 
 10-Cycle Pre-PCR 17% (8/48) 33% (16/48) 50% (24/48) 100 (52) 
 20-Cycle Pre-PCR 13% (6/48) 17% (8/48) 70% (34/48) 140 (62) 
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Table 3.6 Multiplex PCR amplification – peak height ratios  
 ADO (0%) Not Included In 
The PHR Calculation 
ADO (0%) Included In The 
PHR Calculation 
  n
a
 Mean 
PHR 
Std. 
Deviation 
n
b
 Mean 
PHR 
Std. 
Deviation 
100pg: No Pre-PCR 37 71% 19% 39 67% 23% 
 10-Cycle Pre-PCR 39 59% 23% 39 59% 23% 
 20-Cycle Pre-PCR 39 64% 24% 39 64% 24% 
50pg: No Pre-PCR 28 72% 18% 37 55% 35% 
 10-Cycle Pre-PCR 32 65% 23% 38 55% 32% 
 20-Cycle Pre-PCR 29 76% 20% 38 58% 37% 
25pg: No Pre-PCR 6 66% 10% 24 16% 29% 
 10-Cycle Pre-PCR 21 60% 24% 33 38% 34% 
 20-Cycle Pre-PCR 19 61% 23% 36 32% 35% 
12.5pg: No Pre-PCR 2 93% 6% 9 21% 41% 
 10-Cycle Pre-PCR 4 41% 10% 24 7% 16% 
 20-Cycle Pre-PCR 14 66% 23% 31 30% 37% 
6.25pg: No Pre-PCR 1 96% 0% 6 16% 39% 
 10-Cycle Pre-PCR 4 59% 22% 20 12% 26% 
 20-Cycle Pre-PCR 3 65% 10% 11 18% 31% 
n
a
 is the number of loci with both alleles present out of 39 total heterozygous loci 
n
b
 is the number of loci with at least one allele present out of 39 total heterozygous loci 
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3.4 Conclusion 
Overall this research has demonstrated that improved STR profiles from samples with 
low levels of template can be obtained using a 10- or 20-cycle Pre-PCR amplification 
prior to a single locus or multiplex PCR with the 20-cycle Pre-PCR generally providing 
the highest percentage of profiles with both alleles.  The 20-cycle Pre-PCR also 
produced profiles with higher average peak heights compared to 10-cycle Pre-PCR 
samples and control samples for almost all template amounts. The peak height ratios for 
the Pre-PCR amplified samples were not considerably different compared with control 
samples in the single locus experiments for the 100pg and 50pg template amounts 
amplified with 35 PCR cycles, and in the multiplex experiments using 100pg, 50pg and 
25pg starting template, indicating that the linear amplification of the Pre-PCR was 
increasing the number of template copies available for the PCR without introducing 
substantial amplification bias for these template amounts.  The PHRs were reduced for 
the single locus 25pg samples that underwent either Pre-PCR followed by a 35-cycle 
amplification and the 12.5pg and 6.25pg multiplex Pre-PCR samples compared to the 
control samples, likely due to the increased allele recovery in the Pre-PCR samples. The 
increased allele recovery seen in the 12.5pg and 6.25pg single locus Pre-PCR samples 
amplified with 35 cycles improved the PHRs compared to the controls since none of the 
samples showed both alleles in the control samples. However, for both the single locus 
and multiplex 12.5pg and 6.25pg Pre-PCR samples allelic imbalance was still present 
with considerable allele drop out and very low PHR averages when the allele drop-out 
loci are included in the calculation, indicating that the Pre-PCR, at least when limited to 
20 cycles, is not sufficient to improve the number of template copies for the PCR 
amplification for such low level samples. 
 
In these experiments, only half of the first-round Pre-PCR product was used as the 
template for the second-round PCR. While this was still shown to improve allele 
recovery, results may be further improved if the entire first round PCR product was 
used. Future work could therefore involve further reducing the volume of the first-round 
Pre-PCR or increasing the volume of the second round PCR so that all of the possible 
template could be used for the second PCR amplification. The use of fluorescence based 
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CE would also be useful for single locus PCR samples, as this would significantly 
increase the sensitivity and likely allow for more alleles to be seen in final profiles 
without the need for increasing the number of PCR cycles. Future research would also 
need to involve further development of the multiplex Pre-PCR amplification as 
multiplex STR profiling is a primary method of human identification used in forensic 
casework.  
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CHAPTER 4 
 
WHOLE GENOME AMPLIFICATION 
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4.1 Introduction 
Whole genome amplification has been proposed as a promising method for increasing 
the template copy number of limited quantity DNA samples prior to traditional DNA 
profiling [17].  Theoretically, WGA should be capable of copying all of the DNA in a 
representative fashion to produce large quantities of product for standard forensic 
analysis [17]. Several methods of WGA have been investigated including PCR based 
techniques [97-100] and Multiple Displacement Amplification (MDA) [116-118]. 
MDA, an isothermal amplification technique that utilizes φ29 DNA polymerase and 
random hexamer primers, has been shown to produce higher yields [109-113] and 
improved genome coverage [111, 113-115] compared to PCR based methods. 
 
STR profiling on MDA product that used LTDNA as the starting template has been 
investigated [115, 124, 125]. In each case, exaggerated stochastic variation in the form 
of allele drop out was observed in the STR profiles when less than 1ng [115], 500pg 
[124] or 250pg [125] was used as the starting template. Despite this, results showed that 
the profiling success of LTDNA increases with MDA, with one study reporting an 
average of 7 more alleles being observed in WGA samples than non WGA samples 
from 10pg of starting template [115].  However, none of the LTDNA samples in that 
study, with or without WGA, produced STR profiles that had all alleles present [115]. 
Peak height imbalance, increased stutter and allele drop out are also commonly 
observed in many MDA samples from LTDNA starting templates [115, 124, 125]. 
 
Initial WGA experiments aimed to examine the ability of one commercial WGA kit – 
the GenomiPhi V2 DNA Amplification Kit (GE Healthcare, Buckinghamshire, 
England) – to amplify low template DNA for forensic STR analysis. Modifications to 
the standard protocol also were examined to see if these changes could improve the 
MDA efficiency to result in a more complete forensic STR profile with reduced allelic 
imbalance compared to the manufacturer‘s protocol.  
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The first modification, called the ―Cycling protocol‖ involved introducing heating and 
cooling cycles at the start of the MDA reaction. It was proposed that heating the 
reaction to 40°C would halt the reaction such that the amplification process could be re-
initiated at another random site on the template when the sample was returned to 30°C. 
The second amendment, referred to as the ―Split and Pool protocol‖, involved dividing 
the MDA reaction into 4 aliquots prior to amplification, then pooling the aliquots prior 
to STR profiling. It was proposed that splitting the reaction then re-pooling for STR 
analysis could help balance any amplification bias that may be produced in each 
individual aliquot. The third variation involved denaturing only half of the DNA and 
was called the ―Half Denatured protocol‖. Previous work has shown that combining 
WGA product from two reactions, one where the DNA was denatured prior to the 30°C 
incubation and one where the DNA was not denatured, resulted in STR profiles with 
greater balance between alleles at heterozygous loci [129]. The Half Denatured protocol 
followed a similar method. However, denatured DNA was combined with DNA that 
was not denatured prior to the incubation so that the WGA reaction was performed in a 
single tube.   
 
After the initial experiments described above were performed, a novel WGA kit called 
AT GenomiPhi (AT Kit) was provided by GE Healthcare for comparison to the 
GenomiPhi V2 DNA Amplification Kit. This kit is similar to the traditional GenomiPhi 
V2 DNA amplification kit in that it uses φ29 DNA polymerase to amplify genetic 
material in an isothermal reaction. However, in the AT kit novel hexamer primers 
containing 2-amino-deoxyadenosine and 2-thio-deoxythymidine are used to help reduce 
primer dimer formation and consequent non-specific amplification [169]. An additional 
polymerase cleaning step is also introduced to remove any contaminating DNA from 
the reagents [170].  
  
A third WGA kit, the REPLI-g Mini Kit (QIAGEN, Hilden, Germany), was also 
assessed to determine which could best amplify LTDNA for forensic STR analysis. The 
AT kit was also used to amplify low template mixture samples with either equal input 
from both contributors (1:1 ratio) or major and minor contributions (9:1 ratio) to assess 
whether these WGA methods could improve allele recovery.  Finally, the Cycling and 
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Split and Pool protocols were applied to the AT Kit to see if improvements could be 
made compared to the standard protocol. 
 
4.2. Methods 
4.2.1. Sample preparation 
This project was approved by the Bond University Human Research Ethics Committee 
(BUHREC), approval number RO743. Whole blood samples were provided by four 
anonymous donors with informed consent. DNA was extracted using the BioRobot 
EZ1® Workstation with the EZ1® DNA Blood Kits (QIAGEN) according to the 
manufacturer‘s instructions. DNA extracts were quantified using the method outlined in 
section 2.2.1. 
 
For the first group of experiments, extracts were diluted to 1ng/µl and 500pg/µl to be 
used as controls as well as low template levels of levels 60pg/µl, 30pg/µl, 12pg/µl and 
6pg/µl. For the second group of experiments, 10ng/µl, 1ng/µl and 500pg/µl dilutions 
were generated as controls as well as low template samples of 100pg/µl, 50pg/µl, 
25pg/µl and 10pg/µl. Two person mixture samples were also created. The first mixture, 
called ―M1‖ contained 50pg/µl from both contributors such that the total concentration 
was 100pg/µl with a 1:1 ratio. The second mixture, ―M2‖ contained 450pg/µl from one 
contributor and 50pg/µl from the second contributor, for a total concentration of 
500pg/µl with a 9:1 ratio. 
 
4.2.2 Whole genome amplification  
In the first group of experiments ten of each 1ng/µl, 60pg/µl, 30pg/µl, 12pg/µl and 
6pg/µl were amplified using the GenomiPhi V2 DNA Amplification Kit. The same 
dilutions were also amplified using the Cycling Protocol, the Split and Pool Protocol 
and the Half Denatured Protocol. Ten samples were amplified for each of the starting 
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template amounts with the various protocol amendments. Reactions were performed 
using a GeneAmp® PCR System 9700 (Life Technologies, Carlsbad, CA, USA).   
 
In the Cycling Protocol, WGA reactions were set up according to the manufacturer‘s 
instructions then incubated with the following cycling conditions: 30 cycles of 30°C for 
10 seconds then 40°C for 5 seconds, followed by a 30°C incubation for 2 hours. The 
reaction was deactivated with a 65°C incubation for 20 minutes then sampled were 
cooled and held at 4°C.  
 
For the Split and Pool Protocol, samples were prepared as per the manufacturer‘s 
instructions, but were divided into 4 x 5µl aliquots for the 30°C incubation. The aliquots 
were then pooled after the amplification process.   
 
In the Half Denatured protocol, 1µl containing entire template amount to be amplified 
was placed in a 0.2ml PCR tube with 9µl of GenomiPhi Sample Buffer. The sample was 
briefly mixed then 5µl was removed and placed in a separate 0.2ml tube on ice. The 
remaining 5µl was heat denatured at 95°C for 3 minutes then cooled to 4°C on ice. 
Aliquots containing the denatured DNA and the non-denatured DNA were combined 
and the reaction continued as per the manufacturer‘s protocol.  All WGA samples from 
the second set of experiments were diluted 1:100 for STR analysis. 
 
In the second set of experiments, five of each 10ng/µl, 100pg/µl, 50pg/µl, 25pg/µl and 
10pg/µl dilutions were amplified using the REPLI-g Mini Kit and the GenomiPhi V2 
DNA Amplification Kit according to the manufacturer‘s instructions. However, the 
recommended reaction volume was halved to 25µl for the REPLI-g kit.  Amplification 
using the AT kit involved a three step process of Polymerase Cleaning, Template 
Preparation and Reaction Initiation. In the Polymerase Cleaning step, for each reaction 
to be performed, 7µl of water, 10µl of 2X Reaction Buffer, 0.8µl of AT oligo, and 0.4µl 
of Phi29 polymerase were combined in a 0.2ml PCR tube. Samples were incubated at 
30°C for 1 hour then held at 4°C. In the Template Preparation step one volume of 
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required DNA template was combined with one volume of Denaturation Solution (0.4 
M NaOH, 1 mM EDTA) and held on ice for 10 minutes. One volume of Neutralization 
Solution (0.4 M HCl, 0.6 M Tris, pH 7.5) was then added to halt the DNA denaturation 
process. In the Reaction Initiation step, 0.8µl of 10 mM dNTPs and 1µl of prepared 
DNA template were added to each cleaned Reaction Buffer sample and incubated at 
30°C for 2.5 hours. All WGA reactions were performed using a GeneAmp® PCR 
System 9700.  Five replicates of each mixture sample were also amplified using the AT 
Kit according to the manufacturer‘s instructions.  
 
Two modified methods - the Cycling Protocol and the Split and Pool Protocol - were 
also applied to the AT Kit, with 10ng, 1ng, 100pg and 10pg input template amounts 
amplified in triplicate.  All WGA samples from the second set of experiments were 
quantified in triplicate after the WGA reaction using SensiMix
TM
 High Resolution Melt 
Kits. Samples were diluted to 500pg/µl as well as 1:100 for STR analysis. 
 
4.2.3 Short tandem repeat analysis 
STR analysis was performed on 1µl of each WGA dilution using the PowerPlex
®
 ESI 
16 Kits (Promega Corp, Madison, WI, USA) according to the manufacturer‘s 
instructions.  Profiles were also obtained for 10 replicates of each 500pg/µl, 60pg/µl, 
30pg/µl, 12pg/µl and 6pg/µl dilution as control samples that did not undergo WGA for 
the first set of experiments. Five replicates of each 500pg/µl, 100pg/µl, 50pg/µl, 
25pg/µl and 10pg/µl dilution as well as both mixture samples were amplified as controls 
for the second set of experiments. Electropherograms for all samples were obtained 
using the 3130 Genetic Analyser (Life Technologies). For each sample a loading 
cocktail of 10µl Hi-Di
TM
 Formamide (Life Technologies) and 1µl of CC5 Internal Lane 
Standard 500 (Promega Corp) was mixed with 1µl of amplified product and denatured 
for three minutes at 95°C. After cooling, samples were injected on the 3130 using a 3kv, 
5 second injection as is the recommended PowerPlex
®
 ESI 16 protocol. Data were 
analysed using Genemapper ID® software version 3.2.1 (Life Technologies) and 
PowerPlex
®
 ESI 16 panels and bins files. A detection threshold of 100 RFU was used 
for analysis of all sample profiles.   
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All electropherograms were compared to a reference profile to determine if exaggerated 
stochastic sampling variation was present in the profiles. For the purpose of this study, 
exaggerated stochastic effects include preferential amplification of one allele of a 
heterozygous pair resulting in a peak height ratio of less than 60%, failure of one allele 
at a heterozygous locus to amplify resulting in allele drop out, complete amplification 
failure resulting in locus drop out and spurious contamination resulting in allele drop in. 
 
For all profiles allele drop out (ADO), locus drop out (LDO), peak heights and peak 
height ratios (PHR) were recorded. PHRs were determined by dividing the height of the 
smaller peak in a heterozygote pair by the height of the larger peak. If allele drop out 
occurred at the locus, a peak height ratio of 0% was recorded. The peak height averages 
were calculated in two ways. First, the average of all the PHRs from sample profiles 
that showed both alleles was calculated. The second calculation included the PHRs from 
the profiles that showed both alleles, as well as the 0% PHRs recorded in profiles that 
showed allele drop out. Since the PHRs are used to measure how well both alleles at a 
locus amplified, including the 0% PHRs would help to indicate the efficiency of the 
entire reaction. If complete LDO occurred then this locus was not used in calculating 
the PHR average. 
 
4.3 Results and Discussion 
4.3.1GenomiPhi modifications 
This study initially aimed to assess the ability of the GenomiPhi V2 DNA Amplification 
Kit to amplify low template DNA. Modifications to the standard protocol were also 
examined. The efficiency of the WGA reactions was assessed through multi-locus STR 
analysis.  STR results for WGA samples were compared to a reference sample to 
determine if any allele or locus drop out had occurred.  Peak heights and PHRs for each 
heterozygous locus were recorded. WGA sample profiles were also compared to 
profiles obtained using the same low level DNA starting template without WGA 
treatment to determine if allele recovery was improved with the prior amplification. 
Detailed results can be seen in Figure 4.1 and Tables 4.1 and 4.2. 
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STR analysis using 500pg genomic DNA starting template (the PowerPlex
®
 ESI 16 
recommended amount) without prior WGA produced, as expected, profiles with 100% 
allele recovery. Heterozygous loci showed well balanced peaks with a PHR average of 
83% and an average peak height of 2157 RFU. All STR profiles from 1ng samples 
amplified with the standard and modified GenomiPhi methods showed all alleles 
recovered except for the standard protocol, which showed a single allele drop out in one 
profile. Each of the methods showed similar PHRs with averages for each method 
ranging from 68% to 76%, indicating that the standard WGA protocol and the modified 
methods were all amplifying the DNA in a representative fashion. STR profiles also 
showed alleles with similar peak heights. WGA samples were not quantified prior to 
STR analysis rather all WGA samples underwent a 1:100 dilution for STR analysis. 
Therefore, the similar peak heights indicate that, at least with 1ng starting template, all 
methods produced similar amounts of amplification product. 
 
 
Figure 4.1 Correct alleles recovered in STR profiles of samples amplified with modified 
GenomiPhi protocols. Results represent the average percentage of alleles recovered from ten 
reactions for each WGA method. 
a 
For samples that underwent the various GenomiPhi protocols 1ng 
was used as the template for WGA. 1ng WGA results were compared to STR profiles that used the 
ESI 16 kit recommended template of 500pg. All WGA samples were diluted 1:100 for STR analysis. 
Error bars represent standard error of the mean.  A 2-way ANOVA with Bonferroni post-tests was 
performed to compare the samples amplified using various WGA protocols to profiles obtained 
without prior WGA. As indicated, * represents a p-value of less than 0.05, ** represents a p-value of 
less than 0.01 and *** represents a p-value of less than 0.001. 
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Table 4.1 GenomiPhi with modified protocols – allele recovery 
 % Mean Correct 
Alleles Per Profile
a
 
(Std. Dev.) 
% Allele 
Drop Out
b
 
% Locus 
Drop Out
c
 
Rec
d
: Without WGA 100% (0%) 0% 0% 
 Standard 100% (1%) 1% 0% 
 Cycling 100% (0%) 0% 0% 
 Split and Pool 100% (0%) 0% 0% 
 Half Denatured 100% (0%) 0% 0% 
60pg: Without WGA 68% (13%) 25% 19% 
 Standard 96% (4%) 7% 1% 
 Cycling 91% (5%) 15% 1% 
 Split and Pool 61% (6%) 47% 16% 
 Half Denatured 57% (7%) 50% 18% 
30pg: Without WGA 39% (13%) 33% 43% 
 Standard 86% (6%) 26% 2% 
 Cycling 79% (7%) 25% 8% 
 Split and Pool 28% (6%) 38% 54% 
 Half Denatured 30% (7%) 41% 49% 
12pg: Without WGA 5% (4%) 10% 90% 
 Standard 54% (11%) 40% 27% 
 Cycling 51% (13%) 45% 27% 
 Split and Pool 1% (3%) 3% 97% 
 Half Denatured 15% (8%) 24% 74% 
6pg: Without WGA 1% (1%) 1% 98% 
 Standard 33% (8%) 43% 46% 
 Cycling 25% (5%) 39% 54% 
 Split and Pool 0% (1%) 1% 99% 
 Half Denatured 8% (7%) 10% 87% 
a
 Results represent the average of ten reactions per method. 
b
 Results represent the percentage of loci with ADO of 150 heterozygous loci 
c
 Results represent the percentage of loci with LDO of 160 total loci 
d
 Rec = Recommended template amount, with 1ng used as the starting template for all WGA 
reactions and 500pg used as the starting template for STR analysis without WGA. 
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Exaggerated stochastic variation was observed in all STR profiles from LTDNA 
without prior WGA. As expected, allele and locus drop out increased while peak heights 
decreased with reduced starting template amounts. When the various WGA methods 
were used to amplify the low template DNA samples, an overall increase in the number 
of alleles recovered per profile was observed. This was expected since previous studies 
have shown that WGA could improve allele recovery with LTDNA starting template 
[115, 125].  
 
Results showed that the greatest allele recovery was achieved with the standard protocol 
followed by the Cycling protocol, with both protocols continually showing greater allele 
recovery compared to STR profiles from low template samples that did not undergo 
prior WGA (Figure 4.1). The Split and Pool and Half Denatured protocols consistently 
showed lower allele recovery compared to the standard and Cycling protocols, with the 
Split and Pool protocol generally showing the lowest efficiency of the methods.  With 
60pg and 30pg starting templates, the Half Denatured protocol showed lower allele 
recovery compared to samples that did not undergo WGA. However, the allele recovery 
was higher in the Half Denatured WGA samples with 12pg and 6pg starting template 
compared to samples without WGA. Across all low template amounts the Split and Pool 
protocol consistently showed less alleles recovered compared to samples that did not 
undergo prior WGA. 
 
 The low allele recovery for the various WGA protocols is likely due to the 1:100 
dilution of WGA product prior to STR analysis. Since WGA reactions were not 
quantified prior to STR analysis the 1:100 dilutions may have reduced the template to 
sub optimal levels. It is therefore recommended that for further experiments the WGA 
samples be quantified prior to STR analysis so that sufficient DNA template can be 
added for optimal profiling results.  
 
Overall the PHR averages for the LTDNA control samples without WGA were higher 
than the WGA samples when examining loci with both alleles present.   This is likely 
because the various WGA protocols allow for additional alleles to be detected that 
  
107 
 
would not normally be seen in the control samples. Additional small peaks seen in the 
WGA samples may reduce the PHRs, whereas the same alleles would likely have 
dropped out completely in the control samples and therefore not contributed to the PHR 
calculations. Including the 0% ADO scores in the PHR calculation reduced the means, 
such that control and WGA samples showed similar results (Table 4.2).  
 
PHRs were similar for all WGA methods across all LTDNA starting templates, with 
averages generally less than 50% for all protocols using both PHR calculation methods. 
The exception to this was the 12pg samples amplified with the Half Denatured protocol 
which had a PHR mean of 69% when ADO was not included in the calculation.  
However, only three heterozygous loci contributed to this average calculation.  Such 
low PHR averages overall indicate that none of the WGA methods are amplifying the 
DNA in a representative fashion. Any bias introduced during the WGA process can then 
be further amplified by the STR PCR, resulting in DNA profile interpretation 
difficulties. Therefore these results indicate that further improvements must be made to 
the WGA process before this could be routinely introduced into LTDNA forensic 
casework.  
 
4.3.2 Comparison of commercial and novel WGA kits 
After the initial experiments, a novel WGA formulation, called the AT Kit, was 
provided by GE Healthcare for assessment and comparison to other commercial WGA 
kits. The second set of WGA experiments therefore aimed to determine the 
amplification efficiency of the AT Kit compared to the GenomiPhi V2 DNA 
Amplification Kit and the REPLI-g Mini Kit. Modifications to the recommended AT 
Kit protocol were also examined. The efficiency of these reactions was assessed through 
real time PCR quantification and multi-locus STR profiling as outlined below.  
 
Quantification results for all samples can be seen in Figure 4.2. Results show that the 
AT Kit gave the highest levels of product after amplification when 10ng was used as the 
starting template. However below this amount, the AT Kit generally gave the lowest 
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quantification results. The REPLI-g kit, which gave the lowest quantification results for 
the 10ng samples, generally produced the highest quantification results for the low 
template samples. The exception to this was with the 50pg samples, which showed the 
highest amount of amplification product with the GenomiPhi kit followed by REPLI-g 
then the AT Kit. All samples were diluted to 500pg/µl based on the average of the 
triplicate quantification results for each sample, with 1µl of each dilution used as the 
starting template for multi-locus STR analysis using the PowerPlex
®
 ESI 16 kit.  
 
 
Figure 4.2 DNA quantification after whole genome amplification. Results represent the 
average DNA concentration result from five reactions for each WGA method with standard 
error of the mean.   
 
Detailed STR results for control sample as well as samples amplified with the three 
WGA kits prior to STR analysis can be seen in Figure 4.3 and Tables 4.3 and 4.4. As 
expected STR analysis using 500pg genomic DNA starting template without prior 
WGA produced, profiles with 100% allele recovery. Heterozygous loci showed well 
balanced peaks with a PHR average of 82% and an average peak height of 2157 RFU. 
When the three WGA kits were used to amplify the recommended 10ng starting 
template all STR profiles from the amplified templates diluted to 500pg/µl displayed 
100% allele recovery.  Average PHRs for all samples amplified with the WGA kits 
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were slightly higher than the 500pg control samples. Average peak heights were similar 
for control and WGA samples. While 10ng genomic DNA is more than sufficient to 
perform STR analysis without prior WGA, these results could be useful for other 
techniques such as SNP genotyping by microarray or next generation sequencing that 
may require significantly higher amounts of starting template.  
 
 
 
 
Figure 4.3 Correct alleles recovered in single source profiles of samples amplified with 
various commercial WGA kits. Results represent the average percentage of alleles recovered 
from five reactions for each WGA method. 
a 
For samples that underwent the various WGA 
procedures 10ng was used as the template for WGA. Since this amount too high to be used in an 
STR reaction, results were compared to STR profiles that used the ESI 16 kit recommended 
template of 500pg. All WGA samples were diluted to 500pg/µl for STR analysis. Error bars 
represent standard error of the mean. A 2-way ANOVA with Bonferroni post-tests was 
performed to compare samples amplified with the various WGA methods to samples amplified 
without prior WGA. As indicated, *** represents a p-value of less than 0.001. 
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Table 4.3 500pg/µl dilution of WGA products – allele recovery 
 % Mean Correct 
Alleles Per Profile
a
 
(Std. Dev.) 
% Allele 
Drop Out
b
 
% Locus 
Drop Out
c
 
Rec
d
: Without WGA 100% (0) 0% 0% 
 GenomiPhi 100% (0) 0% 0% 
 REPLI-g 100% (0) 0% 0% 
 AT 100% (0) 0% 0% 
100pg: Without WGA 96% (3%) 8% 0% 
 GenomiPhi 88% (7%) 21% 1% 
 REPLI-g 99% (1%) 1% 0% 
 AT 100% (0%) 0% 0% 
50pg: Without WGA 45% (27%) 35% 38% 
 GenomiPhi 87% (11%) 24% 1% 
 REPLI-g 97% (3%) 5% 0% 
 AT 99% (1%) 1% 0% 
25pg: Without WGA 17% (17%) 20% 73% 
 GenomiPhi 68% (19%) 35% 15% 
 REPLI-g 90% (10%) 20% 1% 
 AT 97% (4%) 7% 0% 
10pg: Without WGA 4% (4%) 5% 94% 
 GenomiPhi 37% (12%) 36% 45% 
 REPLI-g 72% (15%) 33% 11% 
 AT 87% (2%) 21% 3% 
a
 Results represent average from five reactions for each WGA method
  
b 
Results represent the percentage of loci with ADO of 75 heterozygous loci 
c
 Results represent the percentage of loci with LDO of 80 total loci 
d
 Rec = Recommended template amount, with 10ng used as the starting template for all WGA 
reactions and 500pg used as the starting template for STR analysis without WGA. 
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As with the initial WGA experiments exaggerated stochastic variation was observed in 
all STR profiles from LTDNA without prior WGA, with allele and locus drop out 
increasing and peak heights decreasing with reduced starting template amounts. As 
expected, introducing any of the WGA procedures prior to STR analysis generally 
produced profiles with more correct alleles compared to control samples across most 
template amounts, with significant differences noted in all samples with starting 
templates of 50pg or less (Figure 4.3).  No significant differences were seen in the allele 
recovery of the 100pg samples. With this starting template amounts both the AT kit and 
the REPLI-g kits produced slightly better allele recovery per profile compared to control 
samples (100% and 99% respectively compared to 96%), but the average allele recovery 
for the GenomiPhi amplified samples was only 88%. While this does not represent a 
significant reduction, it does indicate that even at this template amount the GenomiPhi 
kit is not amplifying all regions of the DNA equally, introducing a bias that may be 
further amplified with the STR reaction. This reduction in alleles seen with WGA 
samples compared to non-WGA controls has also been observed by others [115]. 
However in the work of Ballantyne et al [115], this phenomenon was mostly observed 
when a high starting template (1ng or 0.5ng) was used for WGA. Since reduced allele 
recovery was already observed with the 100pg samples, it was not surprising that the 
GenomiPhi kit consistently produced profiles with fewer alleles recovered compared to 
the other WGA methods with even lower starting template amounts. However with 
50pg, 25pg and 10pg starting templates the allele recovery was still significantly 
increased with the GenomiPhi kit compared to STR profiles from control samples 
without WGA even if it was not as efficient as the other WGA methods.  
 
The average allele recovery per STR profile was always highest with the AT Kit. This 
improvement was particularly notable in the 50pg, 25pg and 10pg samples where STR 
profiles from AT amplified samples showed an increase of 54%, 80% and 83% 
respectively in the average allele recovery per profile compared to control samples. 
Comparatively, the 50pg, 25pg and 10pg REPLI-g amplified samples showed an 
increase in the average allele recovery by 52%, 73% and 68% respectively compared to 
control samples. Results from this work show an improvement in allele recovery 
compared to other studies that examined the ability of WGA to amplify LTDNA for 
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forensic analysis [115, 125]. This could be due to the higher sensitivity STR kit used in 
this study compared to the other studies which used the AmpFlSTR® Profiler Plus® kit 
[115] and the AmpFlSTR® SGM Plus® kit [125].  
 
Overall the PHR averages for the control samples without WGA were higher than the 
WGA samples when examining loci with both alleles present. As with the initial set of 
experiments, this is likely due to the increased allele recovery seen in the WGA 
samples.  Small peaks not recovered in the control samples, and therefore not 
contributing to the PHR average, would be contributing to the PHR average in the 
WGA samples, resulting in lower PHRs for WGA samples.  When 0% PHRs were 
included in the calculation, averages were generally higher for WGA samples compared 
to control samples. This is likely due to more loci showing both alleles with WGA 
resulting in fewer 0% scores contributing to the overall result. 
 
Of the WGA methods, the AT amplified samples had the highest PHR average for most 
template amounts, indicating that the AT kit is amplifying the total DNA in a more 
representative fashion compared to the other kits. The exception was with the 10pg 
samples, where the highest PHR mean was seen with the GenomiPhi when only 
considering loci with both alleles present. As with the control samples, this is also likely 
due to the fact that the AT and REPLI-g methods allowed for additional smaller alleles 
to be detected that would reduce the PHR average, whereas these same alleles were not 
seen in the GenomiPhi samples, which showed the lowest allele recovery of the WGA 
methods. However, even though the AT amplified samples having the highest PHR 
averages of the WGA procedures, results for the 25pg and 10pg averages were still less 
than 50%, indicating that there is still preferential amplification between heterozygous 
alleles at some loci. 
 
Despite triplicate real time PCR quantification of all WGA reactions, many of the 
profiles from LTDNA amplified samples – particularly from the 10pg samples 
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amplified with GenomiPhi or the AT kit – showed numerous over-amplified alleles and 
pull up peaks, indicating that there was more than the measured 500pg in each STR 
reaction. Such artefacts were not seen in the 10ng WGA samples. All WGA samples 
were quantified using primers targeting the OCA2 gene, located close to the centromere 
on chromosome 15q12 [171]. This gene was selected on the basis that it would give a 
more accurate quantification value since the WGA reaction has been shown to under 
represent the telomeric region of the hTERT gene used in the Quantifiler commercial 
qPCR kit [172]. However, since STR profiles demonstrate substantially more template 
has been used in the reaction than is indicated by the qPCR, it is likely that the 
GenomiPhi and AT kits are not amplifying the region of the OCA2 gene in the same 
fashion as the locations of the STRs examined, many of which are located towards the 
end of their respective chromosomes [173]. It would therefore be beneficial to test 
additional target genes for real time PCR quantification to determine which would give 
the most accurate qPCR result. 
 
Since the STR results showed the WGA reactions were producing more DNA than the 
quantification results were indicating, all 100pg, 50pg, 25pg and 10pg WGA samples 
were diluted 1:100 for additional STR analysis. Results can be seen in Tables 4.5 and 
4.6.  Due to the increased dilution alleles were not over amplified, resulting in 
substantially reduced artefacts and pull up alleles seen in the STR profiles. However, 
this also had the effect of diluting out some of the actual alleles from the final profiles in 
the GenomiPhi and AT amplified samples, particularly at loci where the PHR was low 
in the 500pg dilution profiles. Further examination of different dilutions may therefore 
be beneficial to determine the most efficient level for WGA samples from low starting 
templates. Since the REPLI-g samples had the highest quantification results, diluting the 
samples 1:100 did not reduce the allele recovery results in the same manner as the 
GenomiPhi and AT kits. Indeed, the allele recovery was actually higher in the REPLI-g 
1:100 dilutions compared to the 500pg dilution samples. Since the 500pg dilutions of 
the REPLI-g samples did not show the same level of artefacts as the GenomiPhi and AT 
amplified samples it would be preferable to maintain this dilution factor for the REPLI-
g samples.  
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Table 4.5 1:100 dilution of WGA products – allele recovery 
 % Mean Correct 
Alleles Per Profile
a
 
(Std. Dev.) 
% Allele 
Drop Out
b
 
% Locus 
Drop Out
c
 
100pg: GenomiPhi 92% (6%) 16% 0% 
 REPLI-g 100% (0%) 0% 0% 
 AT 97% (4%) 1% 1% 
50pg: GenomiPhi 84% (8%) 23% 5% 
 REPLI-g 99% (2%) 3% 0% 
 AT 90% (4%) 8% 6% 
25pg: GenomiPhi 54% (8%) 51% 22% 
 REPLI-g 94% (2%) 13% 0% 
 AT 74% (8%) 23% 15% 
10pg: GenomiPhi 24% (7%) 35% 60% 
 REPLI-g 73% (8%) 37% 9% 
 AT 63% (7%) 44% 18% 
a
 Results represent the average of five reactions for each WGA method. 
b
 Results represent the percentage of loci with ADO of 75 heterozygous loci 
c
 Results represent the percentage of loci with LDO of 80 total loci 
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4.3.2.1 Modifications to the AT kit recommended protocol  
Two modified methods – the Cycling protocol and the Split and Pool protocol – were 
tested on the AT Kit to determine if the allele balance and recovery could be improved 
compared to the standard method. Two high templates (10ng/µl, 1ng/µl), and two low 
template dilutions (100pg/µl and 10pg/µl) were generated and 1µl of each was used as 
the starting template for each modified AT reaction. For both modified procedures, 
three reactions were performed for each starting template amount.  
 
All reactions were quantified using real time PCR. Using these values all samples were 
diluted to 500pg/µl for STR analysis. Results can be seen in Tables 4.7 and 4.8. For the 
10ng and 1ng dilutions both modified methods produced profiles with 100% allele 
recovery. The Split and Pool protocol also produced 100% allele recovery per profile 
with 100pg starting template, the same result as the standard AT protocol.  
 
The Split and Pool protocol showed similar PHRs and a slightly improved allele 
recovery per profile with 10pg starting template compared to both the Cycling and the 
standard AT protocols. This is surprising since each WGA aliquot would potentially 
contain less than one full genome copy, if the total DNA was divided equally between 
the reactions. It would therefore seem more likely that some regions of the DNA would 
be lost in this process. However, by splitting the reaction it may have allowed each 
small DNA amount to be equally represented in the amplification process. Without 
dividing the sample any early preferential amplification can be rapidly magnified by the 
fast processivity of the enzyme and hyperbranching of the final product. 
 
The original proposition behind the Cycling method was that heating the reaction to 
40°C would force the primers off the template, temporarily terminating the reaction.  
The amplification process could be then re-initiated at another random site on the 
template when the sample was cooled back to 30°C, to ultimately reduce any 
amplification bias that can occur in the WGA process. However, this process was not 
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successful since the Cycling protocol showed the lowest average allele recovery per 
profile and the lowest peak height ratio averages with 100pg and 10pg starting 
templates. One reason for this reduced allele recovery could be that the heating process 
worked to deteriorate the φ29 DNA polymerase activity. However, previous work has 
shown that enzymatic activity is maintained at 40°C [130] so this is unlikely. It could 
also be that an increase of the temperature to 40°C was insufficient to completely 
separate the newly formed strand from the original template so that the reaction could 
be reinitiated. Furthermore, even with the high processivity of the φ29 DNA 
polymerase, if the initial cycling process was successful, the DNA strands produced 
would only be approximately 400bp in length. While all of the STR loci in the ESI 16 
kit produce fragments smaller than 400bp there is no guarantee that the new DNA 
produced by the WGA would encompass the STR loci entirely. As such the template 
would have similar results to degraded DNA, where allele and locus drop out are 
common despite having a high quantification result for the total template.  
 
 
 
Table 4.7 Modified AT protocols – allele recovery 
 % Mean Correct 
Alleles Per Profile
a
 
(Std. Dev.) 
% Allele 
Drop Out
b
 
% Locus 
Drop Out
c
 
10ng: Cycling 100% (0%) 0% 0% 
 Split and Pool 100% (0%) 0% 0% 
1ng: Cycling 100% (0%) 0% 0% 
 Split and Pool 100% (0%) 0% 0% 
100pg: Cycling 94% (4%) 11% 0% 
 Split and Pool 100% (0%) 0% 0% 
10pg: Cycling 68% (11%) 27% 19% 
 Split and Pool 90% (0%) 20% 0% 
a
 Results represent the average of three reactions per modified AT method. 
b
 Results represent the percentage of loci with ADO of 75 heterozygous loci 
c
 Results represent the percentage of loci with LDO of 80 total loci 
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4.3.2.2 Mixture analysis using the AT kit 
Two mixture samples were also examined with the AT kit using the standard protocol. 
The first mixture, ―M1‖, contained DNA from two donors, both contributing low 
template levels of 50pg/µl for a total concentration of 100pg/µl.  The second mixture, 
―M2‖, also contained DNA from two donors, but in this mixture one donor contributed 
the majority of the template of 450pg/µl while the other contributed a low template 
amount of 50pg/µl for a total concentration of 500pg/µl. Five AT reactions were 
performed for each mixture. Each AT reaction was quantified using real time PCR and a 
500pg/µl dilution was made from each sample for STR analysis. Five STR reactions 
were also performed on 1µl of the original mixture samples without prior WGA. Figure 
4.4 shows the total allele recovery per profile from both contributors, while Figure 4.5 
shows the average alleles recovered in each profile from the individual contributors. 
 
Without prior WGA, STR profiles of M1 showed an average of 65% of the total alleles 
from both contributors recovered. When the AT reactions were performed the average 
allele recovery per profile increased to 81%. This average would have been higher but 
one of the AT reactions failed, resulting in only 7 of the total 53 alleles (13%) being 
recovered in the STR profile. The median percentage alleles recovered per profile for 
the AT amplified M1 samples was actually 96%. However, while allele recovery was 
greater with prior AT amplification, mixture profiles were not resolvable since the 
mixture contained an equal amount of DNA from both contributors and this 1:1 balance 
was maintained through the AT process. 
 
The STR profiles from M2 samples with and without AT amplification showed 100% of 
the alleles from the major contributor in all profiles. The average allele recovery per 
profile from the minor contributor was 80% without AT amplification. With AT 
amplification this was reduced to 71%. This is likely due to the abundance of the major 
contributor DNA in the sample compared to the minor contributor, resulting in 
preferential amplification of the major contributor.  
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This highlights one of the major difficulties of working with mixture samples. Even if 
the amount of DNA present in a sample from each contributor could be quantified, there 
is no method for separating the DNA from individual contributors. Therefore only the 
maximum amount of DNA can be added to the STR reaction regardless of the 
quantification from each contributor otherwise amplification artefacts may begin to 
appear in the profiles.  Since these results indicate that WGA only serves to over-
amplify the major component of a mixed sample, this prior amplification may not be the 
best option for analysing samples with unequal contributions from donors.  
 
 
 
 
Figure 4.4 Total alleles recovered in mixture profiles. Results represent the average 
percentage alleles recovered in each profile from a possible 53 total alleles. Five reactions were 
performed for each method. Error bars represent standard error of the mean. Unpaired 2-tailed 
T-tests were performed to compare samples amplified with and without AT amplification. No 
significant differences were found.  
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Figure 4.5 Alleles recovered from each contributor in mixture profiles. Results represent 
the average percentage alleles recovered in each profile from a possible 31 alleles for 
Contributor 1 and 30 alleles for Contributor 2. Five reactions were performed for each method. 
Error bars represent standard error of the mean.  
 
 
 
4.4 Conclusion 
Overall the AT kit was the most effective of the examined kits to amplify single source 
low template DNA samples. STR analysis of the WGA products showed allele recovery 
and peak height ratios were highest when LTDNA samples were subjected to the AT 
kit, followed by the REPLI-g kit then the GenomiPhi kit. However, all three chemistries 
allowed for significantly more alleles to be recovered compared to LTDNA samples that 
did not undergo prior processing when the optimum amount of WGA template was used 
for STR analysis.  
 
Despite having the best results of the three kits, drop out still occurred with the AT kit 
when less than 50pg of DNA was used as the starting template and significant allele 
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imbalance was seen in some loci. Such stochastic variation can make STR profile 
interpretation difficult, and therefore further improvement is needed before this WGA 
procedure could be routinely implemented into the forensic DNA analysis workflow for 
casework. 
 
Modifications to the AT protocol showed varying results. The Cycling protocol samples 
consistently showed reduced allele recovery and PHRs compared the standard protocol. 
However, the Split and Pool Protocol showed equal or slightly higher allele recovery 
and similar PHRs compared to the standard protocol. The slight increase in allele 
recovery with 10pg starting template is promising, suggesting that dividing the reaction 
allows for the small amount of template in each aliquot to be amplified in a more 
representative fashion than would be if the reaction was kept whole for amplification. 
However, like with the standard protocol samples, since stochastic variation was present 
in the Split and Pool WGA STR profiles - even if it was at reduced levels - further 
improvements are necessary before implementation into routine casework.  
 
WGA of mixture samples using the AT kit showed an increase in alleles recovered 
when both contributors were at equal low template levels. However, when the mixture 
samples contained unequal contributions from donors, the WGA reaction preferentially 
amplified the major profile resulting in a reduced number of minor profile alleles 
recovered compared to samples that did not undergo prior WGA. This indicates that 
while WGA may be useful for single source samples or low template mixed samples 
where donors contribute equal amounts of DNA to the sample, it is not the preferred 
analysis option for mixtures with major and minor contributors.  
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CHAPTER 5 
 
LOW COPY ANALYSIS USING INTACT CELLS 
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5.1 Introduction 
Laser microdissection (LMD) can be used to identify and isolate single or small 
numbers of cells from cell populations [78-83]. This technique could be particularly 
useful for forensic DNA analysis. Mixtures of body fluids from different individuals are 
common in forensic casework and the ability to separate cells from individual 
contributors would be beneficial [79]. Samples with limited numbers of cells are also 
becoming an increasingly analysed type of forensic evidence, therefore specific LCN 
techniques that deal with these sample types are necessary [83]. DNA profiling from 
limited template samples could be improved if all possible genetic material was able to 
be collected. The use of isolated cells allows for a known number of genome copies to 
be analysed in each reaction. The decision to apply LCN techniques relies on 
quantification results of the genomic DNA. However, such results may not be accurate 
if the sample contains a very low level of DNA. Furthermore, quantification results do 
not guarantee that an equal number of both alleles are contained in the sample. The use 
of whole cells overcomes such limitations.  
 
Forensic STR analysis has been performed on laser microdissected cells, with full DNA 
profiles obtained from a minimum of 15 epithelial cells or 30 sperm cells using the 
AmpFlSTR® Identifiler® PCR Amplification Kit (Life Technologies, Carlsbad, CA, 
USA) with 28 PCR cycles [88]. However, these results were not consistent and it was 
recommended that at least 50 epithelial cells or 150 sperm cells be collected for 
optimum DNA profiling results [88]. Such cell numbers would be the equivalent of 
approximately 0.3ng or 0.45ng genomic DNA for buccal and sperm cells respectively, 
less than half of the recommended starting template for the Identifiler® kit, which has a 
recommend DNA input of 1ng genomic DNA [174]. Higher sensitivity STR kits, such 
as the PowerPlex
®
 ESI 16 Kit (Promega Corp, Madison, WI, USA), have since been 
developed that require less starting DNA (0.5ng) [173]. Such kits could potentially be 
beneficial for the analysis of single or small numbers of isolated cells since less starting 
DNA template is required.   
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Further improvements in the analysis of limited numbers of cells could also be achieved 
by applying WGA techniques. Some success has been obtained with the use of MDA on 
single or small numbers of cells [119-123]. However, in these studies cell samples were 
isolated by mouth pipetting into small volumes of less than 5µl [119, 122, 123] or 
diluted to approximate cell counts [121]. Such small volumes are not possible with 
LMD systems that use the gravity method of collection as sufficient liquid 
(approximately 8µl) must be placed in the collection cap to will cover the entire surface 
so that cells remain in place once isolated [88].  
 
In this chapter single or small numbers of LMD cells were used as template for forensic 
STR analysis. Cell samples were amplified using both standard and increased cycle 
protocols to determine if improved results could be obtained. Cells were also subjected 
to WGA prior to STR analysis to determine the compatibility of LMD and WGA. 
Results described in the previous chapter (see figure 4.3) showed that the novel AT Kit 
from GE Healthcare gave the best results for low template DNA. Therefore, this kit was 
used to amplify the LMD cell samples for downstream STR profiling. Various DNA 
extraction procedures were examined including the One-Tube method [88], heat 
denaturation, spin columns and a modified alkaline lysis procedure, to determine which, 
if any, were the most effective for use with AT Kit.  
 
5.2 Methods 
5.2.1 Sample preparation 
This project was approved by the Bond University Human Research Ethics Committee 
(BUHREC), approval number RO743. Four buccal cell samples were collected from an 
anonymous donor with informed consent using a cotton swab and allowed to air dry. 
For three of the swabs, the cotton tip was removed and immersed in 200ul of PBS in a 
sterile 2ml tube. The tube was vortexed to allow the release of cells from the cotton tip. 
The tip was squeezed and removed using sterile tweezers. The remaining cotton swab 
was kept as a control sample. 
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5.2.2 Slide preparation 
Slides were prepared according to an internally developed staining method used by the 
Victorian Police. In this method 3 x 10ul aliquots of the buccal cells in PBS were placed 
on a polyethylene naphthalate (PEN) membrane slide (Leica Microsystems, Wetzlar, 
Germany) and dried for 15 minutes on a 34°C heat block. Slides were then removed 
from the heat block and left to cool at room temperature for 15 minutes. To stain the 
slide 2-3 drops of haematoxylin were placed onto the slide and left for 1 minute. Scott‘s 
Tap Water (Leica Microsystems) was added to the slide for 30 seconds to rinse off the 
haematoxylin. 2-3 drops of eosin were placed on the slide for 10 seconds, which was 
then rinsed with 70% ethanol. The slide was placed in a 70% ethanol bath for 5 minutes 
and then allowed to air dry at room temperature for 10 minutes. 
 
5.2.3 Laser microdissection 
Prepared slides were viewed using a Leica LMD 6500 Laser Microdissection System 
(Leica Microsystems) at 20x magnification to identify and mark cells for collection. 
Groups of 50, 10, 5, 2 or 1 buccal cells were isolated by laser ablation and collected in 
the lid of a sterile 0.2ml PCR tube containing either 8µl of 1x TE buffer (10mM 
Tris/1mM EDTA) or 8µl of Extraction Buffer (EB) containing 7µl 1x TE and 1µl 
Tween 20 (1%) as described by Meredith et al [88]. Tube lids were viewed under 5x 
magnification to ensure cells had been collected. 
 
5.2.4 DNA extraction 
DNA was extracted from the remaining buccal swab using the BioRobot EZ1® 
Workstation with the EZ1® DNA Tissue Kits (QIAGEN, Hilden, Germany) according 
to the manufacturer‘s instructions. Cells collected in EB were extracted using the ―One-
Tube Extraction Method‖ described by Meredith et al. [88]. Four different DNA 
extraction methods were examined for cells collected in TE buffer: 1) the One-Tube 
method; 2) heat denaturation; 3) QIAamp® DNA Micro spin columns (QIAGEN, 
Hilden, Germany); 4) a modified alkaline lysis procedure provided by GE Healthcare.  
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5.2.4.1 One-Tube extraction method 
In the One-Tube Extraction Method, 0.2ml tubes containing isolated cells were 
centrifuged for 1 minute at 13000 RPM to ensure all LMD cells were recovered from 
the PCR tube cap. Cells were then gently resuspended and 1µl of 1mg/ml Proteinase K 
added to each tube. Samples were incubated for 1 hour at 56°C followed by 10 minutes 
at 95°C then held at 4°C for WGA or STR analysis.  
 
5.2.4.2 Heat denaturation 
For the heat denaturation, samples were incubated at 99°C for 10 minutes then cooled to 
4°C for WGA analysis.  
 
5.2.4.3 QIAamp® DNA Micro spin columns 
QIAamp® DNA Micro spin columns were used according to the manufacturer‘s 
instructions using the ―Isolation of Genomic DNA from Laser-Microdissected Tissues‖ 
protocol contained in the QIAamp® DNA Micro Handbook.   
 
5.2.4.4 Modified Alkaline Lysis procedure 
In the modified alkaline lysis procedure, 1ul of 1.6 M KOH was added to each tube to 
lyse the cells. The samples were then frozen at -80C for 1 hour, followed by a 10 minute 
incubation at 65°C.  1ul of 1.6 M HCl/0.6 M Tris, pH 7.5 was added to neutralise the 
reaction and samples were cooled to 4°C.   
 
5.2.5 Whole genome amplification 
WGA was performed on the entire cell sample extraction using the novel AT Kit (GE 
Healthcare) using methods described in Chapter 4. However the reaction volume was 
doubled to 40ul to accommodate the volume of the cell samples. After WGA, the 
amount of product was quantified in triplicate using the method described in section 
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2.2.1. Samples were diluted to 500pg/µl for STR analysis. If the quantification result 
was less than 500pg/µl, 1µl of the neat WGA sample was used for STR analysis. 
 
5.2.6 Short tandem repeat analysis 
STR analysis was performed on the entire 9µl of each extracted cell, or 1ul of the 
diluted WGA reaction using the PowerPlex
®
 ESI 16 Kits (Promega Corp, Madison, WI, 
USA) according to the manufacturer‘s instructions.  The cells that did not undergo 
WGA were amplified with either 30 or 34 PCR cycles. Profiles were also obtained for 6 
replicates of each 6pg, 12pg, 30pg and 60pg dilutions, the equivalent amount of DNA 
that should be in the 1-, 2-, 5- and 10-cell samples respectively, using 30 and 34 PCR 
cycles for comparison.  
 
Electropherograms for all samples were obtained using the 3130 Genetic Analyser (Life 
Technologies). For each sample a loading cocktail of 10µl Hi-Di
TM
 Formamide (Life 
Technologies) and 1µl of CC5 Internal Lane Standard 500 (Promega Corp) was mixed 
with 1µl of amplified product and denatured for three minutes at 95°C. After cooling, 
samples were injected on the 3130 using a 3kv, 5 second injection as is the 
recommended PowerPlex
®
 ESI 16 protocol. Data were analysed using Genemapper 
ID® software version 3.2.1 (Life Technologies) and PowerPlex
®
 ESI 16 panels and bins 
files. A detection threshold of 50 RFU was used for analysis of all sample profiles.   
 
All electropherograms were compared to a reference profile to determine allele drop out 
(ADO) and locus drop out (LDO). Peak heights and peak height ratios (PHR) were also 
recorded. PHRs were determined by dividing the height of the smaller peak in a 
heterozygote pair by the height of the larger peak. PHR averages were calculated with 
and without ADO included. 
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5.3 Results and Discussion 
5.3.1 Laser microdissection 
Buccal cells were isolated by LMD in groups of 1, 2, 5, 10 or 50 cells. A total of 25 of 
each cell number were collected, 10 of which were collected in EB and 15 in TE. PEN 
slides were viewed at 20x magnification for identification, selection and isolated of 
buccal cells. All tube caps were viewed at 5x magnification to ensure cells were 
collected (Figures 5.1 to 5.5). 
 
5.3.2 Standard and increased cycle STR analysis of LMD cells 
Six of each 1-, 2-, 5-, 10-, and 50-cell samples were extracted using the One-Tube 
method and amplified using the PowerPlex
®
 ESI 16 kit recommended 30-cycle 
protocol. All 50-cell samples showed the complete STR profile. This is expected since 
each 50-cell sample should contain approximately 300pg genomic DNA. Stochastic 
variation was observed in most STR profiles obtained using 10 or fewer cells as the 
starting template, with allele and locus drop out increasing and peak heights decreasing 
with reduced cell numbers (Table 5.1). Of the 10-cell samples, two gave complete STR 
profiles while the remaining four gave partial profiles, resulting in an average of 80% 
correct alleles recovered per profile. Below this cell number all profiles showed partial 
results only, with all displaying 50% or less of the correct alleles. 
 
Complete amplification failure was evident in some samples with 5 cells or less, with 
zero alleles recovered in one 5-cell samples, two 2-cell samples and all 1-cell samples.  
In studies conducted by others, at least 15 epithelial cells were necessary to obtain a 
complete STR profile using the AmpFlSTR® Identifiler® PCR Amplification Kit [88]. 
Results presented here show an increase in allele recovery with the use of a higher 
sensitivity STR kit. However, improvements are still necessary due to the high allele 
and locus drop out observed in most STR profiles. 
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Figure 5.1 Laser microdissection of one cell. Selection and isolation of a single buccal cell, 
where A shows the PEN slide before collection, B shows the PEN slide after collection (both 
20x magnification) and C shows the cap containing the isolated cell (5x magnification). 
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Figure 5.2 Laser microdissection of two cells. Selection and isolation of two buccal cells, 
where A shows the PEN slide before collection, B shows the PEN slide after collection (both 
20x magnification) and C shows the cap containing the isolated cells (5x magnification). 
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Figure 5.3 Laser microdissection of five cells. Selection and isolation of five buccal cells, 
where A shows the PEN slide before collection, B shows the PEN slide after collection (both 
20x magnification) and C shows the cap containing the isolated cells (5x magnification). 
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Figure 5.4 Laser microdissection of ten cells. Collection cap containing ten isolated buccal 
cells at 5x magnification. 
 
 
 
Figure 5.5 Laser microdissection of fifty cells. Collection cap containing fifty isolated buccal 
cells at 5x magnification. 
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Additional alleles were observed when the cell samples were subjected to an increased 
cycle PCR (Figure 5.6). The results are shown in Table 5.2. When amplified with a 34-
cycle reaction, half the 10-cell samples gave complete STR profiles. The other half 
showed either one or two loci with ADO. Overall, an average of 96% of the correct 
alleles was recovered per profile which is an increase of 17% compared to the 30 cycle 
10-cell samples. One of the 5-cell samples also gave a complete STR profile. Of the 
remaining 5-cell samples, 4 showed partial profiles with more than 50% of the correct 
alleles recovered. However in one profile only a single allele was recovered. On 
average, 69% of the correct alleles were recovered in each 5-cell profile, an increase of 
51% compared to 30 cycle samples. The 2- and 1-cell samples also showed increased 
allele recovery with 34 PCR cycles compared to the samples amplified with the 
recommended 30 cycles. However, the majority of samples showed less than 50% of the 
correct alleles, with an average allele recovery per profile of 35% for the 2-cell samples 
and 28% for the 1-cell samples.  Complete amplification failure occurred in one 2-cell 
sample and one 1-cell sample.  
 
PHRs were generally not affected by the increase in PCR cycles when examining loci 
with both alleles present (Figure 5.7). PHR averages were similar across different cell 
amounts, for samples amplified with 30 and 34 cycles. The exception to this was with 
the 1-cell samples, which showed a significant difference in the PHR average of the 
samples amplified with 34 cycles since no alleles were recovered and thus no PHRs 
recorded for samples amplified with 30 PCR cycles.  When 0% results were included in 
the calculation, mean PHRs were generally higher for samples amplified with 34 cycles 
compared to samples amplified with 30 cycles. This is likely due to the increased allele 
recovery seen in samples amplified with 34 cycles so that there are less 0% results 
contributing to the mean compared to samples amplified with 30 PCR cycles. Compared 
to the samples amplified with 30 PCR cycles, the mean peak height for each of the cell 
numbers was improved when amplified with 34 cycles. Overall these results indicate 
that, despite the improved allele recovery, increasing the PCR cycles alone is not 
sufficient to consistently recover complete and balanced STR profiles from samples 
with limited cell numbers.  
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Figure 5.6 Correct alleles recovered in profiles of LMD cell samples amplified with 30 and 
34 PCR cycles. Results represent the average percentage of alleles recovered from six reactions 
for each cell number and amplification method. Error bars represent standard error of the mean. 
Unpaired, 2-tailed T-Tests were performed to compare results from samples amplified with 30 
PCR cycles to samples amplified with 34 PCR cycles. As indicated,* represents a p-value of 
less than 0.05, and ** represents a p-value of less than 0.01. 
 
 
 
Figure 5.7 Peak height ratios in profiles of LMD cell samples amplified with 30 and 34 
PCR cycles. Results represent the average PHR from all heterozygous loci where both alleles 
were recovered from six reactions for each cell number and amplification method. Error bars 
represent standard error of the mean. Unpaired, 2-tailed T-Tests were performed to compare 
results from samples amplified with 30 PCR cycles to samples amplified with 34 PCR cycles. 
As indicated, ** represents a p-value of less than 0.01. 
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5.3.3 Standard and increased cycle STR analysis of cell-equivalent DNA samples 
STR profiles were also obtained for 6 replicates of each 60pg/µl, 30pg/µl, 12pg/µl and 
6pg/µl dilutions, the equivalent amount of DNA that should be in the 10-, 5-, 2- and 1-
cell samples respectively, using 30 and 34 PCR cycles (Tables 5.3 and 5.4). This was 
done to determine if the cell samples were amplifying in the same manner as DNA 
dilutions or if components of the cells or chemicals involved in the extraction were 
limiting the success of the reaction. As seen in Figures 5.8 and 5.9, allele recovery was 
higher in DNA dilutions across all template amounts with 30 and 34 PCR cycles 
compared to cell samples. The greatest difference was seen in the comparison of 5 cell 
samples and the 30pg samples amplified with 30 PCR cycles, which shows an increase 
of 47% in the average alleles recovered per profile for the DNA dilution compared to 
the whole cell sample. While this may indicate a potential inhibitor in the cell samples 
or extraction chemicals, it may also indicate a potential issue with the qPCR of genomic 
DNA. DNA dilutions may contain more genomic material than the cell samples if the 
quantification result for the original DNA sample was not precise. Since the number of 
cells in each LMD sample is precisely known, it could be that DNA dilutions are not 
faithfully reflecting the results that can be realistically achieved from that exact amount 
of genetic material obtained directly from the cells.  
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Figure 5.8 Correct alleles recovered in profiles of LMD cell samples and equivalent 
amounts of genomic DNA amplified with 30 PCR cycles. Results represent the average 
percentage of alleles recovered from six reactions for each cell number and DNA amount. Error 
bars represent standard error of the mean. Unpaired, 2-tailed T-Tests were performed to 
compare results from cell and genomic DNA samples. As indicated,** represents a p-value of 
less than 0.01, and *** represents a p-value of less than 0.001. 
 
 
 
Figure 5.9 Correct alleles recovered in profiles of LMD cell samples and equivalent 
amounts of genomic DNA amplified with 34 PCR cycles. Results represent the average 
percentage of alleles recovered from six reactions for each cell number and DNA amount. Error 
bars represent standard error of the mean.  Unpaired, 2-tailed T-Tests were performed to 
compare results from cell and genomic DNA samples. As indicated,** represents a p-value of 
less than 0.01. 
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5.3.4 Whole genome amplification with One-Tube extraction 
Results from Chapter 4 showed that improved DNA profiles could be obtained from 
low template samples that underwent WGA using the AT Kit prior to STR analysis. As 
such, this technique was applied to the LMD cell samples to determine if further alleles 
could be recovered compared to STR typing alone. Three of each 1-, 2-, 5-, 10- and 50-
cell samples were extracted using the One-Tube method, and the entire extract was used 
as template for the AT reaction. However, qPCR quantification results of the AT 
product show that amplification was largely unsuccessful. As seen in Table 5.5, while 
some of the samples showed a slightly higher quantification compared to the original 
starting template amount, most of the samples appeared to contain less DNA after AT 
amplification. Furthermore, qPCR results from one of each of the 1-, 2- and 5-cell 
samples showed no amplifiable product. STR analysis was performed on AT extracts to 
determine if results could still be obtained despite the low quantification results. As 
expected none of the samples produced successful STR results. These results indicated 
that the One-Tube extraction method is likely not compatible with the WGA reaction 
and as such alternative extraction methods were investigated. 
 
5.3.5 Whole genome amplification with alkaline lysis extraction 
Three of each 1-, 2-, 5-, 10- and 50-cell samples were extracted using a modified 
alkaline lysis procedure provided by GE Healthcare. The alkaline lysis method is 
recommended by GE Healthcare for the amplification of whole cells using the 
GenomiPhi V2 DNA Amplification Kit [175]. However modifications, as described in 
the methods section, were made to the recommended procedure to keep the volume as 
small as possible without impacting the efficacy of the procedure. After extraction the 
entire sample was used for WGA with the AT Kit after which all reactions were 
quantified with qPCR. As shown in Table 5.5, quantification results were only obtained 
for two of the 50-cell samples, one 10-cell sample and one 5-cell sample. However, the 
result for the AT amplified 5-cell sample was only slightly higher than the original 
starting template amount. All other reactions showed no amplifiable product. 
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STR analysis of all alkaline lysis AT reactions showed limited success. Two of the 50-
cell AT amplified samples had relatively high quantification results of 18ng and 275ng. 
However, only partial STR profiles were obtained from both samples, with 52% and 
61% of the correct alleles recovered respectively. The third 50-cell sample showed a 
0ng quantification result, but 20% of the correct alleles were recovered in the STR 
profile. Only one 10-cell sample showed amplifiable DNA in the qPCR, with a 
quantification result of 18ng. STR analysis of this sample also gave a partial DNA 
profile, with 43% of the correct alleles recovered. The other two 10-cell samples had 
0ng qPCR results. However, the STR profile from one of these samples showed 13% of 
the correct alleles. STR analyses of all 5- and 2- and 1-cell AT amplified samples were 
unsuccessful.  
 
 
Table 5.5 Total DNA concentrations of LMD cell samples before and after WGA  
Number 
of cells 
 Before 
WGA (ng) 
One-Tube 
Extraction & 
AT-WGA (ng) 
Alkaline 
Lysis & AT-
WGA (ng) 
Heat 
Denaturation 
& AT-WGA 
(ng) 
Spin 
Column & 
AT-WGA 
(ng) 
50 1 0.300 1.210 18.00 - 0.000 
 2 0.300 0.518 274.5 - 1468.0 
 3 0.300 0.500 0.000 - 0.000 
10 1 0.060 0.016 18.00 0.000 - 
 2 0.060 0.043 0.000 0.000 - 
 3 0.060 0.139 0.000 0.000 - 
5 1 0.030 0.036 0.000 0.000 - 
 2 0.030 0.026 0.040 0.000 - 
 3 0.030 0.000 0.000 0.000 - 
2 1 0.012 0.049 0.000 0.000 - 
 2 0.012 0.070 0.000 0.000 - 
 3 0.012 0.000 0.000 0.000 - 
1 1 0.006 0.000 0.000 0.000 - 
 2 0.006 0.028 0.000 0.000 - 
 3 0.006 0.011 0.000 0.000 - 
- Method was not performed for this sample 
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There are several reasons that could explain the limited quality STR results achieved by 
LMD samples that have undergone WGA. Improper dilution of the WGA product could 
result in too much template in the reaction resulting in amplification failure. However, 
all dilutions for STR analysis were based on real time quantification results. The qPCR 
was performed on 1:100 dilutions of the WGA products, which should have been 
sufficient to allow for amplification of the WGA product. However, almost all samples 
gave total yields of less than 100pg. Therefore 1µl of neat product was used for STR 
analysis.  
 
The high level of salt in the sample after the alkaline lysis procedure or extraction 
chemicals used in the One-Tube method may be inhibiting the WGA from performing 
optimally. Alternatively, the alkaline lysis method may not be completely efficient in 
disrupting the cells and denaturing the DNA for WGA. Another explanation could be 
that there is an element of the cell samples that is inhibiting the WGA reaction, 
independent of the extraction method used.  It seems unlikely that the 1x TE buffer the 
cells were collected in would be the cause of inhibition since this did not negatively 
affect the STR reaction and is the recommended buffer for genomic DNA dilutions that 
are to be amplified with traditional WGA procedures [175]. However, cells collected 
using other LMD methods that do not require a high volume of liquid to be in the cap 
for cell collection have demonstrated successful WGA [94-96]. This indicates that the 
high TE concentration in the collection buffer could be playing an inhibitory role.   
 
A component of the cells themselves may also be inhibiting the AT reaction. Typical 
DNA extraction methods involve disrupting the cell membrane and removing all 
cellular components apart from the DNA, which is generally eluted into TE buffer or 
water. Since the One-Tube and the alkaline lysis methods retain the sample in the same 
tube for collection, extraction and WGA, any inhibitory component that would normally 
be removed by the extraction procedure would be still present in the sample.  The 
inhibitor levels would likely be higher in 50-cell samples, which could explain why 
poor results are achieved despite the high starting template amount. In 1- or 2-cell 
samples, inhibitor levels may be lower, but STR profiling would be limited by the low 
starting template. 
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To determine if any of the chemicals or salts used in the One-Tube or alkaline lysis 
methods were inhibiting the AT reaction, three of each 1-, 2-, 5-, 10-cell samples were 
also extracted using a simple heat denaturation method. However, real time PCR 
quantification of AT amplified samples after heat denaturation showed that none of the 
reactions contained amplifiable DNA. As expected, STR analysis of all AT amplified 
samples was also unsuccessful. To further assess the effect of the high salt 
concentration from the alkaline lysis procedure on the AT reaction, one 10ng genomic 
DNA sample in 1x TE buffer was subjected to the alkaline lysis method prior to AT 
WGA. Real time PCR quantification of the AT product showed a total concentration of 
1.868µg of DNA. A 500pg dilution of this product was used for STR analysis and the 
resulting profile showed 100% allele recovery. This indicates that it is unlikely that the 
salt concentration from the alkaline lysis procedure is limiting the efficiency of the AT 
reaction of the LMD cells. 
 
The efficiency of the alkaline lysis method in disrupting the cells was also investigated. 
One 10-cell sample was extracted using the alkaline lysis procedure and this extract 
used for STR analysis only. The resulting STR profile showed 65% of the correct alleles 
recovered, which is lower than the average allele recovery of 80% seen in the 10-cell 
samples extracted using  the One-Tube method that were directly amplified with the 30-
cycle PowerPlex ESI 16 reaction. This indicates that the alkaline lysis procedure may 
not be as efficient as the One-Tube method for extracting DNA from cells for STR 
analysis. However, this result was higher than the allele recovery seen in any of the AT 
amplified samples, indicating that there should be sufficient DNA released from the 
alkaline lysis procedure to be used as template for the WGA reaction.   
 
To assess whether a product of the AT reaction was inhibiting the STR reaction 2µl of 
the 50-cell AT amplified sample that gave a 0ng quantification was mixed with 400pg 
of genomic DNA and this mixture was used as the template for STR analysis. Results 
showed 100% of the genomic DNA alleles recovered, with a mean peak height of 2467 
RFU, indicating that the AT reaction does not contain inhibitors for the STR reaction. 
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5.3.6 Whole genome amplification with QIAamp® DNA Micro spin column extraction 
Three 50-cell samples were also extracted using the QIAamp® DNA Micro spin 
columns. Two of the extracted samples were used directly for STR analysis. However, 
this was unsuccessful, with both profiles showing no alleles recovered. This indicates 
that much of the DNA from limited cell samples may be lost in this extraction 
procedure. The remaining column extracted sample was divided into three aliquots and 
each amplified first with the AT Kit. The sample was divided to accommodate the 
maximum volume that can be added to each AT reaction. Each of the three aliquots 
were quantified after WGA followed by STR analysis. Since this method should remove 
any inhibitors from the final extract, with DNA eluted into sterile water, AT 
amplification may have more success compared to the single tube extraction methods. 
However, real time PCR quantification showed the AT amplification achieved limited 
success, with only one of the three aliquots showing a result, with a concentration of 
1.5µg (Table 5.5). This sample was then diluted to 500pg for STR analysis. The 
remaining two aliquots showed concentrations of 0ng, and therefore 1µl of the neat 
product was used as template for STR analysis.  
 
Each of the extracts produced partial STR profiles. The sample with the high 
quantification result showed the lowest percentage of alleles recovered at 26%, which is 
surprising considering the reaction should contain 500pg starting template. The other 
AT samples showed 52% and 43% of the correct alleles recovered. However, numerous 
artefacts such as over amplified alleles, high stutter and pull up were observed in all 
profiles in conjunction with stochastic variation such as allele and locus drop out and 
peak imbalance. These results indicate that the AT reaction is preferentially amplifying 
regions of the DNA, likely due to the low starting template from dividing the sample, 
and the qPCR is therefore not accurately quantifying the amplified product.  As such, 
this column extraction method is not ideal for LMD samples, particularly when the cell 
numbers are limited. 
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5.4 Conclusion 
Overall, these results show that STR analysis of low numbers of LMD cells is, and will 
likely continue to be, improved by the use of recently developed high sensitivity STR 
chemistries combined with single tube extraction methodologies. This study shows that 
complete STR profiles can be obtained from as little as 10 cells using the 
manufacturer‘s recommended protocol or 5 cells when amplified with an increased 
cycle PCR. Increasing the number of cycles did not appear to significantly affect the 
allele balance in the profiles, with similar PHR averages obtained for the standard and 
increased cycle profiles. WGA of the cell samples was largely unsuccessful in this 
study. This is likely due to an inhibitory component in the cells or an inability of the 
examined extraction methods to disrupt the cells and denature the DNA sufficiently for 
use with the AT Kit. Further work would need to focus on improving the compatibility 
of LMD and WGA, as both techniques used together would be a great benefit for 
situations when the source material is limited.   
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CHAPTER 6 
 
FORENSIC MITOCHONDRIAL DNA ANALYSIS 
OF LOW TEMPLATE DNA 
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6.1 Introduction 
Mitochondrial DNA (mtDNA) typing is used routinely in forensic analysis to help 
identify biological samples when the nuclear DNA template amount is too low or too 
degraded for conventional STR analysis. Sample types suitable for mtDNA analysis can 
include bone, hair, blood, saliva, teeth, fingernails and even faeces [132, 137-149]. 
While there are only two copies of the genomic DNA per cell, depending on the type of 
cell examined, there are hundreds to thousands of copies of the mitochondrial genome 
per cell resulting in increased sensitivity of mtDNA assays [135]. The circular structure 
of mtDNA may also protect it from degradation, further increasing the likelihood of 
obtaining a result when autosomal STR typing is problematic [136].  
 
Traditionally, the mechanism for mtDNA analysis is DNA sequencing of the 
hypervariable regions, HV1 and HV2, where all polymorphisms in the fragment can be 
detected [132]. Due to the maternal mode of inheritance of mitochondrial DNA [152], 
and the fact that common mtDNA haplotypes can be found in various populations 
[156], mtDNA sequencing may not yield the magnitude of certainty required for 
positive identification providing a lower power of discrimination. Furthermore, mtDNA 
sequencing does not allow the resolution of mixture samples and can be complicated by 
the presence of heteroplasmy [157]. This is particularly disadvantageous for LTDNA 
samples as many contain DNA from more than one individual. However, this could be 
improved if single cells could be examined. Collection of individual cells using 
techniques such as LMD would give confidence that the haplotype obtained came from 
a single individual, provided no contamination had occurred.  
 
Methods to improve the mtDNA yield prior to sequencing could also be useful for the 
analysis of low template samples. WGA using MDA has been applied to blood and 
tissue samples for detection of cancer causing mtDNA mutations in whole genome 
sequencing [176]. This procedure showed that WGA could be successful, displaying 
concordance between mtDNA samples sequenced with and without prior WGA, when 
up to 20ng of genomic DNA was used [176]. However, this amount of starting material 
is clearly not available in low template samples. WGA has also been applied to 
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artificially degraded samples prior to HV1/HV2 sequencing with limited success [110]. 
WGA methods tended to reduce the amplicon size of the degraded DNA fragments 
making them unsuitable for sequencing [110]. However, while low template and 
degraded DNA often produce similar results, LTDNA can still contain intact genetic 
material. Therefore WGA procedures may have more success when applied to LTDNA 
prior to sequencing.   
 
Whole mtDNA genome sequencing has also been suggested as a method of increasing 
the discriminating power of mtDNA [156, 164-167]. Recently developed massively 
parallel sequencing (MPS) technologies have the potential to provide faster and less 
expensive sequencing compared to traditional sequencing methods [165-167]. 
Furthermore, MPS technologies can achieve greater coverage in single reactions [165-
167]. The data produced by MPS has shown a high level of consistency with Sanger-
type sequencing methods [167]. However, many of the discrepancies observed were 
related to the MPS analysis software‘s alignment algorithms, indicating room for 
improvement in this area [167].   
 
This chapter aimed to examine the applicability of mtDNA sequencing for LTDNA 
samples. HV1 and HV2 regions were sequenced using cycle sequencing. Serial 
dilutions of genomic DNA were examined to determine the limit of detection of the 
sequencing procedure. WGA techniques were also be investigated, with kits targeting 
both nuclear DNA and mtDNA as well a kit that specifically amplifies mtDNA applied 
to low template samples. Mitochondrial sequencing was also performed on samples 
containing various numbers of LMD cells to determine the compatibility of LMD and 
mtDNA sequencing. WGA that specifically targets the mtDNA was also applied to 
LMD cells prior to sequencing. 
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6.2 Methods 
6.2.1. Genomic DNA sample preparation 
This project was approved by the Bond University Human Research Ethics Committee 
(BUHREC), approval number RO743. Buccal swabs were provided by 10 anonymous 
donors with informed consent. DNA was extracted using the BioRobot EZ1® 
Workstation with the EZ1® DNA Tissue Kits (QIAGEN, Hilden, Germany) according 
to the manufacturer‘s instructions. DNA extracts were quantified in triplicate using the 
method described in section 2.2.1. Based on the quantification results, DNA from all 
individuals was diluted serially to 10ng/µl, 1ng/µl, 100pg/µl, 10pg/µl, 1pg/µl, 0.1pg/µl, 
0.05pg/µl and 0.01pg/µl. 
 
6.2.2 Laser microdissection 
Sample preparation, slide preparation and LMD were carried out according to the 
methodologies described in Chapter 5, with four of each 1, 2, 5 and 10 buccal cells 
groups collected. Cells were extracted using the modified alkaline lysis procedure also 
described in Chapter 5. 
 
6.2.3 Whole genome amplification 
Low template DNA samples of 10pg/µl were amplified in duplicate using the 
GenomiPhi V2 DNA Amplification Kit according to manufacturer‘s instructions and 
the novel AT Kit as described in Chapter 4 (GE Healthcare, Buckinghamshire, 
England). Reactions were performed using a GeneAmp® PCR System 9700 (Life 
Technologies, Carlsbad, CA, USA).  After WGA, samples were diluted 1:100 for 
mtDNA sequence analysis. 
 
Low template DNA samples of 60pg/µl, 30pg/µl, 12pg/µl, 6pg/µl, 1pg/µl, 0.1pg/µl, 
0.05pg/µl and 0.01pg/µl were amplified in duplicate using the REPLI-g Mitochondrial 
DNA kit (QIAGEN) according to manufacturer‘s instructions. Samples with 60pg/µl 
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down to 6pg/µl starting template were diluted 1:1000 for mtDNA sequencing, while 
samples with 1pg/µl down to 0.01pg/µl were diluted 1:100 for mtDNA sequencing. 
Two of each 1-, 2-, 5- and 10-cell LMD samples were also amplified using the REPLI-g 
Mitochondrial DNA kit using the recommended protocol. One of each 1-, 2-, 5- and 10-
cell amplified sample was diluted 1:1000 for mtDNA sequencing while the remaining 
samples were diluted 1:100.  
 
6.2.4 Mitochondrial DNA sequencing 
Mitochondrial DNA hypervariable regions were sequenced using the BigDye® Direct 
Cycle Sequencing Kit (Life Technologies) according to manufacturer‘s instructions. 
Initially, the HV1 and HV2 regions were amplified in four individuals using the 
recommended template amount of 4ng. To determine the lower limit of the kit, DNA 
from one of the individuals was also diluted to 1ng/µl, 100pg/µl, 10pg/µl, 1pg/µl, 
0.1pg/µl, 0.05pg/µl and 0.01pg/µl and 1µl of each dilution used for HV1 cycle 
sequencing. HV1 sequences were then obtained for 1pg/µl, 0.1pg/µl, 0.05pg/µl and 
0.01pg/µl dilutions from nine individuals. HV2 sequencing was also performed on all 
ten individuals using 0.1pg of starting template.  
 
HV1 sequencing was performed on two of each 1-, 2-, 5- and 10-cell LMD samples and 
one DNA dilution with the equivalent amount of genetic material (6pg, 12pg, 30pg and 
60pg respectively). HV1 sequences were also generated for samples that underwent 
WGA as described in section 6.2.3.  
 
All samples underwent an initial PCR using M13 tailed primers targeting either the 
HV1 or HV2 region. Primers for HV1 and HV2 were obtained from published data 
[144] and are shown in Table 6.1. Cycle sequencing was then performed with the M13 
forward or reverse primer. Purification of the mtDNA amplicons was performed with 
the BigDye XTerminator® Purification Kit (Life Technologies) according to the 
manufacturer‘s protocol.  
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Table 6.1 Primer sequences for mitochondrial DNA hypervariable regions 
Region Primer Sequence* 
Fragment 
Size 
HV1 F-15971 :  
5'-TGTAAAACGACGGCCAGTTTAACTCCACCATTAGCACC-3' 
 
439bp 
R-16410 : 
5'-CAGGAAACAGCTATGACCGAGGATGGTGGTCAAGGGAC-3' 
 
HV2 F-15 : 
5'-TGTAAAACGACGGCCAGTCACCCTATTAACCACTCACG-3' 
 
374bp 
R-389 : 
5'-CAGGAAACAGCTATGACCCTGGTTAGGCTGGTGTTAGG-3' 
 
* M13 sequencing tails indicated in red 
 
Sequences for all samples were obtained using the 3130 Genetic Analyser (Life 
Technologies). Samples were injected and analysed using the recommended 
‗RapidSeq36‘ instrument protocol and ‗BigDyeDirect‘ analysis protocol provided by 
Life Technologies. Sequences were aligned using Bio Edit software [177] and the 
Revised Cambridge Reference Sequence (rCRS) [133, 134]. Sequencing results were 
classified in one of four ways. The first classification was ―Over-amplified sequence‖, 
which describes sequences that contain numerous instances of dye bleed through due to 
the abundance of starting template. The second classification was ―Complete, good 
quality sequence‖. These samples showed the entire HV1 or HV2 sequence without any 
CE artefacts. The third category was ―Sub-optimal sequence‖ which included samples 
that showed all or the majority of the sequence at a low level but also contained some 
CE artefacts such as dye blobs. The final classification was ―Unsuccessful 
amplification‖ for sequences that showed less than 100 base pairs or no sequence. 
Examples of the first three categories can be seen in Figure 6.1. 
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6.3 Results and Discussion 
6.3.1 Sensitivity testing 
HV1 and HV2 sequencing was initially performed on DNA from four individuals using 
the BigDye® Direct Cycle Sequencing Kit recommended starting template of 4ng 
genomic DNA, which is the amount of genetic material that would be found in 
approximately 667 diploid cells. Assuming that each cell has approximately 1000 
mitochondria, 4ng genomic DNA could contain up to 667 000 copies of the 
mitochondrial genome, an overly excessive amount for PCR and CE detection 
techniques. It was not surprising then that results showed sequence profiles with over 
amplified peaks and extremely high pull up, confirming that this starting template 
amount was too high. The sensitivity of the BigDye® Direct system is also likely quite 
high as the sample stays in the same tube through PCR, cycle sequencing, amplicon 
purification and CE, negating any loss that normally occurs through pipetting or 
changing tubes.  
 
To determine the lower DNA limit of the BigDye® Direct system, DNA from one 
individual was diluted to 1ng/µl, 100pg/µl, 10pg/µl, 1pg/µl, 0.1pg/µl, 0.05pg/µl and 
0.01pg/µl, with 1µl of each dilution used for HV1 cycle sequencing. The HV1 region 
was chosen as this is the larger of the two regions and would best reflect the capabilities 
of the kit. Approximate mtDNA genome copies for each genomic DNA dilution can be 
seen in Table 6.2. 
 
Sequencing results for the 1ng, 100pg, 10pg and 1pg samples showed over amplified 
profiles. This is not surprising since, as can be seen in Table 6.2, 1pg genomic DNA 
could still contain around 167 copies of the mtDNA genome. Results from the three 
samples with the lowest template amounts all showed complete HV1 profiles. However, 
the 0.05pg sample profile was of sub-optimal quality, with small sequence peaks and 
three large CE artefacts seen in the electropherogram, one of which can be seen in the 
third panel of Figure 6.1.  
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Table 6.2 Mitochondrial DNA copies in genomic DNA dilutions 
Genomic 
DNA amount 
Number of diploid cells / 
genomic DNA amount 
Approximate 
mtDNA copies* 
4ng 667 667000 
1ng 167 166700 
100pg 16.7 16670 
10pg 1.67 1667 
1pg 0.167 166.7 
0.1pg 0.0167 16.67 
0.05pg 0.0083 8.3 
0.01pg 0.00167 1.667 
* Assumes 1000 copies of the mitochondrial genome per cell 
 
The amount of mtDNA per cell can vary from person to person, therefore the HV1 
region was sequenced for nine other individuals using 1pg, 0.1pg, 0.05pg and 0.01pg. 
Results for all ten individuals can be seen in Table 6.3.  Overall, six of the ten 1pg 
samples resulted in over-amplified sequence profiles while the remaining four showed 
good quality HV1 sequences. When the template was reduced to 0.1pg, nine samples 
showed complete HV1 sequences, although one of the profiles was of sub-optimal 
quality. One 0.1pg sample was unsuccessful. With 0.05pg starting template, 5 of the 10 
samples gave complete, good quality HV1 sequences, four were sub-optimal quality 
profiles and one was unsuccessful. Using the lowest template amount - 0.01pg - three 
samples gave complete, good quality sequences, three gave sub-optimal quality 
sequences and four were unsuccessful.  Such results are an improvement compared to a 
previous mtDNA sensitivity study, which demonstrated HV1 sequencing with 0.03pg 
genomic DNA using a nested PCR amplification strategy [143].  
 
Since the majority of samples gave complete HV1 sequences with 0.1pg, this dilution 
was used for sequencing of the HV2 region. As seen in Table 6.3, all samples produced 
complete, good quality HV2 profiles. Comparisons of the HV1 and HV2 sequences to 
the rCRS are shown in Table 6.4.  
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The ability to gain complete control region sequences from such small amount of DNA 
means that very little of the sample is consumed by mtDNA sequencing. This is 
promising for LTDNA samples, as the remainder could be used to attempt STR analysis 
or for the determination of the often critical question of tissue of origin. Determining the 
tissue source of forensic evidence samples can be great importance in crime 
reconstruction. Tissue determination techniques, such as mRNA [66, 67] and 
microRNA analysis [68] or DNA methylation studies [69] are being currently being 
investigated, and could be applied to LTDNA samples. Such methods have high 
specificity, fast analysis times and do not consume large portions of the sample. Also, 
since these methods use PCR based techniques they could be integrated easily into the 
current forensic DNA workflow [17]. 
 
 
 
Table 6.3 Sequence quality of LTDNA dilutions 
Sample 
number 
HV1 HV2 
1pg 0.1pg 0.05pg 0.01pg 0.1pg 
1 xs ++ + ++ ++ 
2 xs ++ ++ ++ ++ 
3 ++ ++ + ++ ++ 
4 ++ + + + ++ 
5 xs ++ ++ + ++ 
6 xs ++ ++ - ++ 
7 xs ++ ++ + ++ 
8 ++ - + - ++ 
9 ++ ++ ++ - ++ 
10 xs ++ - - ++ 
xs Over amplified sequence, ++ Complete, good quality sequence, + Sub-optimal quality sequence,  
- Unsuccessful amplification. 
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6.3.2 Mitochondrial DNA sequencing of LMD cells 
HV1 sequencing was also performed on groups of LMD cells. After alkaline lysis 
extraction, 1µl of each cell sample (1/10 of the total sample volume) was used for the 
sequencing reaction. Results for two of each 1-, 2-, 5- and 10-cell samples can be seen 
in Table 6.5. Apart from the 5-cell samples, which both produced good quality 
sequence, only one of each cell number produced the complete sequence, with the 1-cell 
sample sequence of sub-optimal quality.   This is surprising considering previous results 
showed complete mtDNA sequences could be obtained from significantly lower DNA 
amounts (seen in Table 6.3). 1µl of the 10-, 5- 2- and 1-cell samples should contain 
approximately 1000, 500, 100 and 50 copies of the mtDNA genome respectively, which 
previous results showed is more than what is necessary for sequencing and should have 
resulted in some measure of over amplification.  However, the results did not show this 
over amplification, and were more consistent the results from lower template samples 
(0.1pg to 0.01pg) seen in Table 6.3. 
 
Table 6.5 Sequence quality of lasermicrodissected cells 
Number of Cells HV1 Trial 1 HV1 Trial 2 
10 ++ - 
5 ++ ++ 
2 ++ - 
1 + - 
++ Complete, good quality sequence, + Sub-optimal quality sequence, - Unsuccessful amplification. 
 
One reason for these poor results could be that the alkaline lysis extraction method is 
not sufficient to disrupt the cells. However, this is unlikely considering some of the 
samples did display results. Furthermore work in the previous chapter (see Section 
5.3.4) showed that this extraction method was compatible with PCR analysis. 
Additionally, more than 1µl of the cell sample may be necessary to obtain quality data. 
However, as mentioned above, 1µl should contain sufficient mtDNA copies for 
analysis. Another possible explanation is that the samples may contain an inhibitor that 
remains in the sample through the extraction process, since the entire reaction is 
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performed in a single tube. As a comparison sequencing was performed on cell-
equivalent DNA amounts. Samples containing a total DNA concentration of 60pg, 
30pg, 12pg and 6pg in 10µl volumes were generated and 1µl of each used for cycle 
sequencing. As expected, complete HV1 sequences were generated from each of the 
samples, with the 60pg, 30pg and 12pg samples producing over amplified results 
demonstrating too much DNA present. This indicates that whole cell samples were not 
performing optimally. 
 
The ability to sequence single cells would be of great benefit to forensic analysis since 
one of the key issues with mtDNA typing is the inability to resolve mixture samples.  
Therefore future work should be done to investigate different extraction methodologies 
so that LMD can be compatible with sequencing chemistries. 
 
6.3.3 Whole genome amplification of DNA dilutions 
This study also aimed to examine the ability of WGA techniques to amplify low 
template mitochondrial DNA for sequencing. Initially, 10pg samples were amplified in 
duplicate with two WGA kits, the GenomiPhi V2 DNA Amplification Kit and the AT 
Kit, which target nuclear and mitochondrial DNA. WGA reactions were diluted 1:100 
and 1µl used for HV1 cycle sequencing. As shown in Table 6.6, all 10pg samples from 
both kits produced complete profiles of high quality.  
 
Table 6.6 Sequence quality of LTDNA after whole genome amplification 
Sample HV1 Sequence Quality 
10pg with GenomiPhi: 1: ++ 
       2: ++ 
10pg with AT: 1: ++ 
 2: ++ 
++ Complete, good quality sequence 
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The REPLI-g Mitochondrial DNA kit, which is a mitochondrial specific WGA 
(mtWGA) kit, was also examined. With this kit, low template DNA samples containing 
60pg/µl, 30pg/µl, 12pg/µl, 6pg/µl, 1pg/µl, 0.1pg/µl, 0.05pg/µl and 0.01pg/µl were 
amplified in duplicate, with 1µl of each used for HV1 analysis. Amplified samples from 
60pg to 6pg of starting template were diluted 1:1000 as per manufacturer‘s instructions 
for cycle sequencing while mtWGA samples from 1pg to 0.01pg starting template were 
diluted 1:100. As shown in Table 6.7, both 60pg, 30pg and 12pg samples produced over 
amplified sequences, indicating that a higher dilution factor was required. When only 
6pg was used as starting template for mtWGA, one reaction produced a good quality 
profile while the other produced a sub-optimal quality profile, indicating that, while the 
mtWGA had been successful, at this level samples should not be too diluted prior to 
sequencing. Only one of the 1pg samples produced a complete sequence, and all 0.1pg, 
0.05pg and 0.01pg samples were unsuccessful. This suggests that the mtWGA reaction 
was not successful, rather than the 1:100 dilution being too high, since mtDNA 
sequences could be obtained from these samples without WGA. If the WGA reaction 
was successful there should have been sufficient product in the dilution for sequencing. 
Overall, these results are promising, in that high quantities of amplifiable mtDNA 
template are being generated from as little as 1pg of genomic DNA with the REPLI-g 
Mitochondrial DNA kit. This is especially notable considering the recommended 
genomic DNA input for the mtWGA kit is 10ng.  
 
6.3.4 Whole genome amplification of LMD cells 
The mtWGA kit was also used with two of each 1-, 2- 5- and 10-cell samples. However, 
as shown in Table 6.7, all but one 10-cell sample were unsuccessful. The results are not 
surprising considering WGA of LMD cells was not previously successful (See Chapter 
5, Section 5.3.4). As suggested in Section 5.3.4 the failure of the WGA could be due to 
poor extraction or inhibitors not being removed through the extraction and subsequent 
dilution steps that genomic DNA was subjected to. 
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Table 6.7 Sequence quality of LTDNA and laser microdissected cells after mitochondrial 
whole genome amplification 
 
Sample Trial 1 Trial 2 
60pg xs xs 
30pg xs xs 
12pg ++ xs 
6pg + ++ 
1pg ++ - 
0.1pg - - 
0.05pg - - 
0.01pg - - 
10 Cells xs - 
5 Cells - - 
2 Cells - - 
1 Cell - - 
xs Over amplified sequence, ++ Complete, good quality sequence, + Sub-optimal quality sequence, - 
Unsuccessful amplification. 
 
 
The ability to produce large quantities of mtDNA template would be of great benefit in 
forensic analysis, particularly in relation to emerging sequencing technologies. 
Massively parallel sequencing platforms are now able to sequence the entire 
mitochondrial genome in a single reaction [165-167].  Since another of the key 
challenges associated with mtDNA sequencing is the relatively low power of 
discrimination compared to traditional STR analysis, the ability to sequence the entire 
genome would give more information for forensic identification purposes.  However, 
such technologies require a starting template of 1-5ng genomic DNA for an initial long-
range PCR, with 100ng of the PCR product needed for the sequencing reaction [178].  
Low template DNA samples would therefore not be ideal for these purposes unless a 
technique such as WGA could be used to amplify the template prior to sequencing.  
Results presented here suggest that either traditional WGA kits or mitochondrial 
specific WGA kits could be used for such purposes. 
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6.4 Conclusion 
In conclusion these results have confirmed that low template DNA samples containing 
as little 0.1pg to 0.01pg genomic DNA can be successfully used for mitochondrial DNA 
sequencing. The ability to perform mtDNA sequencing with minimal sample 
consumption could allow for additional testing to occur, such as tissue of origin 
determination, which could be of great importance for crime reconstruction. 
 
In this study, limited success was achieved when sequencing LMD cells. However this 
was likely due to the incompatibility of the alkaline lysis extraction technique with the 
sequencing chemistry. Future work should continue to explore other cell extraction 
methodologies for downstream mtDNA sequencing. The ability to amplify single cells 
would be of great benefit since it would be known that the resulting sequence originated 
from a single contributor.  
 
This study also showed that WGA techniques could be applied to low template samples 
for successful mtDNA sequencing. Samples containing as little as 10pg genomic DNA 
were successfully amplified with WGA kits that target both nuclear and mtDNA. After 
WGA, 1µl of a 1:100 dilution of the reaction contained sufficient mtDNA for HV1 
sequencing. Samples containing only 0.1pg genomic DNA amplified with a 
mitochondrial specific WGA kit also produced sufficient template in a 1:100 dilution 
for successful HV1 sequencing. Such results show promise for massively parallel 
sequencing technologies that can amplify the entire mtDNA genome in a single reaction 
but require higher starting template amounts. The application of mitochondrial WGA to 
LMD cells was generally unsuccessful in this study and should be another focus of 
future work.  
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CHAPTER 7 
 
GENERAL DISCUSSION AND CONCLUSIONS 
  
  
166 
 
7.1 Introduction 
Issues associated with LTDNA analysis have been well documented since the technique 
was initially proposed in the mid-1990s. However, until the Omagh Bombing trial in 
2007 there was limited challenge to the use of LCN for legal purposes. Concerns raised 
during this trial, and the subsequent brief suspension of the technique in the UK, 
brought LTDNA analysis into the spotlight. This project aimed to examine the current 
methods for LTDNA analysis and investigate strategies for improving the results that 
could be achieved with limited starting template. 
 
The most common method for genotyping LTDNA is the combined LCN and replicate 
analysis approach. Despite its widespread use, little empirical evidence has been 
provided to confirm that this method does indeed provide the most informative DNA 
profiles. Therefore, initial studies involved a direct comparison between consensus 
profiles derived from replicates of divided DNA samples with profiles obtained using 
the entire low template extract to determine which method gave the most information 
from the limited samples.  
 
Methods to increase the DNA yield prior to traditional STR analysis were also 
investigated.  Initial work examined a non-exponential Pre-PCR amplification that 
produced additional allele copies in each low template sample before undertaking 
traditional DNA typing methods. Various WGA kits were also examined to assess their 
ability to copy the entire LTDNA sample in a representative fashion. Modifications to 
the recommended WGA protocols were investigated to determine if allele recovery and 
balance could be improved.  
 
LMD was used to isolate single and small numbers of cells for forensic analysis. 
Various extraction and amplification methodologies were examined to determine 
optimal techniques for use with LMD cells. STR analysis was performed using both 
standard and LCN PCR techniques. Cell samples were also subjected to WGA prior to 
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STR analysis to determine if any could improvements could be made to the allele 
recovery and balance in the final profile.  
 
As an alternative to STR analysis, mtDNA control region sequencing was investigated 
as a method for LTDNA analysis. Initial sensitivity testing was performed to determine 
the lowest template amount needed to still produce a complete mtDNA HV1 and HV2 
sequence. Techniques previously investigated in this project including WGA and LMD 
were then combined for use with mtDNA sequencing. DNA dilutions were amplified 
with various WGA kits prior to sequencing. LMD cells, with and without WGA, were 
also used as template for the sequencing reaction. 
 
7.2 Analysis of current LTDNA profiling techniques 
Low template DNA samples containing 100pg or 25pg genomic DNA were amplified 
using the PowerPlex® ESI 16 kit with 30 or 34 PCR cycles.  100pg and 25pg DNA 
samples were then divided into three aliquots for a 34-cycle PCR. A consensus profile 
was derived that included alleles that appeared in at least two of the replicates. Profiles 
from the non-split samples were compared to the consensus profiles focusing on peak 
heights, allele drop out, locus drop out and allele drop in to determine which technique 
provided the most informative STR profiles. 
 
Results from this study demonstrated that performing standard 30-cycle STR typing on 
non-split DNA extracts produced profiles with a higher percentage of total loci 
compared with the consensus profiling technique. Increasing the number of PCR cycles 
further improved the sensitivity of the reaction, with reduced allele and locus dropout 
seen for both template amounts compared to both standard-cycle single-reaction profiles 
and consensus profiles. However, profiles from samples containing 100pg genomic 
DNA – a template amount on the upper limits of what would be considered low 
template DNA – contained increased levels of additional alleles, either drop in or 
stutter. This indicates that increasing the number of PCR cycles to this degree may not 
actually benefit such samples if a single reaction, rather than replicate analysis, is to be 
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performed. However, since some allele drop out still occurred in profiles from 100pg 
amplified with the standard cycle number, there may be some advantage to increased 
cycle amplification, but perhaps fewer than 34 cycles would be preferable.   
 
Allele drop in was eliminated using the consensus profiling method for both starting 
template amounts. This has important implications for casework, where errors in the 
profile interpretation could then lead to false inclusion or exclusion of suspects, or false 
matches if the profile is subjected to a database search. However, since all additional 
alleles occurred at heterozygous loci that also showed both correct alleles or were well 
under a typical peak height ratio threshold of 60% to 70%, these alleles would be 
interpreted with caution before being attributed to the final profile for a single source 
profile. All other measures of profile quality were improved when the sample was 
amplified as a whole, with consensus profiling resulting in the least informative profiles 
due to increased allele or locus drop out. Replicate analysis also produced more 
‗incorrect‘ alleles in the individual profiles used to obtain the consensus profile as a 
result of increased stutter.  
 
Overall these results indicate that a single standard cycle PCR on the entire sample will 
produce the most complete profiles when at least 100pg of starting template are 
available for amplification. When only 25pg of template are available, it would be 
beneficial to amplify the entire extract with an increased cycle PCR in terms of 
acquiring a profile with the most information possible. However, since allele and locus 
drop out and allele drop in can still occur when a low template DNA sample is 
amplified in a single reaction, a robust statistical analysis model that takes the stochastic 
effects into consideration must be applied to the data. Statistical tools are being 
developed that may accommodate issues such as drop in and drop out and these have 
been implemented in some laboratories [56-61]. Applying such tools to the DNA profile 
that contains the most information should maximise the evidence. 
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7.3 Improving DNA yield prior to STR analysis 
Two studies were performed to determine if additional starting template could be 
generated to improve results achieved by traditional STR analysis. In the first study a 
novel Pre-PCR linear amplification was investigated. The second study involved an 
analysis of commercial and novel WGA kits using recommended and modified 
protocols.  
 
7.3.1 Linear Pre-PCR amplification of LTDNA 
Low template DNA samples of 100pg, 50pg, 25pg, 12.5pg and 6.25pg were divided 
into two aliquots. One aliquot was used as template for a PCR using only the forward 
primer for a single locus, or a primer mix containing all forward primers for loci 
targeted in the PowerPlex® ESI 16 kit. The remaining aliquot was amplified with the 
reverse primer for the same single locus or a primer mix containing all reverse primers 
for PowerPlex® ESI 16 loci. This Pre-PCR amplification was performed using either 10 
or 20 cycles. Forward and reverse amplification products were then pooled for use in a 
standard PCR with the single locus primer pair or PowerPlex® ESI 16 kit Primer Mix. 
The proposition was that the forward or reverse primer reactions would result in a linear 
amplification, where a single copy of the targeted allele(s) would be produced with each 
cycle, rather than the exponential amplification of traditional PCR, and as such should 
not introduce the same degree of stochastic effects.  With additional template copies, 
STR results may show improved allele recovery without the exacerbated stochastic 
effects commonly seen with LCN DNA analysis. 
 
Overall this research demonstrated that improved STR profiles from samples with low 
levels of template can be obtained using Pre-PCR amplification prior to a single locus 
or multiplex PCR.  The 20-cycle Pre-PCR generally provided the highest percentage of 
profiles with both alleles for the single locus reactions, with all 100pg and 50pg profiles 
displaying the correct genotype. In the multiplex experiments the 10- and 20-cycle Pre-
PCR produced STR profiles with all loci correct in the 100pg samples only. Below this 
template amount, while there was an increase in allele recovery overall with the Pre-
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PCR, none of the control, 10- or 20-cycle Pre-PCR samples showed the complete 
multiplex STR profile.    
 
Despite the increase in allele recovery the peak height ratios for the Pre-PCR amplified 
samples were not considerably different compared with control samples using the 
higher starting template amounts (100pg and 50pg in the single locus experiments, and 
100pg, 50pg and 25pg in the multiplex experiments). This indicates that the linear 
amplification of the Pre-PCR increased the number of template copies available for the 
PCR without introducing substantial amplification bias for these template amounts.  
Results were more variable in terms of allele recovery and peak height balance with the 
lower starting template amounts, indicating that, at least when limited to 20 cycles, the 
Pre-PCR procedure is not sufficient to improve the number of template copies for the 
PCR amplification for such low level samples. 
 
The multiplex results have the most implications for forensic case work as multiplex 
STR profiling is the primary method used for human identification. As such 
improvements would have to be made before any such procedure could be 
implemented. In these experiments, only half of the first-round Pre-PCR product was 
used as the template for the second-round PCR. While this still showed improved allele 
recovery, results may be further improved if the entire first round PCR product could be 
used. Future work could therefore involve further reduction of the volume of the first-
round Pre-PCR or increasing the volume of the second round PCR so that all of the 
possible template could be used for the second PCR amplification. Further 
improvements may also be seen with an increase in the number of Pre-PCR cycles. The 
linear amplification of the Pre-PCR step did not introduce further stochastic variation 
compared to samples amplified without Pre-PCR processing when 20 Pre-PCR cycles 
were used. This bodes well for the possibility for the use of a greater number of Pre-
PCR cycles for very low levels of template. 
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7.3.2 Whole genome amplification 
 The study of WGA techniques was performed as two sets of experiments. In the initial 
set of experiments LTDNA samples were amplified with the GenomiPhi V2 DNA 
amplification kit using the standard protocol and modified protocols to determine if any 
improvements could be made to the efficiency of the reaction. After these initial 
experiments were complete, a novel WGA chemistry, called the AT kit, was provided 
for comparison to the GenomiPhi kit and the REPLI-g Mini kit. Modifications to the AT 
kit protocol were also assessed to determine if improved amplification efficiency could 
be achieve. Mixture samples were also analysed with the AT kit to determine if this 
WGA kit could assist in the recovery of low level contributors 
 
Results from the initial set of experiments showed that the greatest allele recovery was 
achieved when LTDNA samples were amplified using the standard GenomiPhi protocol 
prior to STR analysis.  Of the modified protocols, the Cycling protocol came closest to 
the standard protocol, with more correct alleles recovered compared to STR profiles 
from low template samples that did not undergo prior WGA. The Split and Pool and 
Half Denatured protocols showed significantly lower allele recovery across all 
examined starting template amounts compared to the standard and Cycling protocols, 
with the Split and Pool protocol generally showing the lowest efficiency of the methods.  
Across all low template amounts the Split and Pool protocol consistently showed less 
alleles recovered compared to samples that did not undergo prior WGA.  
 
WGA reactions in the initial set of experiments were not quantified after amplification. 
Instead a blanket 1:100 dilution was applied to all WGA samples and 1µl of this 
dilution was used for STR analysis. The pronounced drop out and allele imbalance in 
the STR profiles from Split and Pool and Half Denatured reactions indicate that these 
two methods produced less amplification product compared to the standard and Cycling 
protocols. Consequently, the high dilution of the amplification product returned the 
samples to low template levels, resulting in increased stochastic variation in the STR 
profiles. It was therefore necessary to quantify all WGA samples prior to STR profiling 
to ensure the optimum amount of starting template is used so that any WGA bias may 
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be assessed without the additional complication of LTDNA associated stochastic 
effects. 
 
In the second set of experiments, all WGA samples were quantified prior to STR 
analysis. Overall, quantification results showed that the novel AT kit produced the 
lowest amount of WGA product when LTDNA was used as the starting template. It was 
surprising then that STR analysis of the WGA products showed allele recovery and 
peak height ratios were highest in the AT amplified samples, followed by the REPLI-g 
kit then the GenomiPhi kit. This indicates that, despite the low quantification results, the 
AT kit is amplifying the LTDNA in the most representative fashion. However, all three 
chemistries allowed for significantly more alleles to be recovered compared to LTDNA 
samples that did not undergo WGA prior to STR analysis. Despite having the best 
results of the three kits, drop out still occurred with the AT kit when less than 50pg of 
DNA was used as the starting template and significant allele imbalance was seen in 
some loci. Such stochastic variation can make STR profile interpretation difficult, and 
therefore further improvement is needed before this WGA procedure could be routinely 
implemented into the forensic DNA analysis workflow for casework. 
 
Modifications to the AT protocol showed varying results. The Cycling protocol samples 
consistently showed reduced allele recovery and PHRs compared the standard protocol. 
However, the Split and Pool Protocol showed equal or slightly higher allele recovery 
and similar PHRs compared to the standard protocol. This result is surprising 
considering that the Split and Pool protocol showed the worst results of the examined 
protocols in the first set of experiments. However, this gives weight to the notion the 
high dilution used in the first set of experiments contributed significantly to the poor 
STR profiles, rather than the WGA protocol introducing a high level of amplification 
bias alone. The slight increase in allele recovery seen in the 10pg starting template 
amplified with the Split and Pool protocol is promising, suggesting that dividing the 
reaction allowed for the small amount of template in each aliquot to be amplified in a 
more representative fashion than would be if the reaction was kept whole for 
amplification. However, as with the standard protocol samples, since stochastic 
variation was present in the Split and Pool WGA STR profiles, even if it was at reduced 
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levels, further improvements are necessary before implementation into routine 
casework.  
 
WGA of mixture samples using the AT kit showed increased alleles recovered when 
both contributors were at equal low template levels compared to samples without prior 
WGA. However, when the mixture samples contained unequal contributions from 
donors, the WGA reaction preferentially amplified the DNA from the major contributor 
resulting in a reduced number of minor contributor alleles recovered. This indicates that 
while WGA may be useful for single source samples or low template mixed samples 
where donors contribute equal amounts of DNA to the sample, it is not the preferred 
analysis option for mixtures with major and minor contributors.  
 
7.4 Low copy analysis of intact cells  
LMD was used to isolate single and small numbers of buccal cells for use as template 
for forensic STR analysis. Compared to previous studies on isolated cells, these results 
show that improved results can be achieved by using recently developed higher 
sensitivity STR chemistries combined with single tube extraction methodologies. This 
study showed that complete STR profiles can be obtained from as little as 10 cells using 
the manufacturer‘s recommended protocol or 5 cells when amplified with an increased 
cycle PCR. Increasing the number of cycles did not appear to significantly affect the 
allele balance in the profiles, with similar peak height ratio averages obtained for the 
standard and increased cycle profiles.  
 
DNA dilutions containing the equivalent template amount to the LMD cell samples 
were also analysed. This was done to determine if the intact cell samples were 
amplifying in the same manner as DNA dilutions. Results showed that overall allele 
recovery was higher in DNA dilutions across all template amounts with 30 and 34 PCR 
cycles compared to cell samples. Cell samples contain a known number of genome 
copies, whereas the dilutions contain an estimated genomic DNA amount based on the 
quantification of a high template sample. This estimation could be higher or lower than 
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the actual amount contained in the sample depending on the accuracy of the 
quantification. However, the higher allele recovery in the DNA dilutions is likely not 
solely the result of inaccurate quantification. Complete amplification failure was seen in 
1-, 2- and 5-cell samples amplified with both 30 and 34 PCR cycles, indicating that 
either the extraction method is not disrupting the cells sufficiently for STR analysis, or a 
component of the cells themselves or chemicals involved in the extraction could be 
inhibiting the success of the reaction.  
 
WGA of the cell samples was largely unsuccessful in this study despite the numerous 
extraction methodologies investigated. This is likely due to an inhibitory component in 
the cells or an inability of the examined extraction methods to disrupt the cells and 
denature the DNA sufficiently for use with the AT WGA kit. Further work would need 
to focus on improving the compatibility of LMD and WGA, with particular focus on 
developing an efficient DNA extraction methodology. The ability to successfully 
amplify the entire genome of a single cell in a representative fashion would be a great 
benefit for forensic purposes, where template amounts can often be limited.  Such 
techniques would also be of benefit to other scientific fields, such as preimplantation 
genetic diagnosis or oncogenetics, where numerous tests can often be required from 
minute or precious samples. 
 
7.5 Alternative markers for LTDNA analysis 
Human identification by mtDNA analysis has been routinely used for challenging 
biological samples that would typically fail with traditional STR analysis due to the 
limited quantity or quality of the genomic DNA. In this study serial dilutions of 
genomic DNA were examined to determine the limit of detection of the sequencing 
procedure. WGA techniques were investigated, with kits targeting both nuclear DNA 
and mtDNA, as well a kit that specifically amplifies mtDNA only to be applied to low 
template samples prior to sequencing. Mitochondrial sequencing was performed on 
samples containing various numbers of LMD cells to determine the compatibility of 
LMD and mtDNA sequencing. WGA that specifically targets the mtDNA was also 
applied to LMD cells prior to sequencing. 
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Results from this study demonstrated that low template DNA samples containing as 
little 0.1pg to 0.01pg of genomic DNA can be successfully used for mitochondrial DNA 
sequencing. The ability to perform mtDNA sequencing with minimal sample 
consumption could allow for additional testing to occur, such as tissue of origin 
determination. This would be of great benefit since determining the tissue source can be 
of critical importance for crime reconstruction.  
 
Limited success was achieved when sequencing laser microdissected cells. This was 
likely due to the incompatibility of the extraction technique used with the sequencing 
chemistry. Future work should continue to explore this avenue. Since one of the key 
issues with mtDNA sequencing is the inability to resolve mixture samples the ability to 
amplify single cells would be of great benefit because it would be known that the 
resulting sequence originated from a single contributor.  
 
This study also showed that WGA techniques could be applied to low template samples 
for successful mtDNA sequencing. Samples containing as little as 10pg genomic DNA 
were successfully amplified with WGA kits that target both nuclear and mtDNA. After 
WGA, 1µl of a 1:100 dilution of the reaction contained sufficient mtDNA for complete 
HV1 sequencing. Samples containing only 0.1pg genomic DNA amplified with a 
mitochondrial specific WGA kit also produced sufficient template in a 1:100 dilution 
for successful HV1 sequencing. The success of WGA for mtDNA is likely due to its 
structure and inheritance pattern. Mitochondrial DNA is circular, which would be a 
benefit for MDA since this was originally designed as a Rolling Circle Amplification 
for use on circularized DNA probes [116]. Furthermore, since mtDNA is inherited as a 
single haplotype, issues surrounding heterozygote balance are avoided. 
 
Mitochondrial DNA sequencing is often avoided for various reasons. One such reason is 
the generally lower power of discrimination compared to traditional STR analysis. 
Statistical analysis to determine the frequency of an mtDNA type in a population is 
often limited to the ―counting method‖, where the number of times a particular type has 
been observed in various databases is presented [150].  The frequency is therefore 
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limited by the size of the database(s) used for comparison. However, despite the lower 
power of discrimination for individual identification, this study has shown that more 
complete information can be gained from sequencing results compared to STR results 
from the same amount of LTDNA. Therefore, depending on the starting template 
amount available for analysis and the size of comparison databases, the mtDNA 
frequency determined by the counting method could potentially be more discriminating 
than a statistic conferring rarity of a partial STR profile. 
 
The time and cost associated with mtDNA sequencing is also often noted as a reason to 
avoid the technique. However standard Sanger-type sequencing uses the same 
equipment as traditional DNA profiling. Furthermore new mtDNA sequencing 
chemistries such as those used in this study allow for the reactions to be performed in 
the same plate for PCR, cycle sequencing, purification and electrophoresis, resulting in 
a processing time not unlike STR analysis. Another issue with mtDNA is the potential 
for contamination. However, many of the necessary anti-contamination procedures such 
as dedicated laboratory areas for pre-and post-PCR work and use of single use lab coats, 
gloves, masks and caps are already in use in many forensic laboratories.  Furthermore, if 
a laboratory is to dedicate areas for LTDNA work, then this space would be equally 
compatible with mtDNA analysis. 
 
Results presented here also show promise for emerging massively parallel sequencing 
technologies. Such technologies can amplify the entire mtDNA genome on a single chip 
but require higher starting template amounts than traditional sequencing. In this study 
extremely low template DNA was successfully amplified with an mtDNA specific 
WGA kit, and this amplification product is potentially a viable sample type for 
emerging sequencing techniques. 
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7.6 Future directions 
Genotyping of low template DNA will likely continue to be a desire of police and 
forensic service providers. Therefore efforts must be made to ensure that the methods 
used to analyse LTDNA are reliable and provide the most information possible. It is 
unlikely that laboratories currently practicing LCN with replicate analysis will 
discontinue these methods since repetition is used to justify reliability, despite the 
replicates producing different DNA profile results. However, it is worth considering the 
loss of information that occurs when an already low template sample is divided for 
amplification and the additional information that can be gained if a LTDNA sample is 
amplified in a single reaction. The introduction of statistical software that 
accommodates stochastic variation into forensic laboratories is a positive development. 
The use of such tools could be maximised by applying them to the most informative 
profile that can be achieved from the limited template sample. It is of note that the 
software interpretation tools analyse a single, not a consensus, profile and the analysis 
of LTDNA in one reaction therefore seems desirable. 
 
The ability to genotype single or small numbers of whole cells would be of great benefit 
for forensic investigation. Using LMD to isolate specific cells can, in certain 
circumstances, eliminate issues with mixture analysis and interpretation. However, the 
currently available STR chemistries are not able to amplify a single cell so that all loci 
are represented completely in the DNA profile. Therefore, either a more robust STR 
chemistry must be developed or a method to first increase the allele copies or the entire 
genome is required for successful STR typing. The linear Pre-PCR amplification 
presented in the thesis shows promising results that could be developed for single cell 
analysis. Efforts should also be made to develop extraction techniques for single or 
small numbers of intact cell that can accommodate the volume necessary for LMD 
collection and are compatible with WGA. Emerging WGA chemistries must also be 
optimised for single cell analysis to eliminate the amplification bias that occurs with 
most current WGA methods. 
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Whole mitochondrial genome sequencing using massively parallel sequencing 
technologies is another promising area for investigation. Amplification of limited 
template using mtDNA specific WGA could enable LTDNA to become a viable sample 
type for whole genome sequencing. Sequencing the entire mtDNA genome as opposed 
to the control region alone would provide significantly more information for human 
identification, and would therefore make mtDNA a sound alternative to traditional 
autosomal STR analysis.  
 
7.7 Final conclusions 
The overall aim of this research was to examine the current methods of LTDNA 
analysis and investigate methods which could produce improved results for human 
identification from samples with a limited starting template. A comparison of consensus 
profiles to profiles obtained using the entire LTDNA samples in a single reaction was 
performed. Methods to increase the DNA yield prior to STR analysis were investigated. 
LMD was examined as a potential collection method for single and small numbers of 
cells to be used as template for STR analysis. Mitochondrial sequencing was also 
investigated as an alternative to traditional autosomal STR profiling for human 
identification from LTDNA. 
 
The specific outcomes of this thesis were: 
1. Direct comparison of consensus STR profiles with profiles from non-split 
samples demonstrated that a considerable loss of information occurred when 
LTDNA was divided for amplification 
2. Applying a linear Pre-PCR amplification to low template samples improved 
STR profile results in both single locus and multiplex reactions.  
3. A novel WGA kit provided by GE Healthcare was shown to amplify LTDNA in 
a manner that produced superior STR results compared to currently available 
commercial kits. 
4. Real time PCR quantification of WGA products was shown to be problematic. 
Using a qPCR primer for a region located close to the centromere provided an 
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under-estimated quantification value, resulting in excess template being added to 
the STR reaction. 
5. Splitting a WGA reaction prior to amplification then pooling the aliquots for 
STR analysis showed slightly improved profiles compared to a single 
amplification of the entire reaction. 
6. WGA with the novel AT kit allowed for increased allele recovery in low 
template two-person mixture samples when both parties provided equal 
contributions to the mixture.  WGA of samples where parties have provided 
major and minor contributions to the mixture resulted in preferential 
amplification of the major contributor. 
7. LMD was successfully performed to isolate single and small numbers of buccal 
cells. 
8. Extraction of LMD cells using the One Tube method followed by amplification 
with the PowerPlex® ESI 16 STR kit using standard and LCN cycling 
conditions showed some success. Complete STR profiles were obtained with 10 
cells using standard cycling conditions or 5 cells using LCN cycling. 
9. None of the examined extraction methodologies used for cellular disruption of 
LMD samples (the One Tube method, alkaline lysis, heat denaturation and spin 
column extraction) were compatible with whole genome amplification using the 
AT kit. 
10. Mitochondrial control region sequencing was performed using as little as 0.01pg 
to 0.1pg genomic DNA. 
11. WGA of 10pg genomic DNA using the GenomiPhi and AT kits allowed for 
successful mtDNA control region sequencing from 1µl of a 1:100 dilution of the 
WGA product. 
12. Whole genome amplification of 1-6pg genomic DNA using a mtDNA specific 
WGA kit – the REPLI-g Mitochondrial DNA kit – allowed for successful 
mtDNA control region sequencing from 1µl of a 1:100 dilution (1pg starting 
template) or 1:1000 dilution (6pg starting template) of the WGA product.  
13. Mitochondrial control region sequencing of LMD cells showed limited success. 
Prior amplification of LMD cells with the mtDNA specific WGA kit did not 
improve mtDNA control region sequencing. Such results are likely due to 
inefficient extraction techniques or inherent inhibitors in the samples. 
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7.8 Summary 
In conclusion this work has shown that improvements can be made to current LTDNA 
analysis techniques to provide additional information to stakeholders for forensic 
investigation or legal purposes. Simply concentrating a LTDNA sample for 
amplification can provide a considerable amount of additional information compared to 
replicate analysis methods. Implementation of WGA or linear Pre-PCR amplification 
can increase the amount of template available for traditional STR analysis. However, 
some stochastic variation is still observed with these techniques therefore further 
improvement is still necessary.  
 
Difficulties with mixture analysis can be avoided if LMD is implemented to isolate 
single cells for analysis. WGA of single cells would allow for immortalisation of the 
genome so that numerous reactions could be performed. However optimised extraction 
methodologies must be developed to ensure that LMD cells can be successfully 
amplified with WGA chemistries.  
 
Mitochondrial DNA control region sequencing can be successfully performed using 
substantially less starting template than traditional autosomal STR analysis. Frequency 
estimates of mtDNA haplotypes may not be as discriminating as rarity statistics 
provided for complete STR profiles. However, depending on the size of the mtDNA 
database(s) used for comparison, a complete mtDNA sequence could potentially be 
more discriminating than a partial STR profile obtained from limited stating template. 
Whole mtDNA genome sequencing using massively parallel sequencing would provide 
considerably more information than control region sequencing. Mitochondrial WGA 
could allow for LTDNA to become a viable sample type for such emerging 
technologies.    
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